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ABSTRACT 
BIOCHEMICAL AND STRUCTURAL STUDIES OF HUMAN 
METHIONINE SYNTHASE REDUCTASE 
         Human methionine synthase reductase (MSR) is a 78-kDa diflavin enzyme 
involved in folate and methionine metabolism. It regenerates the cofactor of 
methionine synthase (MS), from cob(II), to the active cob (I) form in MS. MSR and 
one of its FAD/NADPH binding domains were cloned and expressed as GST fusion 
proteins in Escherichia coli. Two expression plasmids for full-length MSR, which 
contain a N-terminal GST tag and a C-terminal (His)6 tag, were constructed and 
validated by sequencing and restriction enzyme digestion and successfully expressed 
in E. coli and Pichia pastoris. Subsequently, crystals of the FAD/NADPH binding 
domain of MSR that diffracted to 1.9 Ă, both with and without NADP+- were 
produced and the crystal structures were solved by molecular replacement methods. 
In addition, the activation domain of human MS was expressed in E. coli and purified 
and the crystallization conditions were determined. Based on structural information, 
site-directed mutagenesis of the two positions Asp
652
 and Trp
697
 of MSR was 
performed. The variants D652A, D652R and D652N of the FAD/NADPH binding 
domain of MSR and the variants D652A, D652R, D652N, W696A and W697H of 
the full-length MSR were cloned and expressed in BL21 E. coli cells. These variants 
of MSR were purified by affinity chromatography, anion exchange chromatography 
and gel filtration chromatography. The kinetic properties of these variants of MSR 
were investigated using steady-state kinetic studies, steady-state inhibition studies, 
stopped-flow pre steady-state kinetic and redox potential studies. Compared with the 
data for the wild type MSR, the turnover number of the variants all decreased, the 
catalytic ability became lower and the midpoint potential of the cofactor FAD shifted 
to a more positive potential. Both 2‘5-ADP and NADP+ were competitive inhibitors 
for variants of MSR. However, 2‘5‘-ADP was a relatively stronger inhibitor than 
NADP
+
. All the data on variants of MSR suggested the Asp
652 
and Trp
697
 residues are 
important structural and functional determinants in MSR, in particular related to 
coenzyme binding and hydride transfer. To examine their dynamic properties, EPR, 
ENDOR and ESEEM were used to investigate the existence of the semiquinone 
flavin cofactors, FAD and FMN, and the hyperfine coupling arising from the 
interaction of some nuclei with the unpaired electron spin. ELDOR spectroscopy was 
applied to measure the distance between the FAD and FMN in MSR following the 
binding of 2‘, 5‘-ADP, NADP and the activation domain of MS to further analyse 
conformational properties of MSR in solution. 
The University of Manchester 
Xiaodong Lou 
Doctor of Philosophy 
30.09.2010 
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1.1. General aims of this project 
In this section a brief overview of the general aims of the project is given prior 
to reviewing the background literature that supports the research project. The overall 
aim of the research programme was to develop more detailed understanding of the 
thermodynamic, structural and kinetic properties of two key human enzymes 
involved in methionine biosynthesis, methionine synthase reductase (MSR) and its 
protein partner methionine synthase (MS).     
In the case of MSR, a reductionist approach was taken by studying the 
properties of the wild-type full length MSR enzyme the wild type isolated 
FAD/NADP-binding domain of MSR (residues from 163 to 698) [1], and selected 
mutants of MSR (full length and FAD/NADP-binding domain). The variants of  
MSR that were studied include mutants of the FAD/NADP-binding domain of MSR 
D652A, D652R, D652N and the mutants of the full-length MSR D652A, D652R, 
D652N, W697A and W697H, each designed to study protein interactions and 
function of the natural coenzyme (NADPH) binding site in MSR. Studies with MS 
focused on its activation domain (AD) which comprises residues 925 to 1265 [2]. 
The advantage of working with the isolated domains is that the spectral changes 
associated with individual cofactors (FAD or FMN) can be used to illustrate redox 
changes of one flavin cofactor without interference from other cofactors. Rapid 
kinetic methods can also be used to accurately follow the electron transfer reactions 
involving these flavin cofactors. In this project, both MSR and MS were available as 
recombinant proteins and expressed in E. coli or methylotrophic yeast cells (Pichia 
pastoris). A key aspect of this study is the purification, crystallization, structure 
determination and functional analysis of the FAD/NADP-binding domain of human 
MSR.  
14 
 
Purification of the FAD/NADP-binding domain of MSR was carried out by 
affinity chromatography and anion exchange chromatography to facilitate 
crystallization. The structure of the protein at 1.9 Å resolution was determined using 
crystals grown from the purified FAD/NADP-binding domain of MSR [3]. The 
structure was solved via the molecular replacement method [4]. Based on this 
structure, variants of the FAD/NADP-binding domains and full length MSR were 
prepared containing alterations at the positions of residues Asp
652
 and Trp
697
 in wild-
type protein to study interactions with NADPH. Changes in the steady-state turnover 
properties, pre-steady-state kinetic behaviour, substrate specificity and redox 
potentials of the flavin cofactors of the mutants were analysed and compared with 
the wild-type protein.  
Electron paramagnetic resonance (EPR) spectroscopy was also used to identify 
and characterise the radical states of the cofactors (semiquinone FAD and 
semiquinone FMN) [5]. Electron spin echo envelope modulation (ESEEM) 
spectroscopy [6] and electron nuclear double resonance (ENDOR) spectroscopy [7] 
were also employed to identify hyperfine couplings between the nuclei and unpaired 
electrons in the flavin semiquinone moieties. Finally, pulsed electron electron double 
resonance (ELDOR) spectroscopy [7] was used to measure the distance between the 
two unpaired electrons in the flavin semiquinones in the reduced MSR and to 
demonstrate the dynamic nature of the MSR protein. Combined, the results of these 
analytical techniques were used to illustrate a mechanism of electron transfer that 
involves ‗conformational sampling‘ i.e. domain motion similar to that seen in other 
dynamic proteins such as human cytochrome P450 reductase [8]. 
  In the case of MS, the purification and crystallization of the wild-type 
activation domain of MS is reported. This was performed to initiate structural studies 
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of the MS-MSR protein complex. The purification procedure and crystallization 
conditions reported should enable future studies aimed at co-crystallisation of these 
proteins for structural determination 
Collectively, the work described in this thesis has provided more in-depth 
understanding of the electron transfer mechanisms and dynamics in the MSR-MS 
protein complex and makes a significant contribution to our knowledge of this 
complex redox system.  
Prior to more in depth discussion of the MS-MSR system, the general role of 
organic and inorganic cofactors in biology is discussed (Section 1.2). This section is 
followed by a brief overview of the chemistry and biology of flavin-dependent 
systems (Section 1.3).  
1.2 Cofactors in biology 
A cofactor is a non-protein chemical compound bound to a protein [9]. Most 
cofactors are associated with enzymes and they are required for the biological 
activity of the protein. Generally, they can be divided in two groups: organic 
cofactors [10] (such as flavin and heme) and inorganic cofactors [11] (such as the 
metal ions Mg
2+
 and Cu
2+
).  Typically, most organic cofactors are small organic 
molecules, less than 1000 Da in mass [12]. Those that bind tightly to the enzyme are 
called prosthetic groups [13] (e.g. flavins, cobalamin, heme); those more loosely 
bound to enzymes are termed coenzymes [14] (e.g. nicotinamide coenzymes). There 
is, however, no strict division between these two groups. Some common cofactors 
are listed in Table 1.1. Metal ions are the most common inorganic cofactors in 
enzymes [15]. In humans, they include iron [16], manganese [16], cobalt [16], 
copper [16], zinc [16], and selenium [16]. It is worth noting that calcium ions exist in 
many enzymes (e.g. nitric oxide synthase) [17]. Here calcium conformationally 
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activates the enzyme in its calmodulin complex. Calcium is generally considered as a 
cell signalling molecule rather than a cofactor.  
Name of ion inorganic cofactors Examples of enzymes containing ion  
cofactors 
Copper Cytochrome oxidase [18] 
Ferrous or ferric iron Catalase [19] 
Magnesium Glucose-6-phosphatase [20] 
Manganese Arginase [21] 
Molybdenum Nitrate reductase [22] 
Nickel Urease [23] 
Selenium Glutathione peroxidase [24] 
Zinc DNA polymerase [25] 
Table 1.1 Common inorganic cofactors found in biology and examples of 
enzyme systems in which they are found. 
 
Vitamins and derivatives Chemical group(s) 
transferred 
Distribution 
Cofactor Vitamin 
Thiamine 
pyrophosphate [26] 
Thiamine (B1) 2-carbon groups Bacteria, archaea 
and eukaryotes 
NAD
+
 and NADP
+ 
[27] 
Niacin (B3) Electrons/hydride 
ions 
Bacteria archaea 
and eukaryotes 
Pyridoxal phosphate 
[28] 
Pyridoxine(B6) Amino and carboxyl Bacteria archaea 
and eukaryotes 
Lipoamide [29] Lipoic acid Electrons, acyl 
groups 
Bacteria archaea 
and eukaryotes 
Cobalamin [30] Vitamin B12 Methyl groups, 
hydrogen, alkyl 
groups 
Bacteria archaea 
and eukaryotes 
Biotin [31] Biotin CO2 Bacteria archaea 
and eukaryotes 
Coenzyme A [32] Pantothenic 
acid(B5) 
Acetyl group Bacteria archaea 
and eukaryotes 
Flavin 
mononucleotide [33] 
Riboflvin (B2) Electrons Bacteria archaea 
and eukaryotes 
Flavin adenine 
Dinucleotide [33] 
Riboflavin (B2) Electrons Bacteria archaea 
and eukaryotes 
Coenzyme F420 [34] Riboflavin (B2) Electrons Bacteria archaea 
and eukaryotes 
Non-vitamins   
Adenosine triphosphate [35] Phosphate group Bacteria archaea 
and eukaryotes 
S-adenosyl methionine [36] Methyl group Bacteria archaea 
and eukaryotes 
Coenzyme B [37] Electrons Methanogens 
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Coenzyme M [38] Methyl group Methanogens 
Coenzyme Q [39] Electrons Bacteria archaea 
and eukaryotes 
Heme [40] Electrons Bacteria archaea 
and eukaryotes 
Glutathione [41] Electrons Bacteria archaea 
and eukaryotes 
Molybdopterin [42] Oxygen atom Bacteria archaea 
and eukaryotes 
Table 1.2 Examples of organic cofactors in biology, the chemical groups 
transferred and their distribution across organisms. 
 
Three organic cofactors, NADPH, flavin and cobalamin, deserve more detailed 
mention in relation to the work described in this thesis as they are present in MSR 
and MS. NADPH, FAD and FMN are required for the functioning of MSR and 
adenosylcobalamin is the cofactor found in MS. 
NADPH is the reduced form of nicotinamide adenine dinucleotide phosphate 
(NADP
+
). NADP
+ 
differs from NAD
+
 by an additional phosphate group at the 2‘ 
position of the ribose ring that carries the adenine moiety [43]. In plants, NADP
+ 
is 
reduced by ferredoxin-NADP
+
 reductase in the last step of the electron transfer chain 
of the light reaction of photosynthesis [44]. The reduced form, NADPH, acts as a 
reducing agent for the biosynthetic reactions in the Calvin cycle [45] and 
photosynthesis [46]. In animals, NADPH comes mainly from the oxidative phase of 
the pentose phosphate pathway [[47]. NADPH provides the reducing equivalents for 
biosynthetic reactions and oxidation-reductions involved in protection against 
reactive oxygen species. It also provides the reducing power for anabolic pathways, 
such as lipid synthesis [48]. NADPH is also responsible for generating free radicals 
in immune cells through the action of the enzyme NADPH oxidase, a complex 
flavin-dependent heme protein [49]. These radicals can be used to destroy pathogens 
in the respiratory burst. In addition, NADPH is the source of reducing equivalents 
for cytochrome P450 hydroxylation [50] of aromatic compounds [51], steroids [52], 
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alcohols [53] and drugs [54]. In MSR, NADPH binds to the enzyme to transfer 
hydride to cofactor FAD. These electrons are then transferred to FMN and ultimately 
onto MS as part of a natural re-activation process. 
 
 
Figure 1.1 The structure of cobalamin skeleton [55] 
          Cobalamin, the cofactor for MS, exists in a variety of enzymes. The structure 
of cobalamin was first solved in 1961 using crystallographic methods [56]. In the 
centre of the cobalamin structure is a Co atom covalently bound to four nitrogen 
atoms originating from a reduced tetrapyrrole (Figure 1.1). A characteristic feature 
of the corrin ring is its face up conformation and a nucleotide side chain links with 
the D part of the corrin ring. If this nucleotide side chain terminates at  
dimethylbenzimidazole, this cofactor is called cobalamins [55]; when this nucleotide 
side chain terminates at aminopropanol, this cofactor is cobinamides [55]. With any 
other nucleotides, all resulting cofactors are called cobamides [55]. The ligands, such 
as CH3
+
 and 5-deoxyadenosyl, coordinate to the upper position of the Co atom, to 
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generate methylcobalamin and adenosylcobalamin, respectively [55]. The cobalt in 
the cobalamin exists in three oxidation states, I II and III. Two of these states (I, III) 
always occur in the B12-dependent methyltransferase enzymes, such as corrinoid 
Fe/S protein [57], CoM methyltransferases [57, 58] and MS. In mammals, only two 
kinds of cobalamin-dependent enzymes exist, those being methyleneglutarate mutase 
[58] and MS. MS is the best characterised enzyme in this group. The cofactor of MS, 
cobalamin, receives a methyl group from methyltetrahydrofolate to form 
methylcobalamin, and then transfers this methyl group to homocysteine (see Section 
1.5). 
 
Figure 1.2 Chemical structure of vitamin B2 (riboflavin) and flavoprotein 
cofactors flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). 
The flavin precursor riboflavin is shown (on the left) with atomic numbering of the 
isoalloxazine tricyclic ring moiety and N10 bound ribityl chain. Phosphorylation of 
B2 at the 5‘-hydroxyl of the ribityl chain yields the cofactor FMN (on the right). 
FMN undergoes phosphoryladenylation to give the cofactor FAD (centre). 
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Flavin is an essential cofactor in flavoenzymes, such as CPR [59], MSR [60], 
and NOS [17]. The structure of riboflavin consists of an isoalloxazine ring and a 
ribityl side chain attached to the central N10 position on the pyrazine moiety (Figure 
1.2) [61]. When the riboflavin is phosphorylated by flavokinase at the 5-hydroxyl 
group, the cofactor is termed flavin mononucleotide (FMN). When the FMN is 
linked with an AMP group, the product is named flavin adenine dinucleotide (FAD). 
The isoalloxazine ring group in flavin usually serves as a reversible reduction-
oxidation catalyst in many biological redox reactions; the side chain is related to the 
binding of the flavin ring system to protein. In flavoproteins, both noncovalent 
binding of the flavin to protein and covalent binding to an amino acid residue via 8- 
or 6-position of the isoalloxazine ring system is found [61]. Flavin has important 
UV/visible absorption features with peaks at 360 nm and 450 nm in the oxidized 
form of flavin and the extinction coefficients for the FMN and FAD are 12,500 and 
11,300 M
-1
cm
-1
,
 
respectively [62]. With flavin bound to the protein moiety, these two 
extinction coefficients can range from 10,500 to 15,400 M
-1
cm
-1
 [61]. These 
absorption characteristics prove useful in studies of flavoproteins as the spectral 
properties change substantially on reduction to either the semiquinone (one electron 
reduced) or hydroquinone (two electron reduced) forms of the cofactor (Figure 1.3) 
[63]. Because flavin is an essential cofactor for the mechanisms of many enzymes, 
the observed spectral changes will show useful information on the reaction 
mechanism and the binding of substrates and products. The binding of substrate 
analogues and inhibitors can also be monitored by following the changes in the 
flavin absorption spectrum [63]. Also, the spectral properties are useful during the 
purification of flavoproteins, since they can be used to locate protein in purification 
fractions that contain the flavoprotein of interest. 
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Figure 1.3 The three redox states of the heterocyclic isoalloxazine ring system of 
flavin. 
An important property of flavin is that it can be reduced to a two electron 
reduced form (hydroquinone), and one electron reduced form (semiquinone) [63]. 
The flavin semiquinone can be protonated to form the neutral, blue semiquinone, or 
it can be deprotonated to form the anionic, red semiquinone. These two radical 
species can be distinguished by their UV-visible spectral properties: the neutral 
semiquinone radical has a characteristic long wavelength absorbance at 580-620 nm 
(ε = 4,000 M-1cm-1) while the anionic semiquinone radicals have a strong absorbance 
around 380 nm (ε = 16,000 M-1 cm -1) [63] and an additional sharp peak at 400 nm. It 
has been confirmed that the stabilisation of these radicals is related to the enzymatic 
function of the flavoprotein. Although flavin semiquinone exists in cationic, neutral 
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and anionic forms, only the neutral and anionic forms are found in flavoproteins 
[64]. The transient detection of flavin semiquinones in enzyme systems is a useful 
probe of the catalytic mechanisms of flavoproteins. Also, the type of flavin radical 
populated in enzymes is not only affected by the external factors, such as pH [64], 
but also by the binding of substrates, substrate analogues and inhibitors. Changes of 
the spectral features of flavin radicals in flavoprotein under different conditions can 
therefore provide some basic information about the reaction mechanisms of 
flavoproteins. 
Flavin enzymes are involved in a wide range of biological processes including 
redox catalysis [65], light emission [66] and DNA repair [67]. According to the 
functions of these flavoenzymes, they can be classified into several different groups: 
electron transferases [68], photolyases [69], synthases [70], dehydrogenases [71], 
disulpide reductases [72, 73], oxidases [75] and monooxygenases [74]. Most 
flavoenzymes contain a single FAD or FMN; but some such as CPR and NOS, 
which are related to MSR (the subject of this PhD thesis) contain both FAD and 
FMN, and belong to the same family, namely the diflavin reductases. 
1.3 Diflavin reductase enzymes 
1.3.1 The structure and function of the diflavin reductases family 
Diflavin reductases are enzymes that have emerged as a result of gene fusion 
of an ancestral NADP
+
-dependent ferredoxin reductase [75] and a flavodoxin [76]. 
The enzymes in this family contain tightly bound flavin cofactors, including a FAD 
group in the ferredoxin reductase module and FMN in the flavodoxin-like domain. In 
mammalian systems, this family includes the enzymes cytochrome P450 reductase 
(CPR) [77], the isoforms of nitric oxide synthase (NOS) [78], and the cytoplasmic 
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protein novel oxidoreductase 1 (NR1) [79] and MSR. Bacterial members of this 
family include flavocytochrome P450 BM3 (CYP102) [80] and sulphite reductase 
[81].  
The general catalytic function of these enzymes is to provide reducing 
equivalents from NAD(P)H via the flavin cofactors to the respective heme domains 
where a variety of redox reactions are carried out [82]. In the main, this involves 
reaction with molecular oxygen in the classical P450 enzymes [82] and the NOS 
enzymes [83], but also involves long range electron transfer to non-heme dependent 
centres such as cobalamin (the MSR-MS system).  The tightly bound cofactors FAD 
and FMN are intimately involved in the transfer of the reducing equivalents from 
nicotinamide coenzyme to either the heme domains (or alternative redox acceptors as 
in MS). In the first step of the reaction two electrons are transferred from NADPH to 
FAD as a hydride anion; these electrons are subsequently transferred from FAD 
hydroquinone to FMN in sequential one electron transfer reactions setting up a 
quasi-equilibrium of different reduced forms of the flavoprotein reductase (Figure 
1.9). These series of reactions are similar for all members of the family and have 
enabled detailed comparisons of the thermodynamics and kinetics of electron 
transfer in these systems [68]. Ultimately, FMN acts as the electron donor to 
downstream heme domains or alternative electron acceptors.  
A variety of natural and artificial electron acceptors can function with the 
reductases in this enzyme family. Ferricyanide and NADP
+
 can directly receive 
electrons from the reduced FAD cofactor through a series of one electron transfers 
(ferricyanide) or by formal hydride transfer (NADP
+
). The physiological electron 
acceptors [84] (e.g. P450 enzymes, heme oxygenase domains of NOS etc) accept 
electrons from the reduced FMN domain. Also the non physiological acceptors 
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dichlorophenolindophenol (DCPIP) [85], menadione [86] and cytochrome c [87], 
only receive electrons from the reduced FMN. Electron transfer in CPR occurs 
across protein molecules from the reductase to a separate heme-containing 
oxygenase domain [88]. By comparison, NOS is a self-sufficient enzyme with two 
major functional domains (reductase and oxygenase domains) fused into a single 
polypeptide chain [17]. Like CPR, MSR is a discrete reductase component and needs 
to interact with the separate cobalamin-bound MS component to transfer electrons 
[60]. Sulfite reductase consists of two subunits. The α-subunit is a 66-kDa FAD-
FMN-containing protein and the ß-unit contains siroheme and a Fe4S4 cluster. The 
flavoprotein subunits transfer electrons from NADPH to the heme catalytic site to 
finish the reduction of sulfite to sulphide [89]. 
 
Figure 1.4 Comparison of the domain architecture of diflavin reductase family.   
FAD/NADPH binding domain, Green; FMN binding domain, blue; the connecting 
domain, white; the N-terminal membrane anchor of CPR and NOS, yellow. This 
alignment indicated that the members of this family have similar structure, which 
consists of two different domains, one binds FMN and another binds FAD and 
NADPH. The FMN binding domain is located on N-terminal and homologous to 
flavodoxin, while the FAD/NADPH binding domain is homologous to ferredoxin 
reductase and locates in the C-terminal of the protein.    
 
          On comparing alignments of amino acid sequences of the known members of 
the diflavin oxidoreductase family, it is clear that the overall three dimensional 
structures of these proteins are similar. A common structural feature is that the FMN-
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binding domain is located at the N-terminus of the proteins and that the FAD and 
NADPH binding domains (ferredoxin-NADP
+
 reductase module) are located at the 
C-terminus. Reported crystallographic structures of CPR [90], NOS reductase [77] 
and other family members (e.g. sulphite reductase) [91] have confirmed that the 
FMN-binding domain is homologous to the structure of flavodoxin [92] and that the 
FAD/NADPH-binding domain resembles the structure of ferredoxin-NADP
+
 
reductase [93]. There is also a connecting domain that separates the FMN-binding 
and FAD-binding domains in the diflavin oxidoreductases. This connecting domain 
is assumed to be involved in the control and modulation of electron transfer between 
the flavin cofactors through conformational control and recent kinetic [77] and 
spectroscopic studies [94] of human CPR have confirmed the dynamic nature of this 
molecule. The crystal structures of CPR and NOS have also been used to argue that 
domain dynamics are important in controlling electron transfer in these systems, 
consistent with for example EPR [95], kinetic [96] and spectroscopic studies [97] 
also conducted on the NOS enzymes. A hinge region between the connecting domain 
and the FMN-binding domain, which is partially disordered in crystal structures, is 
also in agreement with the dynamic characteristics of these enzymes. In CPR and 
other diflavin reductases this hinge is typically 14-24 residues long [90]. Sequence 
alignments however suggest that this hinge region is much longer in MSR (up to 82 
residues in length). This suggests that large-scale domain motion of the FMN-
binding domain is a feature of the structure of human MSR. 
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Figure 1.5 Three dimensional structure of rat cytochrome P-450 oxidoreductase 
[1]. CPR is divided into: an FAD/NADPH-binding domain (red) with NADP
+
 
(magenta) and FAD (yellow); a connecting domain (blue); an FMN-binding domain 
(green) with FMN (cyan). 
 
Figure 1.6 Three dimension structure of nNOS reductase [98]. The deposited 
PDB only contained one monomer in the asymmetric unit as shown. The structure is 
divided in four domains: an FAD- binding domain (blue, residue 750 to 942) with 
FMN (magenta); a connecting domain (green, residue 943 to 989 and 1039 to 1170); 
an FAD binding domain (Red,  residues 990 to 1038 and 1171 to 1231) with  FAD 
(yellow) and NADPH-binding   domain (orange, residues 1232-1396) with NADP
+
 
(cyan). 
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Other structural similarities in the orientation of the flavin cofactors and 
binding sites in this family have also been found. In CPR, the binding pockets for the 
isoalloxazine rings of FAD and FMN are mainly hydrophobic. Both sides of the 
isoalloxazine rings form π-π stacking interactions with aromatic amino acid residues 
in the protein. The isoalloxazine ring of FMN is partially shielded by the phenyl 
rings of Tyr
140
 and Tyr
178
 on the re- and si-side respectively [99] and the 
isoalloxazine ring of FAD is sandwiched between Tyr
455
 and Tyr
456
 on the si-side 
and Trp
677
 on the re-side. A similar structural organisation has been reported for 
other members such as mammalian NOS [79] and E. coli sulfite reductase [91]. 
Additionally, the binding sites for NADP
+
/NADPH in these enzymes is relatively 
conserved and typically are occupied by an aromatic amino acid (either tyrosine, 
tryptophan or phenylalanine), which is relatively dynamic and allows access to the 
FAD when the nicotinamide group of NADPH binds to the enzyme. Such dynamical 
character has been seen in kinetic (fluorescence) and structural studies of family 
members [100]. 
  Clearly, the main physiological function of the diflavin reductases is to 
transfer electrons to redox partners or domains attached to the reductases. To further 
understanding of the electron transfer mechanisms thermodynamic studies have been 
conducted for many members to define the gradient of electron flow in these 
proteins. The direction of the net electron transfer is determined from the reduction 
potentials of the electron donor and acceptors (i.e. the flavin centres). Electrons 
move spontaneously from the atoms or molecules with more negative reduction 
potential to the atoms or molecules with more positive reduction potential. The 
reduction potentials of the flavin cofactors have been measured under equilibrium 
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anaerobic titration experiments and a summary of available data are shown in Figure 
1.7. 
 
Figure 1.7 Flavin reduction potentials for some members of the diflavin 
reductase enzyme family. These data include the midpoint reduction potentials for 
both the oxidised/semiquinone and semiquinone/hydroquinone couples of FAD and 
FMN for MSR [101], CPR [102], rat neuronal NOS in calmodulin-free (C
-
) and 
calmodulin-bound forms (C
+
) [103] and novel reductase 1(NR1) [79]. 
         These reduction potentials show that the thermodynamic gradient for electron 
transfer is from NADPH →FAD →FMN. However, there are some key differences 
across family members. Also, some of the measured potentials deserve further 
comment. For example, the redox potential for the FMN semiquinone in NOS is -49 
mV, and the redox potential for heme is -220 mV. However, during NOS turnover 
the FMN semiquinone is able to donate electrons to the heme iron. It has been 
suggested that the potentials in these measured equilibrium conditions are not the 
same as those that exist under catalytic conditions.  
1.3.2 Examples of diflavin enzymes NOS and CPR 
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        Nitric oxide synthase, which catalyzes the oxidation of one of the L-arginine 
guanidinium N atoms to nitric oxide (NO), comprises an N-terminal heme domain 
and an FMN/FAD reductase domain at the C-terminus which contains FAD, FMN 
and NADPH binding sites. Electrons are transferred from NADPH to FAD then 
FMN, and further to the heme domain. There are three kinds of NOS isoforms, 
endothelial NOS (eNOS), neuronal NOS (nNOS) and inducible NOS (iNOS). A 
particular characteristic for NOS is that it has one redox cofactor and a regulatory 
protein, calmodulin (CaM). Constitutive NOS proteins which include nNOS and 
eNOS are expressed in mammals constitutively and collectively are controlled by 
CaM with a dependence on the concentration of Ca
2+
 (which binds to CaM). In 
contrast, CaM binds to the iNOS as a permanent additional subunit. Hence, the iNOS 
is not regulated by CaM binding, and regulation is achieved only through 
transcriptional control [104]. 
        The size of NOS ranges from 135 kDa to 160 kDa, but it has no activity in its 
monomeric form. The dimer form of NOS has activity and is tightly dimerised by its 
heme domains. The crystal structures of the heme domains of the three NOS 
isoforms show some similarity with H4B molecules binding at the dimer interface. 
Additionally, a Zn ion is found at the dimer interface and is ligated by two cysteine 
residues from each monomer [17].  
         Kinetic and spectroscopic studies have been carried out to investigate the redox 
potential, electron transfer and cofactor binding properties of the NOS enzymes. 
Direct anaerobic titration has been applied to determine the midpoint reduction 
potentials for the flavin cofactors in the reductase domain of nNOS in CaM-free and 
bound forms [103]. For the CaM-free form, the FMN potentials are -49 ± 5 mV 
(ox/sq) and -274 mV ± 5 mV (sq/hq); the FAD potentials are -232 ± 7 mV (ox/sq) 
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and -280 ± 6 mV (sq/hq) [103]. These data are confirmed by the existence of the 
blue (neutral) semiquinone, which is attributed to the accumulation of FMN 
semiquinone rather than the FAD semiquinone. For the CaM-bound form of nNOS, 
the midpoint potential is identical to that of CaM-free form with a small alteration at 
the midpoint potential of FMN (ox/sq) in -30 ± 4 mV [79]. In comparison to the 
midpoint potential of heme of nNOS (-239 mV, L-Arg-free; -220 mV, L-Arg-bound 
[103]), it is clear that electron transfer from FMN hydroquinone to heme in nNOS is 
thermodynamically feasible. Stopped-flow kinetic studies have also been completed 
to investigate the electron transfer in the reductase domain of nNOS [97]. The 
resulting time-dependent photodiode array spectra were analysed by the global single 
value decomposition (SVD) analysis method. Together with single wavelength 
absorption and NADPH fluorescence data, the authors identified four resolvable 
kinetic steps: the first step represents rapid formation of an equilibrium between an 
NADPH-enzyme charge transfer species and two-electron-reduced enzyme bound to 
NADP
+
; the second and third steps were to further reduction of the flavins and the 
release of NADP
+
; the fourth step represents the accumulation to the equilibrium 
final state of the reduced enzyme. Stopped-flow flavin fluorescence studies over long 
time bases indicated a slow kinetic phase, which was attributed to enzyme 
disproportion and/or conformational change. No di-semiquinones are detected in 
stopped-flow studies after the first hydride transferred from NADPH to nNOS 
reductase. This suggests the internal electron transfer is relatively slow and is 
probably gated by NADP
+ 
release. An important aspect of nNOS function is related 
to the role of CaM binding. CaM binding activates the enzyme and is believed to 
trigger the release of NADP
+
 and facilitate electron transfer through conformation 
change [105]. The binding of NADPH induces a conformational change to restrict 
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the access of FMN with the electron acceptor of nNOS. It is hypothesised that the 
binding of NADPH induces a ‗conformational lock‘ in the reductase domain and 
thereby prevents efficient electron transfer to either the oxygenase domain or other 
electron acceptors. CaM binding on the other hand unlocks this complex at elevated 
Ca
2+
 concentrations and reorients the two domains to trigger interdomain electron 
transfer and NO synthesis.  
1.3.2.2 CPR 
        The cytochrome P450 is a heme-containing monooxygenase and it is critical to 
animal physiology and drug metabolism. In mammalian systems, numerous different 
isoforms of cytochrome P450s catalyse the oxidization of some endogenous 
compounds such as steroids, eicosanoids and a diverse range of xenobiotics. Because 
the P450s require the delivery of two electrons for catalytic function, so an efficient 
electron delivery system is critical to P450 catalysis. Depending on the type of 
reductase system, cytochrome P450 can be grouped into two classes [106]. Class I 
(β-class) P450 includes most bacterial systems and mitochondrial forms, in which 
electrons from NADPH are transferred to FAD in the ferredoxin reductase then 
passing through the small iron-sulfur containing ferredoxin to P450; Class II (E-
class) includes the majority of eukaryotic P450s often referred to as microsomal 
P450s. Microsomal P450s have a single redox partner, cytochrome P450 reductase.       
          Cytochrome P450 reductase, CPR, is the best characterized diflavin reductase, 
which is bound to the endoplasmic reticulum of eukaryotic cells. The size of CPR 
ranges from 75 kDa to 85 kDa [107] in monomeric form depending on the source. It 
is an essential component of microsomal cytochrome P450 dependent 
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monooxygenases systems and catalyses the transfer of electrons from NADPH to 
FAD, FMN then to cytochrome P450. 
          The three dimensional structure of CPR consists of four structural domains: 
from N terminus to C terminus, these are the FMN-binding domain, the connecting 
domain, the FAD-binding domain and the NADPH-binding domain [90]. The 
structure of the FMN-binding domain is similar to the structure of flavodoxin. The 
structure of the FAD/NADP-binding domain is similar to that of ferredoxin-NADP
+
 
reductase (FNR). The connecting domain is responsible for the relative orientation of 
the other domains and the proper alignment of the two flavin cofactors for efficient 
electron transfer. The position of the two flavin isoalloxazine rings is juxtaposed at a 
distance of about 3.5Å [90]. The binding pockets of the isoalloxazine rings of FAD 
and FMN are hydrophobic and are separated on both sides of the oxidised NADP-
bound structure by the methyl groups of the FMN towards the FAD. This structure 
suggests there is a flexible hinge between the flavin domains and that the FMN-
binding domain of CPR moves back-and-forth during the reduction and oxidation 
process. 
The crystal structure of CPR has revealed the electron transfer occurs directly 
between the cofactors with no amino acid residues participating in the redox 
chemistry. In the electron transfer process, a charge transfer complex is formed. This 
complex can be identified by an absorbance band above 500 nm and is assumed to 
reflect a direct interaction between the flavin (FAD) isoalloxazine ring with the 
pyridinium ring of NADPH, which leads to a rapid hydride ion transfer. Studies by 
Isenberg and Szent-Gyorgyi [108] have shown that riboflavin in free solution can 
form charge transfer complexes with amino acids with distinctive absorption 
properties that are similar to the charge-transfer spectra for FAD-NADPH interaction 
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formed in CPR amino acids.  Also, studies with bis-nucleotide analogs containing 
covalently attached nicotinamide and isoalloxazine rings show that a charge transfer 
complex absorbance maximum and the band intensity depend on pH, solvent polarity 
and the distance between the aromatic rings. In addition, CPR has also demonstrated 
that the interaction of NADPH with CPR can affect the reduction potential of the 
flavin cofactors and help to stabilize the reduced flavin. This is confirmed by the 
studies of the semiquinone form of CPR which is much more stable after interaction 
with NADPH than with NADH [109]. 
          Different parts of the NADPH coenzyme make different contributions to the 
binding reaction with CPR. With rat CPR the 2´-phosphate part contributes 5 
kcal/mol to the binding energy of NADPH; this 2´-phosphate is not only critical for 
the binding of NADPH to CPR but is also important for the fast hydride transfer 
from the nicotinamide ring to FAD [110]. Although the distance between the 2´-
phosphate group to the nicotinamide ring is about 10-12 Å, the phosphate group is 
believed to induce distal conformation changes required for reorganization and 
optimal binding. Different forms of NADPH, such as the reduced form and oxidized 
form have different binding affinities for CPR. For example, the neutral reduced 
nicotinamide ring interacts with the oxidized form of CPR in a tight binding complex, 
but the positively charged oxidized nicotinamide does not bind tightly. It is thought 
that there are two steps in the binding of NADPH to CPR: the first step is the 
recognition of the 2‘-phosphate group which controls the affinity of the enzyme for 
NADPH. The second step is the effect of the binding of the 2´-phosphate group 
which ‗turns on‘ the recognition system of the nicotinamide ring portion of the 
coenzyme. This might involve movement of a tryptophan residue that is positioned 
34 
 
close to the FAD isoalloxazine ring in the crystal structure of the oxidised form of 
CPR.  
Temperature-jump relaxation studies have been used to investigate the affect 
of NADPH binding on internal electron transfer in CPR [111]. It was found that 
NADPH binding triggers conformational changes which slow down the rate of 
internal electron transfer between the CPR flavin domains. This conformational 
change is also sensitive to solution viscosity changes suggesting the involvement of 
domain motion [111].  
The redox potential of flavin in full-length human CPR has been determined in 
solution without its membrane spanning domain by anaerobic redox titration 
methods [102]. The midpoint potential of the flavin cofactors for CPR are: FMN, - 
66 ± 8 mV (ox/sq), -269 ± 10 mV (sq/hq); FAD, -283 ± 5 mV (ox/sq), -382 ± 8 mV 
(sq/hq). These data confirm the electron transfer direction is from NADPH to FAD 
then FMN. This direction is consistent with what is known of the potentials for the 
other members of the diflavin reductase family.  
         The reduction of NADPH for the FAD and FMN redox centres in human CPR 
has been studied by rapid-mix stopped-flow spectroscopy. The reduction of the 
isolated FAD/NADP-binding domain has three kinetically resolvable steps. In the 
first step, there is a rapid formation (~500 s 
-1
) [94] of a charge-transfer species 
between the oxidised FAD and NADPH; in the second step, a second charge-transfer 
species is formed in isomerisation with an intense absorption in a long wavelength 
region; in the third step, a second hydride is transferred from NADPH to FAD with a 
further change in the tryptophan fluorescence of the FAD/NADP-binding domain. 
The hydride transfer to FAD is reversible and the reduction of NADP
+
 by FADH2 is 
more rapid (8 s
-1
) relative to the reduction by NADPH (3 s
-1
) [94]. This is consistent 
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with the midpoint reduction potential data. The observed rate for the electron transfer 
between the isolated FAD/NADP-binding domain and isolated FMN is about 9.5  
 104 M-1s-1 depending on the domain concentration. This result suggests that this 
reaction is a bimolecular reaction and that the connecting domain plays an important 
role. The structure and function of CPR shares other common features with another 
member in this diflavin reductase, MSR. 
1.4 Methionine synthase reductase 
1.4.1 Cloning and mapping of the cDNA of the methionine synthase reductase 
         Megaloblastic anaemia, developmental delay, hyperhomocysteinemia [112] 
and hopomethioninema [113] are serious recessive diseases which threaten human 
health. Studies have suggested that mutations that might affect the reductive 
activation of methionine synthase (MS) are the main cause of these diseases. MS 
catalyzes the methylation of homocysteine to methionine (Figure 1.8). In this 
reaction, methylcobalamin serves as an intermediate methyl carrier but after 200 to 
1000 turnovers, MS is rendered inactive owing to the oxidation of cob(I)alamin to 
cob(II)alamin [1]. The regeneration of the function of MS requires reductive 
methylation of the cob(II)alamin using S-adenosylmethionine as a methyl donor and 
using MSR as electron donor. Based on the gene sequence from selected patients 
deficient in the reactivation process catalysed by MSR and the predicted consensus 
binding site of FAD, FMN and NADPH, the cDNA of MSR has been cloned and 
termed MTRR. The gene MTRR is localised at chromosome 5p15.2 -15.3 [1]. One 
predominant mRNA of 3.6 kb is detected by Northern blot analysis. The deduced 
protein from this gene contains 698 amino acids with a predicted molecular mass of 
77.700 Da. This gene also shares 38% sequence identity with human cytochrome 
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P450 reductase [114]. The sequence was confirmed by identifying the mutations in 
cblE patients, including 4-bp frame shift in two affected siblings and 3-bp deletion 
[115]. The cloning of cDNA was the starting point for biochemical research on 
human MSR.  
 
Figure 1.8 Scheme illustrating the catalytic cycle and reactivation of MS. During 
the primary catalytic cycle, MS uses enzyme-bound cob(I)alamin to remove a methyl 
group from methyl tetrahydrofolate to generate tetrahydrofolate and 
methylcob(III)alamin. Regeneration of MS involves one electron from NADPH 
catalyzed by MSR and methyl transfer from S-adenosyl methionine. 
 
1.4.2 Molecular and functional properties of human MSR 
          MSR restores the activity of MS through the reductive methylation of cob (II) 
alamin using S-adenosylmethionine as a methyl donor. In E. coli, this reductive 
methylation of MS is performed by a two-component flavoprotein system. The 
NADPH-dependent flavodoxin reductase, a member of the ferredoxin 
oxidoreductase (FNR) family, transfers reducing equivalents from NADPH to an 
FMN-containing flavodoxin (FLD); the reduced FLD then donates an electron to MS 
to complete the reductive methylation. In humans, MSR plays the same role as the 
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two-component reductase system found in E. coli. As discussed above, MSR 
contains two flavin binding domains: the FMN-binding domain and FAD/NADPH 
binding domain and it is a member of the diflavin reductase family. 
         In order to investigate the catalytic and thermodynamic mechanism of MSR, 
the recombinant human MSR and its component FAD/NADPH-binding domain and 
FMN-binding domain have been expressed individually in E. coli as GST fusion 
proteins [1]. The GST tags have permitted these proteins to be purified using 
glutathione affinity chromatography. After cleavage of the GST tag with thrombin 
and its separation from other GST fusion proteins, full length MSR, the isolated 
FAD/NADPH binding domain and FMN-binding domain were further purified by 
anion-exchange chromatography prior to in-depth analysis. The resultant molecular 
masses of the purified MSR, FAD/NADPH- binding domain and FMN- binding 
domain were shown to be 78 kDa, 60 kDa and 30 kDa, respectively, in agreement 
with the values calculated from the amino acid sequences of MSR (77.7 kDa), 
FAD/NADPH-binding domain (59.4 kDa) and FMN-binding domain (27.1 kDa) [1].  
During the purification process, the apparent colour of MSR indicates the 
redox properties of the FAD and FMN cofactors. The blue colour for the FMN 
domain at the start of purification shows that FMN is partially reduced at the level of 
the blue semiquinone. The yellow appearance of the FAD/NADP-binding domain 
shows that this cofactor is isolated in the fully oxidized state. The green colour of 
purified full-length MSR at the early stages reflects a mixture of blue semiquinone 
FMN and yellow semiquinone FAD. The appearance of the purified proteins and 
inferred redox states are consistent with UV-visible optical spectroscopy analysis of 
the bound flavin. The absorbance spectra of the fully oxidized full length MSR and 
the isolated FMN domain show typical flavin absorbance spectra with peaks at 380 
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nm and 454 nm and a shoulder at 474 nm. The fully oxidized FAD/NADP-binding 
domain has an absorbance peak at 383 nm and 454 nm [1]. In addition, summation 
of the component FMN domain and FAD/NADPH domain spectra generates a 
composite spectrum that is very similar to that measured for full length MSR. This 
suggests that the domain structure of each domain is retained when expressed as 
individual FMN- and FAD/NADH-binding domains.  
          The appearance and absorbance characteristics of full length MSR suggest it is 
purified in a functionally active form. It has been demonstrated that the full length 
protein has the ability to catalyze the NADPH-dependent reduction of cytochrome c 
and FeCN [1]. The apparent steady-state turnover rates for MSR are 0.8 s
-1
 and 8.7 s
-
1
 for cytochrome c and FeCN reduction, respectively, at 25 °C. The apparent Km for 
NADPH with cytochrome c as the terminal electron acceptor is 4.0 ± 0.3 µM. These 
reduction activities are about 25 to 100 times lower than those reported for CPR and 
NOS using comparable assays. Anaerobic redox titration studies were performed 
with the isolated FMN-binding domain and full-length MSR. For the FMN-binding 
domain, the midpoint potentials for the oxidized/semiquinone (ox/sq) couple and 
semiquinone/hydroquinone (sq/hq) couple are -112 mV and -221 mV, at pH 7.0 and 
25 °C; the corresponding couples of the FAD/NADP-binding domain are -222 mV 
(ox/sq) and -288 mV (sq/hq) [1]. In full length MSR, the values for the FMN couples 
are -109 mV (ox/sq) and -227 mV (sq/hq) and the values for FAD are -254 mV 
(ox/sq) and -291 (sq/hq) mV [1]. The similarity of the midpoint potentials of the four 
couples in full length MSR and the isolated domains confirmed that the separation of 
MSR does not disturb their dynamic properties. Comparison with the midpoint 
potential of the other members of diflavin reductase family, such as CPR and NOS, 
shows that the midpoint potential of MSR are more closely compressed but despite 
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this, that MSR has a similar electron transfer mechanism with respect to other 
members in this family. 
1.4.3 Electron transfer on human MSR 
In order to investigate the electron transfer mechanism on MSR, the pre-
steady-state kinetic behaviour of the reductive half-reaction of MSR was performed 
by anaerobic stopped-flow absorbance and fluorescence spectroscopy [60]. Stopped-
flow analysis of the NADPH reduction of MSR used a photodiode array to detect the 
change in flavin spectra of the isolated FAD/NADP-binding domain and full length 
MSR [60]. The globally analyzed spectra for the FAD/NADP-binding domain were 
best fitted to a one step reversible kinetic model with two spectral species: the 
oxidized species A and two- electron reduced species B. The rate constants for the 
conversion of A→B and B→A were determined as 20.1 ± 0.1 s-1 and 0.017 ± 0.001 
s
-1
, respectively [60]. For full length MSR, the spectral data were best fitted to a 
three-step reversible kinetic model A⇄B⇄C⇄D with four discrete spectral species. 
The rate constants for the conversion of A⇄B were found to be 24.9 ± 0.1s-1 
(forward) and 0.0003 ± 0.0001 s
-1 
(reverse); to B⇄C are 0.18 ± 0.01 s-1 (forward) 
and 0.002 ± 0.0001s
-1 
(reverse); C⇄D are 1.6 x 10-2 ± 0.001 s-1 (forward) and 0.0001 
± 0.00001 s
-1
 [60]. It should be emphasised that the spectral intermediates, such as A, 
B, C, are not the discrete enzyme intermediate but are simply spectral intermediates 
indentified from global fitting of spectral data. Based on these results, the electron 
transfer scheme for MSR was suggested. 
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Figure1.9 Kinetic scheme for the proposed electron transfer mechanism in 
human MSR [116]. 
        Under single turnover conditions, the reduction of the FAD- binding domain by 
NADPH consists of two kinetically resolved steps: a rapid phase (120 s
-1
) with the 
formation of a charge-transfer complex between the oxidised FAD and NADPH 
followed by the second phase (20 s
-1
), which involves flavin reduction [60]. Single-
wavelength absorbance measurements at 450 nm and 600 nm demonstrated that the 
observed rate constants for flavin reduction are hyperbolically dependent on the 
concentration of NADPH. Work with deuterated NADPH (NADPD) also established 
a primary kinetic isotope effect of 2.2 and 1.7 [60] for the isolated FAD/NADP-
binding domain and full length MSR, respectively. Additionally, hydride transfer in 
the FAD-binding domain and full length forms of MSR were also analysed by 
stopped fluorescence analysis, following excitation of residue Trp
697
.  This residue is 
positioned over the isoalloxazine ring of FAD and flips away from the ring to allow 
binding of NADPH for hydride transfer. The movement of this tryptophan is 
accompanied by a change in the fluorescence signal associated with this residue. The 
observed rate constant for the fluorescence change was found to be 18.0 s
-1 
[60]
 
for 
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the isolated FAD/NADP-binding domain, a value that is consistent with the observed 
rate constant determined from absorbance stopped-flow experiments of hydride 
transfer. Together, stopped-flow kinetic data and determination of the flavin redox 
potentials have provided a detailed framework for understanding the mechanism of 
electron transfer in human MSR.  
1.4.4 Complex formation between human MSR and human MS 
MSR is a redox partner of the human methionine synthase (MS) redox system 
required for methionine synthesis. As discussed, MS is a cobalamin-dependent 
enzyme, which transfers a methyl group from methyltetrahydrofolate to 
homocysteine to form methionine and tetrahydrofolate (see Section 1.5.1). Human 
MS is similar to the E. coli cobalamin dependent MS [117] (known as Met H) and 
consists of four discrete functional modules [117]. The C-terminal activation domain 
(AD) of human MS interacts with human MSR to form a protein complex and it is 
this complex that facilitates the reaction of MS by electron transfer from MSR (see 
Section 1.5.2). 
          Complex formation between the AD of MS and the isolated FMN-domain of 
MSR or full length MSR has been studied to determine the binding affinity between 
the protein partners. Fluorescence titration assays were performed in which the flavin 
cofactors in the FMN domain or full length MSR were excited at 450 nm and the 
change in emission monitored (between 500-600 nm) during titration with AD [118]. 
The quenched intrinsic flavin fluorescence on adding AD suggested that the flavin is 
shielded from solvent in the protein complexes. The decrease in the intensity of 
fluorescence had a hyperbolic dependence on the concentration of AD (dissociation 
constant ~15 µM) [118] for the binding of AD to MSR. Analysis of a molecular 
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model of MSR and the known structure of AD suggested that electrostatic 
interactions might be important in the formation of this complex. This hypothesis 
was confirmed by the observation of weaker binding as the ionic strength of the 
solvent was increased. Additional studies have involved protein chemical cross 
linking analysis of the complex to identify key residues at the protein interface of the 
AD—FMN binding domain complex. These studies used the protein chemical cross 
linkers 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide (EDC) or sulfo-N-
hydroxysuccinimide (NHS) [118] to identity the crossed link residues by mass 
spectrometry. These data suggested that acidic residues on the surface of the FMN-
domain interact electrostatically with basic residues found on the surface of the AD 
of MS. Two lysines (Lysine
987
 and Lysine
1071
) were identified as potential basic 
residues of importance [118]. Changing these residues to threonine caused the 
dissociation constant to be significantly increased when compared to data obtained 
for the wild type complex. The importance of electrostatic interactions in protein 
complex assembly was therefore confirmed. 
The thermodynamic features of the binding affinity of full length MSR or the 
isolated FMN-domain to the AD of MS were also investigated by isothermal titration 
calorimetry (ITC) [118]. The data suggested that during the interaction 
conformational changes occur with associated increases in enthalpy (Ho) and 
decreasing entropy (So). The calculated binding stoichiometry is between1:1 (FMN 
domain: AD) and 0.5 (MSR: AD). This suggests the binding model for the MSR-AD 
complex involves two molecules of AD interacting with one molecule of MSR, or 
that a conformational subpopulation of MSR interacts with AD, which may exist in a 
monomer-dimer equilibrium [118]. In addition, measurement of the mid-point redox 
potentials for the flavin cofactors in these two complexes showed there is a 
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substantial endergonic barrier for the electron transfer from MSR to MS. This 
endergonic ‗uphill‘ electron transfer is followed by an exothermic methyl transfer 
reaction, ensuring that the overall reaction chemistry is essentially ‗downhill‘.  
1.5 Methionine Synthase 
1.5.1 The catalytic reaction of E.coli MS as a basis for understanding human 
MS 
         MS catalyzes the transfer of a methyl groups from methyltetrahydroflate to 
homocysteine generating H4folate and methionine (see Figure 1.8). Studies of the E. 
coli MS are reasonably well advanced; both mechanistic and partial structural data 
are available, providing an important knowledge base for studies of the less well 
characterised human MS. The gene for MetH in E. coli encodes a similar cobalamin-
dependent MS and this gene has been cloned and sequenced [117]. The gene was 
expressed and the protein isolated with cobalamin in the active site. The cobalamin 
was found non-covalently bound to MS and its role is to function as an intermediary 
in methyl-transfer reactions.  In this reaction, MS first catalyses the transfer of a 
methyl group from enzyme-bound methylcobalamin to homocysteine to generate 
methionine and cob(I)alamin. The cob(I)alamin is then remethylated by CH3-
H4folate to regenerate methylcobalamin and H4folate (Figure 1.8). These two half 
reactions represent the primary turnover cycle of MS. However, the cob(I)alamin in 
MS is occasionally oxidized to an inactive cob(II)alamin after 100 to 2000 turnovers 
so it needs to be reactivated in a reductive methylation reaction. In E. coli, this 
methylation reaction requires electron transfer mediated by a flavodoxin and 
flavodoxin reductase. AdoMet acts as a methyl provider in this reductive chemistry. 
In humans, MSR substitutes for flavodoxin/flavodoxin reductase and the electron 
transfer from MSR to MS is the primary function of MSR in the cell.  
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The kinetic mechanism of the reaction catalyzed by cobalamin-dependent MS 
has been investigated by both steady-state and pre-steady-state kinetic methods. 
Steady-state kinetic analysis reveals an ordered sequential mechanism [117], in 
which two substrates, homocysteine and CH3-H4folate, bind to the enzyme prior to 
methyl transfer. The homocysteine then obtains a methyl group from 
methylcobalamin generating cobalamin and methionine. The cobalamin is then 
remethylated by methyl group transfer from methyltetrahydrofolate, which is bound 
to the enzyme. Pre-steady-state kinetic studies have been carried out to determine the 
rate constants for these reactions. Enzyme bound cob(I)alamin reacts rapidly with 
methyltetrahydrofolate with an observed rate of catalytic turnover of 19 s
-1 .
. The rate 
of product release at 50 s
-1
 is probably the rate-limiting step during turnover [117]. 
1.5.2 Mechanism of reductive activation of E. coli MS 
The mechanism of reductive activation of MS can be illustrated as follows: 
Cob(II)alamin + 1 e
-1→ Cob(I)alamin 
Cob(I)alamin + AdoMet → Methylcobalamin + adenosylhomocysteine 
The conversion of AdoMet to adenosylhomocysteine is associated with a large 
free energy decrease to trap the Cob(I)alamin formed by reduction. Because the +1 
and +3 states of cobalamin cofactor are diamagnetic [119], electron paramagnetic 
resonance spectroscopy was used to the study this mechanism. UV-visible 
absorbance spectra and EPR spectra on the isolated inactive MS demonstrated the 
characteristic features of cob (II) alamin [119]. The oxidation and reduction of the 
cob(II)alamin were quantified using the dominant EPR signal and the midpoint 
potential for the enzyme-bound cob(II)alamin/cob(I)alamin and the 
cob(III)alamin/cob(II)alamin couples were determined  to be -526 ± 5 mV and 273 ± 
4 mV versus a standard hydrogen electrode [120]. During the reduction of cob (I) 
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alamin to form methylcobalamin, the presence of either CH3-H4folate or AdoMet can 
change the distribution of the cobalamin species and this result suggests that there is 
a absolute requirement for AdoMet in this coupled reduction/methylation reaction 
with a -350 mV potential.  At this potential, the equilibrium distribution of 
cobalamin is in favour of cob(II)alamin species in presence of CH3-H4folate and of 
methylated enzyme in the presence of AdoMet[120]. 
 
1.5.3 Function modules of E. coli MS 
         Most of the information on the structural and functional behaviours of MS 
comes from the research on the MetH in E coli [121] and Homo sapiens [30]. 
Although the whole structure of the full-length MetH has not been determined, the 
structures of the four divided functional modules have been solved. From the N-
terminus to C-terminus, the structure of MetH from Thermotoga maritina consist of 
homocysteine-  and CH3-H4folate-binding domains, cobalamin-binding domain and 
the AdoMet-binding domain, which is also called the activation domain (AD).   
The first two domains, the homocysteine and CH3-H4-folate-binding domains, 
comprise residues 1 to 354 and have a molecular mass of 38 kDa, consisting of two 
(βα)8 barrels [122]. These barrels are packed tightly to each other and have some 
distinctive distortion to accommodate the metal ion binding sites and substrates. The 
active sites for homocysteine and folate binding are located near the C terminal ends 
of the barrel strands and are exposed to solvent. These two barrels stay associated 
during the catalytic process. As part of the interdomain linker, some residues on the 
outside of helices and loops of the barrels form an extensive interface [122].  
         The third functional domain, the cobalamin binding domain, with a conserved 
structural feature typical of B12-dependent enzymes, consists of two parts. One is a 
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four-helix bundle (also called the cap domain) positioned over the upper (β) face of 
the cobalamin; the second part is a Rossmann α/β domain (named cob domain) with 
a critical histidine residue, which coordinates the cobalt of cobalamin from 
underneath. In MetH, the dimethylbenzimidazole nucleotide is displaced from the 
lower face of the cobalamin and is extended into the core of the Rossmann fold. In 
MS, the Hcy and CH3-H4folate substrates are bound to their respective barrels and 
separated by about 50 Å [122]. So to complete the catalytic cycle, the cobalamin-
binding domain is believed to travel back and forth between these active sites. The 
active sites for the Hcy barrel are grouped in metal-(Zn
2+
) and substrate binding sites 
such as Glu
146
; and the active site for folate barrel includes Asp
390
, Asn
411
, Asp
473 
and Asn
508
 [122]. 
         The fourth functional module, the activation domain, is comprised of residues 
from 897 to 1227 with a molecule mass 37 kDa [123]. It consists of C-shaped 
module with a bent anti parallel sheet which contains the domain core. AdoMet is 
bound at the centre of the inner surface of the ―C‖ structure in a extended 
conformation, in which the adenine base is anti to the sugar and the adenine ring is 
flanked by Tyr
1139
 and Tyr
1189
 [123]. 
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Figure 1.10 Structural model of E. coli MS. A. The blue coloured model is the 
homocysteine-binding domain; B. The pink domain is the CH3H4folate-binding 
domain; C. The green coloured model is the cobalamin-binding domain. And the red 
stick molecule is the cobalamin cofactor; D. The golden colour is the activation 
domain. 
1.5.4 A working model  for E. coli MS 
          Based on the structure of the MS three different major conformational changes 
are thought to be required to carry out the SN2 methyl transfer reactions [30].  The 
first conformation of MS is a resting state, in which the α-helical cap domain of the 
cobalamin-binding region shields the methyl group of the methylcobalamin and the 
upper face of the corrin keeps apart the substrate and solvent; the second 
conformation appears in reductive activation. In this conformation, the cap structure 
is replaced and the activation domain around the cobalamin allows 
adenosylmethionine to react with the cobalamin; the third conformation occurs in the 
reaction with homocysteine and/or methyltetrahydrofolate, in which the substrate 
binding region in the N-terminal region can contact with cobalamin. According to 
these conformational changes, the reactivity of cobalamin is dependent on both the 
properties of the enzyme bound cofactor and its access to a particular substrate. The 
conformational changes in MS are also controlled by a ‗ligand triad‘ which is a set of 
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hydrogen-bonded residues His
759
-Asp
757
-Ser
810
, that positions and secures the 
histidine ligand and is in charge of the switching between the catalytic and activation 
cycles. 
1.5.5 Human methionine synthase 
Human MS has been cloned and sequenced with a molecule mass of 140 kDa 
[124]. The sequence of human MS shows about 55% sequence identity with the 
protein from E. coli and 64% sequence identity with the MS from Caenohabditis 
elegans.  The crystallographic structure of the activation domain of human MS has 
been reported and it is C-shaped with the core comprising mixed α and β-sheet with 
a β-meander region [118]. The main features of this structure are similar to the 
structure of the activation domain of MetH from E. coli.     
1.6 The molecular basis for the autosomal recessive disorders related with 
MSR 
The physiological function of MSR is to regenerate the inactive MS, which 
catalyzes the methyl transfer from methyltetrahydrofolate to homocysteine to form 
methionine. So MSR and MS are key enzymes in homocysteine and folate 
metabolism [125]. Deficiency of the function of MSR and MS results in 
hyperhomocysteinemia, homocystinuria [126] and megalobstic anemia without 
methylmalonic aciduria [127]. Some hereditary defects have contributed to the 
functional deficiency and are inherited as autosomal recessive disorders. Those 
patients with these disorders mainly consist of two complementary groups [128]: one 
group, cblG is thought to be caused by the defects on MS apoenzyme; another group, 
cblE is related with the reducing system of MS, MSR. Several mutants on the whole 
MSR coding region have been identified. The patients containing these 
polymorphisms on the MSR gene exhibit certain clinical symptoms, such as 
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development delay, ataxia, cerebral atrophy, neonatal seizures, blindness, thrombosis 
and arterioscherotic vascular modification [129, 130]. One mutant A66G substitutes 
an isoleucine to methionine with an allele frequency of ~0.55 and is a genetic 
determinant of the increased blood homocysteine level; another mutant S175L has 
also been identified [125]; other mutants such as L576S, C405R, G487R and G554R 
are associated with these diseases [131].  The residue L576S, a conserved residue on 
β-sheet 9 of the NADPH-binding domain of MSR; the G554R, which locates within 
the α-helix 9, is believed to disrupt the secondary structure of MSR; the G487R, 
which is near the pyrophosphate moiety of FAD, decreases the binding affinity of 
FAD because of the volume of arginine; another mutant C405R, which is near the 
surface of the protein and close to Pro
243
 in the extended linker, is suggested to 
trigger some clashes in the secondary structure. These mutants cause structural 
change and affect the function of MSR as well as affecting the function of MS and 
folate and methionine mechanisms in the human body.   
In summary, the broad aim of this thesis is to expand the understanding on the 
structure and function of MSR and further elucidate the relationship between MS and 
MSR. A variety of technologies: purification, crystallization, spectroscopic, kinetic 
and Potentiometric techniques have been applied to this research project. The 
research results are illustrated in these six chapters of this thesis. 
Chapter two contains all the details of the materials, equipments, experimental 
protocols and conditions, data treatment methods with the equations and software 
used in this thesis.  
Chapter three describes the research on the FAD/NADPH-binding domain of 
MSR. The experiments include the purification, crystallization, X-ray diffraction, 
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steady-state and stopped-flow pre-steady-state kinetics and the crystal structure 
building.  
          Chapter four illustrates the research on some variants of MSR, namely the 
D652A, D652R and D652N of the FAD/NADPH-binding domain of MSR and 
D652A, D652R, D652N, W697A and W697H of the full length MSR. The research 
results obtained from purification, steady-state, pre-steady-state and redox potential 
studies are shown and compared with the data obtained with the wild-type protein.  
 Chapter five details the research on the dynamic properties of wild type full-
length MSR. EPR, ENDOR, ESEEM and ELDOR are used to check the 
conformational changes occurring on MSR at different redox potentials and in 
different complexes. 
Chapter six shows two experimental results. The first experiment is the 
construction of two expression plasmids of full-length MSR: one expression plasmid 
contains GST and (His)6 two tags to be expressed in E. coli and another plasmid with 
pPICZ vector to be expressed in Pichia pastoris Yeast system; the second 
experiment is the purification and crystallization of the activation domain of MS. 
         Chapter seven is a discussion of the data in this thesis and a suggestion for the 
further research on the MSR and the MSR-MS complex. 
          In general, the special aim of this PhD study is to apply biochemical and 
biophysical research methods to investigate the relations of the structure and 
function of MSR. For example, protein purification, crystallization and model 
building methods were used to illustrate the structure of MSR; the kinetics methods, 
including steady state kinetics and pre-steady state stopped flow, were designed to 
check the electron transfer catalytic ability and substrate specificity of MSR; the 
EPR, ENDOR, ESEEM and ELDOR were applied to uncover the dynamic features 
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of MSR. All of these research results will deep the understanding of the structure, 
catalytic mechanism and electron transfer ability of MSR. Further, this research will 
provide a good background for the invention of new medicine, which is purposely 
designed to cure some patients with the rare autosomal recessive disorders such as 
megaloblastic anemia, hyperhomocysteinemia and hopomethioninema. These 
diseases have believed related with the deficiency of MSR in human body. 
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CHAPTER TWO  
MATERIALS AND METHODS 
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 2.1      Materials 
  All chemicals used in this project were Analar grade or equivalent purity. 
Glycerol, sodium chloride, potassium chloride, calcium chloride, potassium 
dihydrogen orthophosphate and dipotassium hydrogen orthophosphate were from 
Fisher Chemicals. Restriction enzymes and the plasmid pGEX-4-T1 were from 
Amersham Pharmacia Biotech. Genelute
TM
 miniprep and midiprep kits were from 
Sigma-Aldrich. PfuTurbo
TM
 DNA polymerase was purchased from Stratagene. 
Complete EDTA-free protease inhibitor tablets were from Roche. NADPH, 2‘, 5‘-
diphosphate, NADH, isopropyl-β-D-thiogalactopyranoside (IPTG) were from 
Melford. 
 EPR tubes (cat.no.W706-PQ-9) from Wilmad-Labglass were ordered from 
Fluorochem Ltd.  
2.2.   Media 
 Luria-Bertani (LB) medium was made up using 4 g tryptone, 4 g sodium 
chloride, and 2 g yeast extract with 400 mL ddH2O and autoclaved at 121°C for 20 
minutes; the LB agar medium was prepared by adding an additional extra 5 g agar. 
Terrific Broth included 20 g yeast extract, 10 g bactotryptone, 4 mL glycerol, 4.33 g 
Na2HPO4 and 2.65 g KH2PO4 with 1 litre ddH2O. SOC medium consists of 20 g 
Bacto-tryptone, 5 g Bacto-yeast extract, and 2.5 mL 1 M KCL with 1 litre ddH2O. 
2.3.    Recombinant DNA techniques 
2.3.1. Isolation of plasmid DNA 
 In the mini-preparation of plasmid DNA, a single transformed colony of 
Escherichia coli (E. coli), containing the target plasmid, was picked from an agar 
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plate and inoculated into 5 mL of LB medium with 50 µg/mL ampicillin. This 
culture was grown with shaking at 200 rpm, at 37 °C for 12 hours. Next, the target 
DNA plasmids were extracted from the culture using the supplied reagents from the 
Sigma Genelute
TM
 miniprep kit. For a midi-preparation of plasmid DNA, 5 mL of 
cells were used to inoculate to 50 mL LB medium containing 50 µg/mL ampicillin at 
37 °C for 12 hours, and harvested and manipulated with the midiprep kit reagents 
according to the manufacturer‘s instructions. The concentration of the target plasmid 
was estimated by comparing its band intensity with that of marker bands of known 
concentration in a 1% agarose gel. 
2.3.2. Transformation of E. coli cells 
 E. coli JM109 strain was chosen as the competent cells for transformation with 
plasmid DNA. The transformation experiment was begun by thawing the JM109 
cells on ice. Frozen competent cells were obtained from Promega. Then 2 µL 
plasmid DNA (the lowest concentration used was 10 ng/µL) was mixed with 50 µL 
JM109 cells and kept on ice for 30 minutes. A heat shock at 42°C for 45 seconds 
was performed and the mixture was cooled on ice for 2 minutes. After adding 200 
µL SOC medium, which was at room temperature, and gently shaking at 37 °C for 1 
hour, the mixture was plated onto LB agar plates, containing 50 µg/mL ampicillin, 
and incubated inverted at 37 °C for 12 hours. 
Competent cells of E. coli BL21 (DE3) and BL21 (DE3) pLysS were used for 
transformations to generate expression hosts for recombinant proteins because of 
their ability to express recombinant DNA from T7 promoter systems. First, the 
competent cells were thawed on ice. Then in a pre-chilled 1.5 mL polypropylene 
micro centrifuge tube, 20 µL competent cells were added to 1 µL of DNA plasmid 
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(the lowest concentration used was 10 ng/µg) and gently mixed. After 5 minutes, the 
cell mixture was placed in a water bath at 42 °C for 30 seconds and cooled on ice for 
2 minutes. After adding 250 µL SOC medium, at room temperature, the cell mixture 
was shaken at 250 rpm, at 37 °C for one hour. Then the mixture was spread on an 
LB plate containing 50 µg/mL ampicillin. Finally, the plates were incubated in 
inverted position at 37 °C for 12 hours. 
2.3.3 Construction of MSR expression plasmids 
2.3.3.1 Construction of plasmid pET41aMSR containing cDNA encoding the 
MSR gene with a GST tag and a (His)6 tag. 
 
Figure 2.1 Construction of plasmid pET41aMSR         
General methods to construct expression clones for human MSR are described 
in following sections. To overcome some difficulties, such as proteolysis of the MSR 
protein, the expression plasmid, pPET41aMSR, was constructed (Figure 2.1). This 
plasmid contains the cDNA that encodes the MSR protein with a GST tag and a 
(His)6 tag. The plasmid pGEXMSR, which contains the MSR cDNA and an N-
terminal GST tag that was previously constructed by Dr Kirsten Wolthers in the 
Scrutton laboratory [1]. The plasmid was digested with the restriction enzymes 
pGEXMSR ×EcoR1+Not1 
pPET41a ×EcoR1+Not1 
Fragment containing 
MSR cDNA+ GST tag 
Fragment containing 
Vector + 6×His tag 
T4 DNA ligase pET41aMSR 
Transform to BL21 (DE23) 
Verified in Western Blot 
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EcoR1 and Not1 to release the gene encoding MSR. A second plasmid (pET41a) that 
contains a (His)6 tag was also digested using the same two restriction enzymes. The 
products of the restriction of plasmid pGEXMSR were run on a 1% agarose gel. The 
DNA pieces corresponding to the MSR cDNA with the GST tag were isolated from 
the gel and purified using the QIAquick Gel Purification Kit (QIAGEN). Similarly, 
the DNA from the pET41a digest was purified using the QIAquick PCR Purification 
Kit. Next, the MSR cDNA was cloned into the pET41a vector by combining 200 ng 
of insert with 60 ng vector to achieve a 3:1 (insert: vector) ratio. The ligation 
reaction was incubated at 16 ºC for 16 hours. The reaction (10 µL) was transformed 
to E. coli XL1 Blue and BL21 (DE3) competent cells by the heat shock method. The 
transformed colonies were grown in 5 mL LB medium containing 30 µg/mL 
kanamcyin and incubated overnight at 37 °C. The plasmids, extracted from the 
growth culture, were digested by the restriction enzyme EcoR I, Not I and Avr I to 
screen for the correct construct. In addition, Western Blot analysis using an XCell 
II
TM
 Blot Module from Invitrogen Life Technologies was used to test for the 
expression of MSR protein in the recombinant E. coli strain. Mouse primary 
antibodies against the His tag region of the protein were used to identify the protein 
and a nitrocellulose membrane was used for transblotting. Western blot methods 
used were essentially as described by the manufacturer. Prior to electrophoresis, 
sample preparation involved several steps including: (i) IPTG induction of 
recombinant E. coli strains during the exponential growth phase of the culture. 
Induction of recombinant protein was at different final concentration (0 mM, 0.1 
mM, 0.5 mM and 1 mM) and cells were collected 1 hour, 3 hour and 16 hour after 
induction; (ii) cell lysates were prepared by the addition of BugBuster; (iii) SDS-
PAGE electrophoresis; (iv) transfer protein to the nitrocellulose membrane; (v) 
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blocking and immune-detection followed by exposure to X-ray film. The general 
component methods used in Western blotting are described in more detail below. 
2.3.3.2 Construction of a plasmid containing MSR cDNA encoding the MSR 
fused to a GST tag for expression in Pichia pastoris.  
 
 
Figure 2.2 Construction of plasmid pMSRGST    
 The yeast expression system combines some of the advantages of both the 
prokaryotic and eukaryotic expression systems.  For example, the methylotrophic 
yeast Pichia pastoris produces a high yield of recombinant proteins from cells grown 
to a high cell density on minimal media and offers a cost-effective method for 
example of making 
15
N or 
13
C-labelled proteins for NMR structural analyses [132]. 
In addition, the expression of a gene in Pichia pastoris can be easily controlled and 
tightly regulated using the alcohol oxidase1 (AOX1) promoter. With this efficient 
expression and control in mind, the plasmid pMSRGST was constructed to express 
human MSR in Pichia pastoris. First, a PCR reaction was performed with a pair of 
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primers (sequences shown in Table 2.2) which were synthesised by MWG Biotech 
Company. These PCR primers were designed to contain Nco I and Not I restriction 
sites. PCR reactions used plasmid pGEXMSR9/1 as PCR template. The PCR product 
is a 2.8 kb DNA fragment which contains MSR cDNA and an N-terminal GST tag. 
The PCR product was purified using the QIAquick PCR Purification Kit, and then 
digested with the restriction enzymes Nco I and Not I. The product was ligated to 
Nco I and Not I cut pPICZa using T4 DNA ligase. The ligation reaction was 
transformed to XL1-Blue competent cells and transformants were selected for on 
low salt LB (10 g tryptone, 5 g yeast extract, 10 g NaCl, per litre) plates containing 
25 µg/mL Zeocin
TM
. The plasmid was subsequently extracted from an overnight 
culture of the recombinant host and digested using Not I and Nco I or Not I alone. 
The digests were electrophoresed on a 1 % agarose gel to confirm that the clone size 
is correct. Containing MSR cDNA and a GST tag and a (His)6 tag at the C-terminus, 
this new plasmid, named pMSRGST, was sequenced commercially by the company 
MWG to confirm the correct construction of this plasmid.              
2.3.4. Agarose gel electrophoresis 
 A 1 % (w/v) agarose gel was prepared for use in electrophoresis by dissolving 
0.5 g agarose in 50 mL 1x TBE buffer, which had been diluted from a stock 10x 
TBE buffer ( 10x TBE buffer consists of 324 g Tris base, 165 g boric acid and 27.9 g 
EDTA with 2 litre dd H2O).  After heating in a microwave oven for 50 seconds and 
following the addition of 2 µL ethidium bromide solution (0.5 µg/µL), the gel was 
cooled to 40 °C and poured into the gel former and a Teflon comb was inserted. 
Once the gel was completely set, it was covered with 1x TBE buffer and the comb 
was removed to form the sample wells. Wells were filled with individual samples, 
each of which was prepared using 30 µL DNA and 20 µL loading buffer, which was 
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made up of 60   % v/v glycerol, 0.25 % w/v bromophenol blue, 0.25 % w/v 
xylenecyanol [133]. 
2.3.5. Polymerase Chain Reaction (PCR) 
 Polymerases chain reaction (PCR) is a modern technology that had an 
enormous impact in the development of the biological sciences. PCR is a molecular 
genetics technique for making multiple copies of small pieces of DNA. Under 
controlled conditions, small segments of DNA are produced by the enzyme, DNA 
polymerase, with the coupling of deoxynucleotides (dNTPs) to the target DNA, 
which is called ‗template‘ DNA. Some small pieces of DNA, called ‗primers‘ are 
required as the starting point for the reaction. During a typical PCR reaction, the 
template DNA is heated and separated to single strands; in the next annealing 
process, the primers bind to the template to begin the synthesis of DNA; then the 
extension step is required to extend the synthesis of the DNA strand until completion 
of the reaction. Conceptually and experimentally, PCR technology can produce 
microgram quantities of defined sequences of DNA ranging from 100 bp to 10 kb, in 
a couple hours.  
        In this project, PCR was applied in two experiments. The first use was in the 
cloning of the gene coding full-length MSR which also contained a GST tag and a 
(His)6 tag; The second use was in the site-directed mutagenesis of the gene encoding 
the MSR protein. The products of this site-directed mutagenesis reaction include the 
variants D652A, D652R and D652N of the FAD/NADPH binding domain of MSR 
and the D652A, D652R, D652N, W697H and W697A of variants of the full-length 
MSR.  
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 The PCR experiments were performed using a Techne TC-512 thermo cycler, 
which was programmed to carry out the initial denaturation, annealing and extension 
steps of the PCR reaction. All of the DNA primers were synthesised commercially 
by MWG. The following principles were used in the design of the primers: (1) The 
length of the primers was between 25 to 45 bases, with a melting temperature Tm   
78 °C; (2) Melting temperatures were calculated using the following equation 
[QuikChange Instruction manual]: 
Tm = 81.5 + 0.41 (% GC) – 675/N 
Equation 2.1 
Where N is the length of the primers; % GC is GC content of each DNA primer. 
(3) The primers were designed to have a minimum GC content of 40 % and to 
terminate in one or more C or G bases. The primers in this project are listed in 
Table2.2  
name Forward primer Reverse primer 
pMSRGST 5‘-cat gcc atg gcc cct  ata cta 
ggt tat tg-3‘ 
5‘-acg atg cgg ccg cac ttg acc aaa 
tat cct g-3‘ 
D652A 5‘-cca tat tta tgt gtg tgg agc 
tgc aaa gaa tat ggc caa g-3` 
5‘ctt ggc cat att ctt tgc agc tcc 
aca cac ata aat atg g-3‘ 
D652R 5`-cca tat tta tgt gtg tgg acg 
tgc aaa gaa tat ggc caa g-3` 
5`-ctt ggc cat att ctt tgc acg tcc 
aca cac ata aat atg g-3` 
D652N 5‘-cca tat tta tgt gtg tgg aaa 
tgc aaa gaa tat ggc caa-3‘ 
5‘-ctt ggc cat att ctt tgc att tcc 
aca cac ata aat atg g-3‘ 
Full D652A 5‘-cca tat tta tgt gtg tgg agc 
tgc aaa gaa tat ggc caa g-3` 
5‘ctt ggc cat att ctt tgc agc tcc 
aca cac ata aat atg g-3‘ 
Full D652R 5`-cca tat tta tgt gtg tgg acgtgc 
aaa gaa tat ggc caa g-3 
5`-ctt ggc cat att ctt tgc acg tcc 
aca cac ata aat atg g-3` 
Full D652N 5‘-cca tat tta tgt gtg tgg aaa 
tgc aaa gag tat ggc caa g-3‘ 
5‘-ctt ggc cat att ctt tgc att tcc 
aca cac ata aat atg g-3‘ 
Full W697A 5‘-gct acc ttc agg ata ttg cgt 
cat agc ggc  cgc atc gtg ac-3‘ 
5‘-gtc acg atg cgg ccg cta tga cgc 
aat atc ctg aag gta ac-3‘ 
Full W697H 5‘-gct acc ttc agg ata ttc act 
cat aaa acc aga aat taa 
5‘-ctt taa ttt ctg gtt tta tga gtg aat 
atc ctg  aag gta gc 
Table2.2.The DNA primers used in PCR experiments. The yellow highlighted 
colour indicates alterations in DNA sequence compared with the template DNA 
sequence. 
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 All PCR reactions performed in this project included 1 µL template DNA (see 
Section 2.3.6), 5 µL 10x Pfu Turbo DNA polymerase buffer, 1.25 µL of 25 
µM forward primer, 1.25 µL of 25 µM reverse primer, 1 µL of 10 mM of each of  
the four kinds of dNTPs, and 40 µL of sterile dd H2O. PCR reaction conditions were 
determined according to the different primers and template DNA used. 
 Initial reaction Cycle reaction Last cycle 
GST+MSR 
construction 
1 cycle 
94 °C, 2 mins 
36 cycles 
94  °C, 2mins; 
59  °C, 1 mins; 
72 , °C, 7 mins. 
1 cycle 
4 °C, 24 hour 
 
PCR reactions for 
site-directed 
mutagenesis to 
generate variant 
forms  of MSR 
1 cycle 
95 °C, 2 mins 
18 cycles 
94 °C, 45 seconds; 
55 °C, 1 mins; 
72 °C, 10 mins 
1 cycle 
4 °C, 24 hour 
 
Table 2.3 PCR reaction conditions used in this project.  
Details of the mutagenesis methods used are given in Section 2.3.7. 
2.3.6.   Sources of DNA 
The plasmids encoding wild-type MSR, the FAD/NADPH binding domain of 
MSR [1] and the activation domain of MS [118] were all constructed by Dr Kirsten 
Wolthers and have been described previously. 
2.3.7. Site-directed mutagenesis 
The aim of these mutagenesis reactions was to substitute one aspartic acid 
residue (Asp
652
) in MSR to alanine, arginine and asparagine and one tryptophan 
residue (Trp
697
) in MSR to asparagine and histidine, respectively.  The Quikchange 
site-directed mutagenesis kit from Stratagene was used in all these mutagenesis 
reactions.  
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  For each mutagenesis reaction, one forward and one reverse direction primer, 
which contained the code of the target amino acid to be changed, were designed and 
then synthesised by MWG Biotech.  Each PCR reaction consisted of 5µL of 10 x 
PCR reaction buffer, 1.25 µL (125 ng) of each of the forward and reverse direction 
primers, 50 ng ds DNA template, 1 µL Pfu Turbo DNA polymerase (2.5 unit/µL), 1 
µl dNTP mix (10 mM dNTPs stocks) with dd H2O to a final volume of 50 µL. The 
PCR reaction cycling parameters are shown in Table 2.2. When the cycling reaction 
finished, 1 µL Dpn1 (20 units/µL) was added at 37°C for 1 hour to digest the DNA 
template.   
 The product of the PCR experiment was identified by electrophoresis on the 
basis of size in a 1 % agarose gel by comparison with the standard DNA ladder 
marker and then transformed in to E. coli JM109 competent cells to amplify the 
DNA. After growing at 37 °C over night in 5 mL LB medium with 5 µg/µL 
ampicillin, the cells were treated with the QIAGEN plasmid purification kit to 
extract the plasmid DNA. Some of the extracted plasmids were digested with 
specific restriction enzymes and sequenced to confirm the target mutants. After 
confirmation, the plasmids were transformed to competent E. coli BL21 (DE3) cells 
to express target mutant proteins.  
2.4.      Protein expression and purification 
2.4.1.   Protein analysis  
2.4.1.1 Protein concentration 
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 The concentration of the wild-type and variant proteins of full-length MSR 
and the FAD/NADPH binding domain of MSR were calculated using the absorbance 
of the flavin cofactors and the Beer-Lambert relationship [134]. 
A= ε. c. l 
Equation 2.2 
 Where A is absorbance, c is the concentration of the protein sample, l is the 
path length in cm, and ε is the molar extinction coefficient.  At 454 nm the molar 
extinction coefficient for MSR and the FAD/NADPH binding domain are 21,600 M
-
1
cm
-1
 and, 11,300 M
-1
cm
-1
, respectively. 
2.4.1.2 SDS-PAGE electrophoresis 
SDS-PAGE electrophoresis was performed to separate and characterise mixed 
protein samples. It was also used as a routine method to determine the purity of the 
proteins. A Biorad mini-protean assembly was used with a 15 % running gel, which 
consists of 5 mL 30 % acrylamide, 2.3 mL ddH2O, 2.5 mL 1.5 M Tris-HCl pH 8.8, 
100 µL10 % APS and 10 µL TEMED. After the running gel formed, the stacking 
gel, which comprised of 2.1 mL ddH2O, 0.5mL 30 % acrylamide, 0.38 mL 1 M Tris-
HCl pH 6.8, 30 µL10 % SDS, 50 µL 10 % APS and 3 µL TEMED, was poured on 
the top of the running gel and a Teflon comb inserted. When the gels were 
completely cooled and set, samples were added. 
 Protein samples were mixed with an equal volume of loading buffer, which 
contains 0.25M Tris-HCl, 1% SDS, 10% glycerol, 2-mercaptoethanol (v/v) and 0.2% 
bromophenol blue and boiled for 5 minutes. Then the mixture was added to the well 
on the gel which was left by removing the comb from the gel. The gel was 
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submerged in SDS-PAGE running buffer, which consisted of 25 mM Tris base, 192 
mM glycine, and 3.5 mM SDS. Once the sample was loaded, it was run under a 
constant voltage of 160 V. It took about 1 hour for the dye front to travel to the 
bottom of the gel. Then, the gel was unpacked and stained in Coomassie Brilliant 
Blue R250 buffer, which comprised 50 % v/v methanol, 10 % v/v acetic acid, 0.25 % 
w/v Coomassie Brilliant Blue R250, for 30 minutes with gentle shaking. Finally the 
SDS-PAGE gel was destained in a solution including 40 % v/v methanol, 10 % v/v 
acetic acid for at least 30 minutes.         
2.4.2.Expression of wild-type MSR, MSR mutant proteins, and MS activation 
domain 
All of the protein samples used in this thesis including the wild-type full-
length MSR, its FAD/NADPH binding domain, mutants of these proteins and the 
activation domain of MS, were expressed in E. coli. The E. coli strain BL21 (DE3) 
which harboured the target expression plasmids, was grown in 5 mL LB medium 
containing ampicillin (100 µg/mL) at 37 °C overnight. Then 0.2 mL of the overnight 
culture was used to inoculate 200 mL LB medium containing ampicillin (100 
µg/mL) at 37 °C overnight for use as a seed culture. 10 mL of the seed culture was 
used to inoculate 500 mL modified Terrific Broth medium (TB) with ampicillin (100 
µg/mL). This TB medium culture was grown at 28 °C whilst checking the optical 
density (OD) at 600 nm after 5 or 6 hours. When the OD600nm reached about 1.0, 
IPTG was added to a final concentration 0.1 mM to induce expression of the target 
protein. The culture was grown further at 25°C  overnight. Finally, the overnight 
culture was centrifuged at 5000 g for 20 minutes to harvest the cells. The cells were 
stored at -80 °C for further purification. 
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2.4.3.   Purification of MSR and MS 
2.4.3.1. Purification of wild-type FAD/NADPH binding domain of MSR and 
mutant proteins 
 Purification of the wild-type FAD/NADPH binding domain of MSR was 
essentially as described previously [1]. In the purification process, cells which had 
been stored at -80 °C were thawed on ice and suspended in 1x GST binding buffer 
(4.3 mM Na2HPO4, 147 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, 0.5 mM EDTA, 
pH7.2) containing a Complete
TM
 protease inhibitor tablet (Roche) (~ 2 per 200 mL 
cell pellet volume) and lysozyme at a final concentration of 200 unit/mL. Then, after 
20 minutes of gentle mixing of the suspended cells, the cells were sonicated in a 
Misonix XL2020 sonicator (Misonix Inc) using the following parameters: 20 
seconds burst, 3 minutes pause intervals for 40 minutes in position 7. Then the 
sonicated cells were immediately centrifuged at 15000 g for 60 minutes.    
 After adding one volume of ice cold 1 x GST binding buffer to adjust the pH 
and to decrease the ionic concentration, the supernatant from the centrifugation 
mixture was loaded on to a Glutathione-Sepharose 4B (Glutathionine Superflow 
Resin, Fisher Scientific) column (75 x 39 mm), which had been equilibrated with 1 x 
GST binding buffer.  The washing speed is an important factor which affects the 
protein binding to this column, and it was discovered that protein bound more 
efficiently when applied at a slow rate 20 mL/min. After loading, 1 litre GST binding 
buffer was applied to the column to wash off any non-specifically bound protein. 
After the washing step, the bound protein was eluted from the column in 50 mM 
Tris-HCl buffer pH8.0 containing 10 mM reduced glutathionine, 0.5 mM EDTA and 
1 mM DTT.  
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 After concentrating to a small volume of about 10 mL, the elution mixture, 
(the target enzyme protein containing a GST tag,) was incubated with Thrombin 
protease (Thrombin Protease, 500 units, Amersham Biosciences No. 27-0846-0) to 
separate the GST tag and the target protein. The solution was dialysed against 50 
mM Tris-HCl buffer, pH 8.0 containing 0.5 mM EDTA and 1 mM DTT at 4 °C 
overnight. Then the dialysis mixture was applied to a small Glutathione-Sepharose 
4B column (54 x 30 mm), which had been equilibrated with 1x GST binding buffer 
to completely separate the target protein from the GST tag. Finally, the target protein 
was collected and concentrated by ultracentrifugation at 145,421g (maximum 
193,357g) for 1 hour for further purification. 
 After purification on the GST affinity column, the target protein was purified 
further by anion exchange chromatography. A Q-Sepharose high-performance 
column (145 x 25 mm) was used, which was equilibrated in 50 mM NaCl in 50 mM 
Tris-HCl buffer, pH 7.5 containing 50 mM NaCl. After loading the sample and 
washing to remove weakly bound proteins, the target protein was eluted using a 
linear gradient (50 mM to 500 mM NaCl) at a flow rate of 4 mL/min. The eluted 
fractions, containing the target protein, were identified by the absorbance spectrum 
at 454 nm and 280 nm and the protein identity was confirmed by electrophoresis in a 
10 % SDS-PAGE gel by comparison with a standard protein marker ladder. After 
concentration and dialysis against 50 mM Tris-HCl buffer, pH 7.5, 20 % glycerol 
was added to the target protein, (wild-type FAD/NADPH binding domain of MSR or 
it corresponding variants) and proteins were frozen in liquid nitrogen and stored at -
80 °C for further crystallography and kinetic studies.  
2.4.3.2. Purification of wild-type full-length MSR and its mutant forms 
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         The procedure for the purification of the wild-type full-length MSR and mutant 
proteins consists of two phases. The first phase of purification is identical to the 
purification procedures used for the FAD/NADPH binding domain of MSR, which is 
described in section 2.4.3.1. In the second phase of the purification, the MSR 
protein, which had undergone GST affinity chromatography and Q-Sepharose anion 
exchange chromatography, was loaded onto a Superdex 200 gel filtration column 
(volume 180 cm
3
), which had been equilibrated with 50 mM Tris-HCl buffer, pH 7.5 
containing 0.3 M NaCl. The protein was eluted in the same buffer at a flow rate of 
0.3 mL/min. The MSR fraction in the elution profile was indicated by its absorbance 
at 280 nm and 454 nm and the protein identity was confirmed by SDS-PAGE 
electrophoresis. Protein samples of interest were pooled and concentrated by 
ultracentrifugation at 145,421 g (maximum 193,357 g) for 1 hour and 20 % glycerol 
was added to the purified MSR and the solution prior to freezing in liquid nitrogen 
and storage at -80 °C for further kinetic studies. 
2.4.3.3. Purification of the activation domain of MS 
 The protocol for the purification of the activation domain of MS comprises 
sonication, centrifugation, and affinity and anion exchange chromatography 
procedures. First, the frozen E. coli BL21 (DE3) cell pellet, which had been stored at  
-80°C and contained the over expressed protein, was thawed on ice and suspended in 
cold 50 mM potassium phosphate buffer, pH 7.4, also containing 1 mM EDTA. 
Complete protease inhibitor tablets (~ 2 tables per 200 mL cell pellet volume, 
Roche) and lysozyme 200 µg/mL were also contained in the buffer. The cell 
suspension was sonicated 10 times using a High Intensity Ultrasonic Liquid 
Processor (Sonics, Sonics & Materials, Inc) in 20 second bursts with 50 second 
cooling intervals on ice. After sonication, the mixture was centrifuged at 15000 g, 4 
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°C for 1 hour. The supernatant from the centrifugation was then mixed with Ni-NTA 
resin (Ni-NTA His Bind Resin, Novagen 70666-4) concentrated in 0.5 M sodium 
chloride, 20 mM imidazole and 50 mM potassium phosphate buffer, pH 7.4, for 1 
hour. Then, the Ni-NTA resin was centrifuged at 3000 g, 15 minutes, 4 °C and 
packed in a column (54 x 30 mm) for purification by affinity chromatography.  
 The Ni-NTA column, containing the bound activation domain of MS, was 
washed with 50 mM potassium phosphate buffer, pH 7.4, which also contained 0.5 
M NaCl and 60 mM imidazole. Then the target protein was eluted from the column 
in 50 mM potassium phosphate buffer, pH 7.4, containing 0.5 M NaCl and 0.4 M 
Imidazole. The eluted fractions were dialyzed against 2 litres ddH2O at 4°C for 2 
hours and 50 mM Tris-HCl buffer, pH 7.5, at 4 °C for 16 hours. The dialysed protein 
was loaded onto a Q-Sepharose column (54 x 30 mm) which had been pre-
equilibrated with 50 mM Tris-HCl pH 7.5. The column was then washed with 300 
mL 50 mM Tris-HCl buffer, pH 7.5. The column was developed with a linear 
gradient ranging from 0 mM to 500 mM NaCl in 50 mM Tris-HCl buffer pH 7.5. 
The fractions containing the activation domain of MS were identified by the 
absorbance peak at 280 nm and confirmed by 12 % SDS-PAGE electrophoresis. 
Finally, the purified activation domain of MS was concentrated and stored at -80 °C 
with 20 % glycerol for further crystallography experiments. Prior to the 
crystallography experiment, the frozen enzyme samples were thawed and  passed 
over a 10 mL Bio-Rad Econo-Pac 10 DG column, which had been equilibrated with 
10 mM Tris/HCl buffer, pH 8.0 containing 0.5 mM DTT, 1 mM EDTA, and 0.05 % 
NaN3, to remove the glycerol. 
 2.5.  Crystallogenesis, X-ray diffraction and model building 
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2.5.1. Crystallogenesis of the FAD/NADPH binding domain of MSR 
 Crystals of the FAD/NADPH binding domain of MSR were produced using 
the sitting drop vapour diffusion method. In this process the purified enzyme 
(10mg/mL) was first dialyzed against 10 mM Tris/HCl buffer, pH 8.0 containing 0.5 
mM DTT, 1 mM EDTA, and 0.05 % NaN3 to desalt. The enzyme then was mixed 
into different precipitant buffers at 4 °C. Some higher resolution diffraction crystals 
came from the reservoir solution which contains 0.1 M Tris/HCl buffer, pH 7.5, 0.2 
M KBr and 15 % PEG 4000. Some of these crystals were bathed in the mother liquid 
to which a saturating concentration of NADP
+ 
was added. These crystals were then 
soaked in a 50:50 mixture of Paratone and mineral oil (cryoprotectant) at 4 °C before 
being flash-cooled in liquid nitrogen and prepared for an X-ray diffraction 
experiment. 
2.5.2. X-ray diffraction on the FAD/NDAPH binding domain of MSR 
The X-ray diffraction experiment on the FAD/NADPH binding domain of 
MSR was carried out at the European Synchrotron Radiation Facility (Grenoble, 
France) on ID14-EH3 using an ADSC Q4 CCD detector. The data sets were 
collected to 1.9 Å resolution with and without bound NADP
+
 and used for model 
building of the structure of protein. Data collection was performed by Dr David Leys 
(University of Manchester). 
2.5.3.Structure determination and refinement of the model for the 
FAD/NADPH binding domain  
The data from the X-ray diffraction studies of the FAD/NADPH domain of 
MSR were processed and scaled by the HKL package program DENZO and 
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SCALEPACK [135]. With the aid of the recorded structure of cytochrome P450 
reductase as the research mode (PDB code 1 AMO), the structure was resolved using 
the molecular replacement method and the program AMoRE [4]. The REFMAC5 
program [136] was used to do the positional and B-factor refinement using the 
restrained and TLS modes; the program TURBO-FRODO [137] and COOT [138] 
were used for the alternate rounds and manual rebuilding of the model; the program 
ARP/wARP was used to build the waters and partial rebuilding of the model. Dr 
Helen Toogood provided assistance with data analysis and model building 
throughout the crystallographic work presented in this thesis, and this input is 
gratefully acknowledged. 
2.5.4. Crystallogenesis on the activation domain of MS 
The crystals of the activation domain of methionine synthase (MS) were 
grown using the sitting drop vapour diffusion method at 4 °C and 19 °C respectively. 
The Mosquito robot from TTP Lab Tech Ltd was used in these experiments. The 
concentration of the activation domain of MS was 20 mg/mL and it took 3 days until 
the crystals appeared in reservoir solutions, which comprised 0.1 M tri-sodium 
citrate buffer, pH 5.5, 0.1 M tri-sodium citrate 10 % w/v PEG 3000, 0.2 M sodium 
malonate 20 % w/v PEG 3350, respectively.  The crystals were picked out and 
identified by 12 % SDS-PAGE electrophoresis and the SDS-PAGE gel was stained 
using one Silver Quest
TM
 Silver staining Kit (Invitrogen
TM
 Life Technology). The 
crystallogenesis of the activation domain of MS provided useful information for 
further crystallization trials of the complex formed between MSR and the activation 
domain of MS (now being pursued by others in the research group). 
2.6.    Kinetic studies 
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2.6.1. Steady-state kinetic studies with the FAD/NADPH binding domain of 
MSR 
 Steady-state kinetic activities of wild-type FAD/NADPH binding domain of 
MSR and the mutants D652A, D652R and D652N, were measured using FeCN as an 
electron acceptor and NADPH as electron provider using a Varian Cary 50 Bio 
single-beam UV-Visible spectrophotometer with a 1 cm light path. Each 1 mL 
reaction mixture consisted of 50 mM potassium phosphate buffer, pH 7.0, 1µM 
FeCN and NADPH, the concentration of which was varied from 0 to 100 µM and 
was measured by the absorbance at 340 nm, (ε340= 6,220M
-1
cm
-1)
 and the wild-type 
FAD/NADPH binding domain of MSR or its mutants. The reaction was started by 
the addition of the FAD/NADPH binding domain of the MSR enzyme to a final 
concentration of 0.0126 µM at 25°C and data were recorded over 1 minute. The 
initial velocities were determined by the change in the absorbance at 420 nm using 
the extinction coefficient for FeCN at 420 nm (ε420 =1020 M
-1
cm
-1
). The initial 
velocity obtained under the varied NADPH concentration from 0.5 to 100 µM were 
analysed using the Michaelis-Menten equation to obtain the apparent values for Vmax 
and apparent Km [139]. Origin (version 6.0) software was used to finish the non-
linear least-squares regression analysis on the data. After several iterations 
reasonable estimates, the final data was repeat at least 30 times, allowing the Vmax 
and Km values to vary in the final fitting sessions. 
 
m
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Equation 2.3 
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2.6.2.Steady-state kinetic studies with the wild-type full-length MSR and its 
mutant forms 
  The methodology and equipment employed for the measurement of the steady-
state activities of wild-type full-length MSR and some of the mutant forms (W697A, 
W697H and W697) were similar to that used for analysis of the FAD/NADPH- 
binding domain of MSR, but with some changes to the substrate and enzyme 
quantities. Cytochrome c was chosen as the electron acceptor and NADPH as an 
electron provider. The rate of the reduction of cytochrome c was monitored at 550 
nm using the extinction coefficient ε550 = 21,100 M
-1
cm
-1
 after the addition of 1 to 2 
µg MSR to start the reaction. Finally, the initial velocity was obtained by varying 
concentrations of electron donor and acceptor and data were analysed using the 
Michaelis-Menten equation to obtain the apparent values for Vmax and the apparent 
Km (see Equation 2.3). Origin (version 6.0) software was used to finish the non-
linear least-squares regression analysis on the data. After several iterations 
reasonable estimates, the final data was repeat at least 30 times, allowing the Vmax 
and Km values to vary in the final fitting sessions. 
2.6.3. Steady-state inhibition studies with wild-type and the mutant forms of the 
FAD/NADPH- binding domain of MSR 
  Steady-state inhibition studies were carried out in a 1.0 mL mixture at 25 °C in 
a 1 cm path length cuvette. The mixture contained 50 mM Tris/HCl, pH7.5, 8 µM 
FeCN for the mutants of the NADPH/FAD binding domain (or 8 µM cytochrome c
3+
 
for the full length MSR mutants), a variable concentration of NADPH, and a variable 
concentration of the inhibitors NADP
+ and 2‘5‘ ADP. The reaction was initiated by 
the addition of the enzyme, one of the NADP/FAD binding domain mutants or the 
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full length MSR mutants. The absorbance change at 420 nm for FeCN, ε420nm = 1,100 
M
-1
cm
-1
, was used to monitor the reaction and data fit with the nonlinear least-
squares analysis to the equation for competitive inhibition [140]. Origin (version 6.0) 
software was used to finish the non-linear least-squares regression analysis on the 
data. After several iterations reasonable estimates, the final data was repeat at least 
30 times, allowing the Vmax , Km  and Ki values to vary in the final fitting sessions 
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Equation 2.4 
         In Equation2.4, ν is the initial velocity; Vm is the maximal velocity; A is the 
varied substrates concentration; KM is the apparent Michaels constant; I is the 
inhibitor concentration and Ki is the inhibition constant. 
2.6.4.Pre-steady-state kinetic studies on the wild-type FAD/NADPH binding 
domain of MSR and mutants. 
  Pre-steady-state turnover studies with the FAD/NADPH binding domain of 
MSR were performed using an Applied Photophysics SX1.7 MV stopped-flow 
spectrophotometer. The following conditions were used for these experiments: 
reaction buffer, 50 mM potassium phosphate buffer pH 7.0 at 25 °C; enzymes 
concentration, 4µM for single-wavelength studies and 20 µM for photodiode array 
experiments. To avoid any undesired oxidation, experiments were carried out under 
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anaerobic conditions using a stopped-flow device maintained in a Belle Technology 
anaerobic glove box. The buffer was made oxygen-free by evacuation and extensive 
bubbling with nitrogen before being placed in the glove box overnight. Before 
starting the experiment in the glove box, the enzyme sample was treated with 
potassium ferricyanide to ensure that it was fully oxidized and then passed through 
an Econo-Pac 10 DG column (Bio-Rad) equilibrated with anaerobic 50 mM 
potassium phosphate buffer pH 7.0, to remove excess ferricyanide. In addition, the 
NADPH was prepared in the glove box and the concentration was calculated using 
ε340 = 6,220 M
-1
cm
-1
. These experimental conditions were used for both the multiple 
wavelength absorbance studies and single-wave length absorbance studies. 
 The stopped-flow multiple wavelength absorbance studies were carried out 
using a photodiode array (PDA) detector and X-SCAN software (Applied Photo-
physics Ltd). Under the single turnover condition, the FAD/NADPH- binding 
domain of MSR was mixed with NADPH (20-fold excess over MSR to ensure 
pseudo-first order conditions). The reduction of the FAD/NADPH binding domain of 
MSR was detected by the bleaching of the absorbance maxima at 454 nm. The 
resulting spectra were interpreted using global analysis and numeral integration 
methods (PROKIN software, Applied Photophysics Ltd). The resulting stopped-flow 
traces were fitted to a single-exponential expression equation [113]. Origin (version 
6.0) software was used to finish the non-linear least-squares regression analysis on 
the data. After several iterations reasonable estimates, the final data was repeat at 
least 30 times, allowing the kobs values to vary in the final fitting sessions : 
beCA
tk
1
obs    
Equation 2.5 
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Where kobs is the observed rate constant, t is time, C1 is the amplitude change 
and b is the offset value corresponding to the non-zero baseline value. This method 
was also used in the stopped-flow studies with the mutant forms of the 
FAD/NADPH binding domain of MSR (F652A, F652R and F652N) and wild-type 
of full-length MSR and its mutants (F652A, F652R and F652N,W697A, 
W697H). However, for full length MSR rate constants (kobs1 and kobs2) for successive 
hydride transfers were obtained by fitting to a double exponential function. Origin 
(version 6.0) software was used to finish the non-linear least-squares regression 
analysis on the data. After several iterations reasonable estimates, the final data was 
repeat at least 30 times, allowing the values to vary kobs1 and kobs2 in the final fitting 
sessions: 
beCeCA
tk
2
tk
1
2o bs1b s0 
  
                              Equation 2.6 
Where kobs1 and kobst2  are the obsereved rate constants and C1 and C2 are their 
relative amplitude and b is the final absorbance. 
 
2.6.5.Redox titrations of the flavin cofactors in FAD/NADPH binding domain of 
MSR  
As with the stopped flow experiments, redox titration experiments with the 
FAD/NADPH binding domain of MSR were carried out in a Belle Technology glove 
box under a nitrogen atmosphere (oxygen concentration < 5 ppm) at 25 °C. The 
enzyme sample was put into the glove box and oxidized with added potassium 
ferricyanide to ensure full oxidation and, then applied to the 10 mL Bio-Rad Econo-
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Pac 10DG column(15 x 60 mm). This column had been equilibrated with 100 mM 
potassium phosphate pH 7.0, which had been extensively bubbled with argon and 
stored in the glove box. After adding three kinds of redox mediators [i.e. benzyl 
viologen (final concentration 1 µM), methylviologen (final concentration 0.5 µM), 
2-hydroxy-1, 4-naphoquinone (final concentration 5 µM)], the enzyme sample was 
initially titrated to the reduced state by adding sodium dithionite, then reoxidized by 
adding potassium ferricyanide. The absorbance spectra from 280 nm to 800 nm were 
recorded by a fibre optic absorption probe (Varian) linked to a Varian Cary 50 probe 
UV-visible spectrophotometer. After the addition of the reductant or oxidant, the 
electrochemical potential was measured with a Hanna instruments pH21 
pH/voltmeter coupled with Pt/calomel electrode (Thermo Russell Ltd). The 
Fe(II)/Fe(III)-EDTA couple (+108 mV) was used as a standard to calibrate the 
instrument. Because every observed potential needed to be normalized to the 
standard hydrogen electrode, it was necessary to add 244 mV to every potential 
value. Finally, the absorbance data for the FAD cofactor at 600 nm of the enzyme 
sample was plotted to the determined redox potential and the data were fitted to 
equation 2.7 [113]: 
     
 
Equation2.7 
          This equation is derived from the Beer- Lambert Law and Nernst equation to 
describe a two electron reduction process. In this equation, A is the total absorbance, 
and a, b, c are the component absorbance values contributed by one flavin in the 
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oxidized, semiquinone and hydroquinone state. E is the observed potential; E1
’
, E2
’
 
are the midpoint potential for the ox/sq and sq/hq couples. The absorbance of the 
enzyme sample versus potential was illustrated by non-linear least-squares 
regression analysis using Origin software (version 6.0) according to these equations. 
After several iterations reasonable estimate, the final data was repeated at least 30 
times, allowing the values to vary E1 and E2 in the final fitting sessions.The midpoint 
potential for the ox/sq and sq/hq can be calculated from this treatment. 
Analysis of redox titration experiments for mutants of the FAD/NADPH 
binding domain of MSR, D652A, D652R and D652N were performed using similar 
procedures. 
 2.7.  Fluorescence studies on the wild-type MSR and mutants 
 Fluorescence is one of the most useful tools in flavoprotein research. It can be 
employed to investigate the structure integrity, kinetic properties and other aspects of 
flavoproteins. The basic theory of fluorescence is that the sample molecules can 
absorb a photon of energy at a defined wavelength. The absorbed energy promotes 
electrons from a low state to higher energy state with return to the ground state 
accompanied by the loss of energy and emission of photons. In flavoproteins, two 
types of groups can emit fluorescence. One is flavin, which has absorption maxima 
at 369 nm to 390 nm and 440 nm to 470 nm. The other comprises the amino acids 
tryptophan (the indole group of which absorbs with a λ max = 280 nm with the 
extinction coefficient, ε = 5050 M-1 cm-1 and fluorescence emission maxima between 
320 nm to 360 nm); there are also smaller contributions from the fluorescence 
emission of tyrosine and phenylalanine [141].  
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 Tryptophan fluorescence was used in stopped-flow fluorescence studies of 
electron transfer of wild type full-length MSR and the mutant W697A full length 
MSR protein. These studies were used to report on local dynamic changes associated 
with residue W697 located in the NADPH binding pocket. In stopped-flow studies 
the emission wavelength 340 nm and excitation 295 nm was selected using an 
appropriate band-pass filter. Time dependent fluorescence data were analysed by 
fitting to a standard monophasic equation. Corresponding static (i.e. not time 
resolved) fluorescence studies were performed using a Cary Eclipse fluorimeter 
(excitation wavelength of 295 nm and an emission wavelength of 340 nm was 
selected with an appropriate band-pass filter). 
 
2.8.    Electron spin echo (ESE) studies on the wild-type full-length MSR 
2.8.1  Sample preparation for ESE 
The enzyme samples for ESE experiments on the wild-type full-length MSR 
were prepared within the Belle Technology glove box under anaerobic conditions 
(O2<5 ppm).  The fully oxidized enzyme was reduced by adding sodium dithionite to 
generate the semiquinone or hydroquinone state of the cofactor FAD. The 
concentration of the sample was determined using the extinction coefficient ε454 of 
25,600 M
-1
cm
-1
. While titrating with sodium dithionite, the absorbance of the sample 
was monitored. When the spectral feature of semiquinone or hydroquinone were 
identified, 100 µL aliquots of 400µM protein samples were transferred into four EPR 
tubes and mixed with either 100 µL 800 µM NADP, 100 µL 800 µM, 2,5-ADP or 
100 µL 800 µM activation domain of MS, respectively. The final 200 µL protein 
sample which contains 200 µM protein were immediately sealed in EPR tubes by 
79 
 
using parafilm and flashed-frozen in liquid nitrogen and stored in liquid nitrogen for 
subsequent analysis by EPR, ENDOR, ESEEM and ELDOR spectroscopy. 
2.8.2 EPR 
2.8.2.1. Theory of EPR 
 Paramagnetic centres refer to the sites in molecules and atoms with free 
unpaired electrons. Under the absence of an external magnetic field, the unpaired 
electron spins in a random way; when the external magnetic field is applied, the 
unpaired electron spins around an axis in either +1/2 or -1/2 spin state. Under the 
external magnetic field, the unpaired electrons are divided into two groups: one 
group spins parallel to magnetic field orientation with decreasing energy level; 
another group spins anti-parallel to the magnetic field orientation with increasing 
energy level. EPR can detect these spin state transitions.  
 Sample are placed into a strong homogenous magnetic field and 
simultaneously exposed to an electromagnetic radiation with a frequency ν, which is 
equal to the difference between the two electron levels [142].  
h ν = g β H 
Equation 2.8 
 Where h stands for the Plank constant; ν is the electromagnetic radiation 
frequency; g is a constant (g factor); β is the Bohr magneton, a unit that expresses the 
magnetic moment of the electrons. 
 The radiation energy will cause the odd electron, which is located on the low 
energy level, to jump to higher level with a simultaneous change in the spin direction 
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and energy absorption. When the upper level electrons pass onto the lower level, 
radiation of a quantum of electromagnetic energy occurs. This kind of change of spin 
direction at the resonance conditions is related with net absorption energy from the 
applied electromagnetic radiation, which can be detected by a spectrometer to 
produce an EPR signal. Among the main parameters of EPR spectrum, such as the 
integral intensity, line width, and saturation effect, the g-factor is the most important 
parameter g-factor characterises the resonance point position and is determined by 
the field value giving rise to the resonance. The g-factor of a free electron B is 
2.0023 [143]. Now EPR spectroscopy is a routine method to provide reliable and 
detailed information on the formation of flavin semiquinone in the flavoprotein. 
2.8.2.2. EPR experiments and conditions 
All EPR spectra were obtained using a Bruker ELEXSYS E500/E580 
spectrometer operating at X-band. Temperature control was achieved using an 
Oxford Instruments ESR900, for continuous wave EPR, or ESR935, for pulsed 
measurements, cryostat connected to an ITC503 temperature controller. Continuous 
wave spectra were obtained at 80K using the parameters given in the figure caption.  
2.8.3. ENDOR 
2.8.3.1. Theory of ENDOR       
Electron Nuclear double Resonance, ENDOR, is a double resonance technique 
which combines the high resolution and nuclear selectivity of an NMR experiment 
with the sensitivity of an EPR experiment. An ENDOR experiment is performed by 
monitoring the EPR signal intensity while sweeping a RF (Radio Frequency) signal 
to drive the NMR transitions. Double resonance experiments such as ENDOR 
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require more effort than EPR or NMR experiments, but provide greater insight into 
the structure, dynamics, and electronic structure of the sample.                        
 In biochemical research on flavoproteins, ENDOR spectroscopy provides 
improved spectral resolution and information on the molecular structure and 
electronic distribution on model flavin and flavin radicals. Usually, ENDOR focuses 
to detect the strong hyperfine coupling aroused by 8-CH3 and 6-CH3 proton in 
anionic and neutral semiquinone and the change of the electron density distribution 
on the flavin ring. ENDOR spectra of flavin semiquinones are essentially 
symmetrical about the central ‗matrix‘ feature which occurs at the proton Larmor 
frequency which is ~14.7 MHz in the spectrometer used. The symmetrical pairs of 
lines are separated by the hyperfine coupling constant, A, of the proton in question. 
Anisotropy (asymmetry) in the hyperfine coupling constant is manifested as 
asymmetry in the ENDOR lines. 
2.8.3.2 ENDOR experiments and conditions 
          The sample preparation, equipments and conditions for ENDOR are the same 
as those employed for EPR. The Davies pulsed ENDOR methodology was used to 
acquire the spectra. The pulse sequence was π-T-π/2-τ-π-τ-acquire with π = 200 ns, τ 
= 1200 ns and T = 12 μs with a 10 μs radiofrequency (NMR) pulse applied 1 μs after 
the initial π pulse.  
2.8.4 ESEEM 
2.8.4.1 Theory of ESEEM 
Electron spin echo envelope modulation, ESEEM, is a pulsed EPR method, 
which is used to detect weak hyperfine interaction between the paramagnetic centers 
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and quadrupolar nuclei such as 
14
N
, 2
H. The electron spin echoes in ESEEM are 
induced by the application of two or more resonant microwave-pulses and the 
amplitude of the echo modulates with a periodic variation as a function of the 
interval between the pulses and coupling of the unpaired electron to ‗magnetic‘ 
nuclei. Fourier transformation of the modulation pattern indicates the resonant 
frequencies of the nuclei coupled to the paramagnetic center. These frequencies can 
be used to determine the hyperfine and electric quadrupole couplings of nuclei 
within the sample. 
 2.8.4.2 Sample preparation and equipment  
The sample preparation and equipment for ESEEM are the same as that for the 
EPR experiment. The ESEEM spectra were recorded using a π/2-τ-π-τ-acquire 
sequence with τ increasing from 200 ns to 4296 ns in 4 ns steps. The echo decay 
obtained contained the nuclear modulation information. The decay function, 
essentially TM, was fitted as an exponential and subtracted. The remaining 
modulation pattern was apodized using a Hamming window function and then 
Fourier transformed. 
2.8.5. ELDOR 
2.8.5.1 Theory of ELDOR 
Electron-electron double resonance, ELDOR, is an EPR technique in which 
two microwave frequencies are applied to a sample. One frequency, called the 
observe frequency, is applied to monitor a specific region of the EPR spectrum and a 
second frequency, called the pump frequency, is applied to other regions of the EPR 
spectrum. An ELDOR response is any pump frequency dependent change in the EPR 
spectrum. Principally, ELDOR measurement is a way to study a variety dynamic 
83 
 
processes that control relaxations between the pumped and observed spins. Since 
pulsed ELDOR can generate electron spin echo modulation via dipolar coupling, it is 
possible to determine the distance between the FAD and FMN centres in the wild-
type MSR. The dipole-dipole coupling between the two electronic magnetic centers 
is related to the distance between them, and can be calculated by equation 2.9 [115]. 
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Equation 2.9 
         Where g1 and g2 are the g values of the two spins, r is the distance between 
them, and θ is the angle between the inter-spin vector and the applied magnetic field. 
Therefore, determination of the dipole-dipole coupling between the two 
flavosemiquinone of MSR provides a means of quantitating differences in inter-
flavin distance brought about by ligand binding. The four pulse ELDOR experiment 
provides a means of determining such dipole-dipole couplings. 
2.8.5.2 Sample preparation and equipment  
        The sample preparation, equipment and conditions for ELDOR are exactly the 
same as that for EPR. Some changes on the parameters are mentioned. Four pulse 
ELDOR spectra were recorded using a π/2-T-π-T+τ-π-τ-acquire sequence with T = 
200 ns and τ = 1280 ns. The π pulse was 32 ns. The ‗fourth‘ pulse was a π pulse 
applied at the pump frequency 300 ns after the beginning of the sequence. The 
position of this pulse within the sequence was incremented by 16 ns during the T+τ 
period. All pulse experiments were recorded at 80K and at a repetition frequency of 
200 Hz due to the long electron spin lattice relaxation time of the flavosemiquinone 
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radical. Inter-electron dipolar couplings were determined using Fourier transform of 
the baseline corrected four pulse ELDOR data to produce dipolar spectra [144].  
Some materials, purification and kinetic research protocols in this chapter have 
applications in the further structure and kinetics studies on the FAD/NADPH binding 
domain. 
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CHAPTER THREE 
STRUCTURAL STUDIES ON THE WILD-TYPE FAD/NADPH 
BINDING DOMAIN OF MSR 
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3.1.    Introduction 
 Human MSR, one member of the diflavin reductase family, is known to 
comprise two structural domains: a N-terminal FMN-binding domain and a C-
terminal FAD/NADPH-binding domain. The FAD/NADPH binding domain contains 
536 amino acids, which range from residue 163 to residue 698. In previous work this 
domain has been fused genetically to a GST tag in plasmid pGEX-4-T1 and 
expressed in E. coli, to enable rapid purification of the domain [1]. This domain is an 
essential part of MSR and is involved in the binding of NADPH and the electron 
transfer from NADPH to cofactor FAD.  
 In this chapter, the expression of the FAD/NADPH-binding domain of MSR in 
E. coli BL21 cells is described. Further, the extraction by sonification and 
centrifugation methods and the purification by affinity chromatography and ion-
exchange chromatography procedures are also described. The purified 
FAD/NADPH-binding domain was then studied using steady-state and pre-steady-
state kinetic analysis, and crystallogenesis experiments were performed to enable 
structure determination of the domain. Diffraction quality crystals of the 
FAD/NADPH-binding domain were obtained and employed in X-ray diffraction 
experiments. Data obtained from the X-ray diffraction studies were used to build the 
crystal structure of the FAD/NADPH domain. 
 X-ray diffraction crystallography is a method used to determine the protein 
structure at atomic level, in which a beam of X-rays is applied to a protein crystal 
which subsequently diffracts into many specific directions. Based on the angle and 
intensity of these diffracted beams, a three dimensional picture of electron density 
within the crystal can be produced. From such an electron density map, the positions 
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of the atoms and chemical bonds of the protein are determined. Being the only 
method used for investigating protein structure at the atomic level, X-ray 
crystallography is still the main and most effective method for the study of protein 
structure. X-ray diffraction techniques originated in the 1950s and studies were 
focused on the measurement of a single protein structure [145]. In the 1960s and 
1970s, this method was developed to illustrate the structure of protein complexes 
such as the enzyme-substrate complex [146], enzyme-inhibitor complexes [147], 
antibody-antigen complexes [148], and DNA-protein complexes [149]. The 
complexity of protein structures being determined by this method is increasing. 
Now, the structure of macromolecular assemblies such as microtubules and flagella 
are the targets of structure determination and there are additional new technological 
developments enabling research on dynamic crystal structures [150], conformational 
changes within the crystal as a function of time [151] and cryogenic X-ray crystal 
structure analysis [116]. 
 X-ray crystallography has been employed in studies of the diflavin reductase 
family of enzymes. The crystal structures of rat CPR (free enzyme and in complex 
with ligands) have been solved [51], as well as the crystal structure of neuronal NOS 
reductase [52]. In this chapter, the crystal of the FAD/NADPH-binding domain of 
MSR was determined by the sitting drop vapour diffusion method [152]. The 
structure was solved using the DENZO [135] and AMoRE software [4] via 
molecular replacement. Structures for free FAD/NADPH-binding domain of MSR 
and the FAD/NADPH-binding domain combined with NADP
+
 are reported.    
3.2.    Results 
3.2.1.Expression of the FAD/NADPH binding domain of MSR 
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The FAD/NADPH-binding domain of MSR was available cloned in plasmid 
pGEXFADH (residues 163-698) [52]. This plasmid was transformed into E. coli 
BL21 (DE3) competent cells. The product of the transformation was plated onto the 
selective LB agar containing ampicillin added at a final concentration of 100 µg/ mL 
and incubated overnight at 37 °C. A single colony was picked from the plate and 
inoculated in 5 mL liquid LB medium with 100 µg/mL ampicillin. Following 12 
hours incubation at 37 °C, 0.2 mL was used to inoculate 200 mL LB containing 100 
mg/mL ampicillin and grown for a further 12 hours at 37 °C. 5 mL of the 200 mL 
LB product culture was transferred to 500 mL TB containing 100 µg/ mL ampicillin. 
This TB culture was grown at 28 °C for about 4 hours. When the optical density at 
600 nm reached 1.0 OD unit, IPTG was added to the culture in a final concentration 
of 0.1 mM. This culture was then grown for a further 12 hours at 25 °C. Finally, the 
cells containing the expressed FAD/NADPH-binding domain of MSR were 
harvested using centrifugation at 5000 g for 25 minutes at 4 °C. Cells were then 
stored at -80 °C for further purification. 
3.2.2. Purification of the FAD/NADPH-binding domain of MSR. 
  The purification of the FAD/NADPH-binding domain was carried out in the 
same manner as described in chapter two, which exploits the use of GST affinity 
chromatography and Q-Sepharose chromatography. A typical elution profile from 
the Q-Sepharose chromatography is shown (Figure 3.1) and an analysis of fractions 
throughout the purification process was achieved using SDS-PAGE electrophoresis 
(Figure 3.2). Following purification, the enzyme sample was analysed using 12 % 
SDS PAGE electrophoresis which revealed a single band corresponding to a 
molecular mass of ~ 60 kDa. This was in agreement with the theoretically calculated 
mass of 60 kDa determined from the amino acid sequence of the FAD/NADPH-
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binding domain. The purified protein was further analysed by UV/VIS spectroscopy 
and revealed two peaks at 382 nm and 454 nm, which are the two characteristic 
absorbance peaks for the FAD cofactor. These data confirmed the FAD/NADPH-
binding domain of MSR had been purified successfully. The protein sample was then 
stored at -80 °C for crystallization experiments. 
 
Figure 3.1 Q-Sepharose anion-exchange chromatography of the FAD/NADPH-
binding domain of MSR. The plot shows the traces of signal intensity from the 
UV light detectors analysing the elution from a Q-Sepharose anion-exchange 
column after the application of FAD/NADPH binding domain. The Y-axis 
represents the intensity of the signal from each respective detector. The X-axis 
indicates the volume of buffer eluted from the column. The protein of the 
FAD/NADPH-binding domain of MSR is eluted from 1050 mL to 1250 mL. The 
blue line indicates the absorbance intensity at 280 nm; the red line represents the 
absorbance intensity of 454 nm; the green line indicates the anion gradient of the 
buffer. 
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Figure 3.2: Analysis by SDS/PAGE electrophoresis of the purification 
procedure for the NADPH/FAD-domain of MSR. Lane 1 is the low molecular 
weight marker (97.0, 66.0, 45.0, 30.0 and 20.1 kDa), lanes 2 and 3 are the whole cell 
protein samples from BL21 (DE2) cells which contain the FAD/NADPH-binding 
domain expression plasmids, lane 4 is the elution fraction from the  GST glutathione 
affinity column, lane 5 is the mixture of the digestion of thrombin, lane 6 is the 
elution protein from the anion-exchange column.        
         Typically, the FAD/NADP-binding domain was pure following GST affinity 
chromatography, but a final ‗polishing‘ chromatography step was sometimes used 
using Q-Sepharose chromatography prior to attempts to grow protein crystals. In 
some cases, this chromatography step was successful in removing additional 
contaminants from the protein sample (Figure 3.1) 
3.2.3.   Kinetic studies on the FAD/NADPH binding domain of MSR 
 Prior to performing crystallisation studies with the purified FAD/NADPH-
binding domain it was considered important to characterise the protein both 
spectroscopically and kinetically to ensure that the protein was functionally active 
and that it was behaving in a manner expected. Consequently, a series of steady-state 
and stopped-flow studies with the isolated domain were performed to be sure that the 
protein was functionally active. These studies are described in the following 
sections. 
3.2.3.1. Spectral properties of the FAD/NADPH-binding domain of MSR 
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 The absorbance spectrum of fully oxidized wild-type FAD/NADPH-binding 
domain of MSR was found to have two absorbance peaks at 382 nm and 454 nm 
(Figure 3.3). These two absorbance peaks are characteristic of flavoproteins and 
confirmed that FAD was indeed bound to the purified enzyme sample. The ratio of 
absorbance at 280 nm and 450 nm was ~ 6.75 [153], similar to published values and 
indicates that the FAD cofactor was stoichiometrically assembled with the protein.  
 
Figure 3.3 The absorbance spectra of the oxidized FAD/NADPH-binding 
domain of MSR. The protein was contained in 50 mM Tris HCl buffer, pH 7.5, 20 
% glycerol. Protein concentration was approximately 3.5 M. 
 3.2.3.2. Steady-state reduction properties of the FAD/NADPH binding domain 
of MSR 
  The FAD/NADPH-binding domain of MSR was evaluated using the steady-
state experiment described in chapter two (section 2.6.1). The result of this 
experiment shows that the initial velocity was hyperbolically dependent on NADPH 
concentration. The Michaelis-Menten equation was used to calculate the kcat (67.26 ± 
1.4 s
-1
 for FeCN reduction at 25 °C) and the apparent Km for NADPH (9.788 ± 
1.5µM ) for the steady-state reduction of FeCN by NADPH. 
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Figure 3.4 The apparent steady-state turnover rates of the FAD/NADPH-
binding domain of MSR with variable NADPH concentration and using 
ferricyanide as artificial electron acceptor. Fitting to the Michaelis-Menten 
equation gave values for apparent kcat of 67.26 ± 1.45 s
-1 
and Km of 9.78 ±1.64 M. 
3.2.3.3 Pre-steady-state reduction properties of the FAD/NADPH binding 
domain 
 Two pre-steady-state stopped-flow kinetic studies on the FAD/NADPH-
binding domain were carried out based on the methods described in chapter two 
(section 2.6). The first study involved a reduction of the FAD cofactor by mixing 
with NADPH and following flavin reduction using photodiode array spectroscopy. 
The second study was a similar analysis for flavin reduction, but with the reduction 
process being monitored at 450 nm. Given the second experiment was performed 
using a photomultiplier tube rather than a photodiode array detector, the data are less 
noisy and rate constants can be extracted from these data with a high degree of 
confidence.   
3.2.3.3.1. Photodiode array spectroscopy analysis of reduction of the 
FAD/NADPH binding domain by NADPH 
 Flavin reduction reactions were performed under a pseudo first order single 
turnover condition (i.e. where the NADPH concentration is 20-fold excess over 
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enzyme concentration). The FAD/NADPH-binding domain of MSR was mixed with 
NADPH under anaerobic conditions at 25 °C. The reduction of the FAD/NADPH 
binding domain of MSR was detected by the bleaching of the maximal flavin 
absorbance at 454 nm over 1 second. The spectral data (Figure 3.5(A)) were 
collected using a photodiode array detector and X-SCAN software (Applied 
Photophysics Ltd., Surrey, UK) and spectral deconvolution was performed by the 
singular-value decomposition (SVD) method using PROKIN software (Applied 
Photophysics Ltd.). A one-step reversible kinetic model with two species (A, 
oxidised enzyme; B, two electron-reduced reduced enzyme) adequately described the 
kinetic process (Figure 3.5(B)). The calculated rate constant from the fitting of the 
spectral data were as follows: for the reduction of the enzyme by NADPH (A  B; 
20.1 ± 0.001s
-1
) and for the reverse reaction (B   A; 0.0017 ± 0.001s-1). The 
calculated concentration profiles of the enzyme species shown as a function of time 
are depicted in Figure 3.5 (B).  
 
94 
 
 
Figure 3.5 Reaction of the FAD/NADPH-binding domain of MSR with NADPH 
followed by stopped-flow photodiode array spectroscopy. (A) Time-dependent 
spectral changes (recorded over 1 second) shown after rapid mixing the 
FAD/NADPH-binding domain and NADPH. (B) Deconvoluted spectra of the 
intermediates generated by global SVD analysis of the reaction depicted with spectra 
in panel (A). The data in (A) were fitted globally to a reversible one step A⇄B 
model. The insert plot in (B) is the calculated concentration profile of intermediates 
in the reaction of the FAD/NADPH-binding domain with NADPH. 
3.2.3.3.2 Single-wavelength analysis on FAD/NADPH binding domain of MSR 
  Under pseudo-first-order conditions, the rate constants for the reduction by 
NADPH to FAD/NADPH binding domain of MSR were monitored using single-
wavelength absorbance spectroscopy at 454 nm. Following mixing of NADPH with 
the FAD/NADPH-binding domain of MSR, a monophasic absorbance change was 
observed which could be fitted using Equation 2.5. The resulting rate constant is 
similar to the rate constant obtained from the species A   B in the SVD analysis, 
suggesting that the minimal kinetic model used in SVD analysis is adequate in 
describing this reaction. 
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Figure 3.6 Single-wavelength absorption (454 nm) transient for the reaction of 
the FAD/NADPH-binding domain of MSR with NADPH. The condition used 
was: 50 mM potassium phosphate buffer (pH 7.0) at 25 °C, [FAD/NADPH-binding 
domain] = 10 µM, and [NADPH] = 1000 µM. A monophasic absorption trace for the 
reduction of FAD/NADPH binding domain.  The reaction is best described by a 
monophasic absorption change at 454 nm, consistent with the simple reversible 
model used in SVD analysis of diode array spectral data. 
The kinetic data collected for the isolated FAD/NADPH-binding domain of 
MSR is similar with that published previously by Wolthers et al [60] (Table 3.1). 
This provides confidence that the samples purified in this thesis are suitable for use 
in crystallisation trials with the aim of determining the molecular structure of the 
domain. These studies are described in the following sections.  
 Results from this work Published results by Wolthers.[60] 
kcat 67.3 ± 1.4 s
-1 
Not determined 
Km 9.8 ± 1.5 µM Not determined 
k+1 20.1 ± 0.001 s
-1 
20.1 ± 0.01s
-1 
k-1 0.017 ± 0.001 s
-1 
0.018 ± 0.001 s
-1
 
Table 3.1. Comparison of the kinetic data of the FAD/NADPH binding domain 
of MSR 
3.2.4. Crystallization, X-ray diffraction, structure elucidation and molecular 
modelling 
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 A Mosquito robot was used to carry out a crystal growth experiments with the 
FAD/NADPH-binding domain of MSR using the sitting drop method and QIAGEN 
screening kits. The enzyme samples were desalted and centrifuged prior to 
crystallization trials. The desalting process was accomplished by dialysing the 
protein sample against 5 litres 50 mM Tris/HCl buffer pH 7.2 overnight at 4 °C. 
After dialysis the protein sample was centrifuged to remove particulates. Generally, 
one drop of enzyme sample (1 µL) was mixed with 1 µL mother liquor and 
incubated with 98 µL mother liquor in a reservoir at 4° C and 19 °C, respectively. 
Crystals were allowed to form for about 4 days under one of four conditions: 0.1 M 
Tris/HCl, pH 7.5, 0.2 M KBr or PEG4000; 0.2 M KBr 8 % PEG 20 K+8 % PEG 
550, MME pH 8.5 at 4 °C; 0.2 M sodium citrate with 25 % PEG 1500 pH 5.0 or 0.2 
M ammonium citrate 25 % PEG 2K MME pH 5.0 at 19 °C.  
 
Figure 3.8 Crystals of the FAD/NADPH binding domain of MSR. The conditions 
used to produce this crystal are: one drop of enzyme sample (1 µL, 10 mg/mL) was 
mixed with 1 µL mother liquor (0.1 M Tris/HCl, pH 7.5, 0.2 M KBr), and incubated 
with 98 µL the same mother liquor in a reservoir at 19 °C. Crystals formed after 
about 4 days. 
 Crystals of the FAD/NADPH binding domain of MSR were grown in mother 
liquor (0.2 M sodium citrate pH 5.0 containing 25 % PEG 1500) at 19 °C for 4 days. 
Some crystals were soaked in mother liquor containing saturating levels of NADP
+
. 
The soaked crystals were immersed in cryoprotectant (50:50 Paratone: mineral oil) 
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and the excess mother liquor was removed. Crystals were flash frozen in liquid 
nitrogen. Some of the crystals were bathed in saturated NADP
+
 before cryo-
protection and transfer to the synchrotron at the European Synchrotron Radiation 
Facility Grenoble. X-ray diffraction data collection and structure calculations were 
performed mainly by Dr Helen Toogood and Professor David Leys (University of 
Manchester). The statistics presented below are from these studies and are presented 
to indicate the overall quality of the structures for the NADP
+
-bound protein and the 
protein in the absence of bound ligand. Since this aspect of the work was performed 
by Dr Toogood and Professor Leys, detailed discussion of these data is not presented 
herein. A more detailed discussion of the diffraction data can be found in Wolthers et 
al [3].  X-ray diffraction data were collected to 1.9 Å resolution and the related data 
are shown in Table 3.2. The structure of the FAD/NADPH-binding domain of MSR 
was solved by the molecular replacement method using a truncated structure of CPR 
as the search model (PDB code 1 AMO). CPR is the most widely researched 
member of the diflavin reductase family and was used as the initial model.  
 NADP
+
-free structure NADP
+
-bound 
structure 
 Data collection 
Resolutionlimits(Å) 20-1.9 (1.95-1.90) 20-1.9 (1.95-1.90) 
Space group P21 P21 
Unit cell(Å) a=52.6 b=67.3, c=78.8 a=51.8 b=67.2 c=78.6 
Total reflections 593861 644500 
Unique reflections 39892 39791 
Redundancy 3.5 3.6 
Completeness (%) 100.0 (100.0) 100.0 (100.0) 
I/σI 25.3 (3.1) 23.6 (3.3) 
Rmerge (%) 4.0 (26.1) 5.2 (30.4) 
Solvent Content (%) 45 44 
 Refinement 
No. of residues 448 447 
No.of water molecules 498 359 
Rfac/Rfree (%) 18.4/23.2 (22.9/35.8) 17.6/21.2 (19.7/26.5) 
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RMSD bond lengths(Å) 0.016 0.014 
RMSD bond angles (º) 1.527 1.493 
Average B factor(Å
2
) 31.2 29.3 
 Ramachandran plot 
Most favoured region(%) 98.9 99.1 
Additionally allowed regions 0.9 0.7 
Outliers 0.2(Gly
544
) 0.2(Gly
544
) 
Table 3.2 The final crystallographic and refinement values for the 
FAD/NADPH binding domain of human MSR with and without NADP
+ 
bound. 
Data were analysed by Dr Helen Toogood and Prof David Leys and a full description 
is given in Wolthers et al [3]. 
 In the following sections a description of the overall structure of the 
FAD/NADPH-binding domain is given and the complex formed with NADP
+
. These 
structures form an important part of the hypothesis tested in chapter four and the 
basis of solution and mutagenesis work described in the same chapter. 
3.2.5.     Description and analysis of the structural model of the FAD/NADPH-
binding domain of MSR  
3.2.5.1. Overall domain structure of the FAD/NADPH-binding domain of MSR 
The whole structure of the FAD/NADPH binding domain consists of 448 
visible residues extending from residue Ser
217
 to Ser
698
. The first 54 residues of this 
domain are disordered suggesting a high degree of flexibility in this region of the 
protein. There are also additional flexible regions, notably Leu
258
-Asp
271
, Gln
502
-
Ala
515
, and Val
615
- Ala
620
, as indicated by the poor electron density observed for 
these residues. The flexibility of the N-terminal region is consistent with the idea that 
in full length MSR the FMN-binding domain ―toggles‖ between MS and the 
FAD/NADPH binding domain of MSR during the electron transfer process.  
 The domain structure of the FAD/NADP-binding domain comprises from the 
N- to C- terminus a hinge region, a connecting domain region, an FAD-binding 
region and NADPH-region domain (Figure 3.9). The hinge and the connecting 
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region are mainly made up of α-helices. The FAD-binding region consists of six β-
strands to form a flattened anti parallel β-barrel and the NADPH binding region has 
five-stranded parallel β-sheets sandwiched between six α-helices to form an αβα 
structural motif. A more detailed analysis of the structural properties within the 
individual domains/regions is given below. 
 
Figure 3.9 A cartoon representation of the human MSR FAD/NADPH-binding 
domain. The extended hinge region is in red, and the connecting domain, FAD-
domain, and NADPH-binding domain are in pink, blue, and green, respectively. The 
FAD (yellow) and the NADP
+ 
(cyan) are shown in stick format. The figure was 
produced using PyMOL software: (http://pymol.sourceforge.net/). 
 
3.2.5.2. The hinge region and connecting domain 
The hinge region is positioned between the FMN-domain and the connecting 
region in full length MSR and consists of 82 amino acids, of which only 31 residues 
are visible (Ser
217
 to Pro
247
) in the X-ray electron density map. Because of their 
interaction with a symmetry-related molecule, the initial seven visible residues 
(Ser
217
to Asp
223
) probably adopt a non physiological structure. This is likely due to 
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truncation of the protein (i.e. in making the isolated FAD/NADP-binding domain) 
and/or crystal packing. The region from Ser
227
 to Pro
247
 forms a random coil at the 
surface on the axis of three short helices. The analysis of the interface between the 
hinge region and other parts of the connecting domains shows that 41 hydrogen 
bonds and salt bridges have formed. The other part of this region is thought to be 
folded behind the connecting domain to position the FMN-domain at the binding 
interface of the FAD-binding domain and the NADPH binding domain. 
 The connecting domain mainly contains α-helices and is structurally integrated 
with the FAD-domain region with three β-strands of the FAD-domain mixed into the 
connecting domain. The domain is globular and reasonably compact (Figure 3.10). 
 
Figure 3.10 A cartoon representation of the connecting region of the 
FAD/NADPH-binding domain of MSR. The red part indicates the extended hinge 
region visible in X-ray studies. The purple region represents the connecting domain. 
The figure was created using PyMOL software (http://pymol.sourceforge.net/). 
 
3.2.5.3. The FAD binding region and FAD binding site 
 The FAD-binding region consists of six β-strands which form a flattened anti 
parallel β-barrel (Figure 3.11). This region is bound to the FAD cofactor which 
adopts an extended conformation. The FAD cofactor is made up of two parts:  the 
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riboflavin moiety and an ADP molecule. The isoalloxazine ring in the riboflavin is 
located at the interface between the FAD-binding domain and the NADPH-binding 
domain and it is stabilized via hydrophobic interaction and several hydrogen bonds. 
The O2 atom of the isoalloxazine ring forms hydrogen bonds with the main chain 
atom Ser
454
 (amide nitrogen) and the water molecule. The N3 atom in the 
isoalloxazine ring interacts with Val
469
 (carbonyl oxygen) through hydrogen bonds, 
and the N5 and O4 atoms in the isoalloxazine ring are in contact with single water 
molecules via hydrogen bonds. The pyrophosphate group of ADP in the FAD 
cofactor interacts with water molecules, the amide nitrogen and the hydroxyl group 
of Thr
490
, the side chains of Arg
451
 and the peptide backbone of the Cys
489
 and Val
488
 
(Figure 3.12). The electron density of the ribose group in the ADP part shows that it 
has more than one position in the structure and the oxidization of nearby Cys
421
 to 
cysteinic acid is related to the mobility of the ribose group. 
 
Figure 3.11 A cartoon representation of the FAD-binding region of the 
FAD/NADPH-binding domain of MSR. The yellow stick represents the FAD. The 
figure was produced using PyMOL software. 
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Figure 3.12 Structure of the FAD-binding domain in MSR in the region of the 
FAD cofactor. FAD and residues are shown as atom-coloured sticks and lines, 
respectively. Water molecules are denoted by red spheres. Interactions are shown as 
dotted lines. The image was created using PyMOL software ( 
http://pymol.sourceforge.net/). 
 
 
 
3.2.5.4. The NADPH-binding domain and NADPH binding sites  
 The NADPH-binding domain contains six α-helices sandwiched with five 
stranded parallel β-sheet to form an αβα structural motif. NADPH is bound at one 
end of the β-sheet (Figure 3.13). The NADPH molecule comprises of a 
ribitylnicotinamide ring and a 2‘-phosphoryl-AMP moiety. However, the solvent-
exposed ribitylnicotinamide ring is disordered and only the 2‘-phosphoryl-AMP 
group can be observed. The oxygen atom (AOP2) of the 2‘-phosphate forms several 
hydrogen bonds with a water molecule and the hydroxyl group of Ser
610
, Arg
611
 and 
Tyr
624
. In addition, three well ordered water molecules form hydrogen bonds with 
the 2‘-phosphate. This network of residues stabilizes the 2‘-phosphate of the 
nicotinamide and presumably accounts for the substrate specificity of MSR in its 
preference for NADPH over NADH (Figure 3.14).  
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Figure 3.13 A cartoon representation of the NADPH-binding region of the 
FAD/NADPH binding domain of MSR. The coenzyme NADP
+
 is shown in cyan. 
Image created using PyMOL software (http://pymol.sourceforge.net/). 
 
 
 
Figure 3.14 Superposition of the MSR and rat CPR 2’-phosphate binding sites. 
The colour scheme is: oxygen, red; nitrogen, blue; carbon of CPR, cyan; carbon of 
MSR, green; phosphorus, orange. Residue numbers for MSR are written in green, 
and those are named in italics. Hydrogen bond contacts in MSR and CPR are 
denoted by black and red dashed lines, respectively, and water molecules are red 
spheres. The structure of CPR is from the PDB file: 1JA1. 
 The structure of the FAD/NADPH-binding domain provides some useful 
information from which to design new kinetic and mutagenesis studies of the 
enzyme. 
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3.3.     Discussion 
 In mammalian systems, MSR belongs to the diflavin reductase family which 
also include CPR, NOS and NR1. When comparing the structure of these four 
reductases, some similarities and differences in the structure were found.              
The overall inferred structure of full length MSR, from N- terminus to C-terminus, 
consists of the FMN-binding domain, the connecting domain and the FAD domain 
and the NADPH-binding domain. The structures of NOS and CPR are similar and 
are constructed in the same modular fashion as MSR. However, the analysis 
presented in this chapter shows that the connecting domain of MSR, which contains 
82 residues, is much longer than the connecting domain of CPR (14 residues) and 
NOS (24 residues). It is considered that the long connecting domain of MSR 
facilitates the electron transfer between the cofactor FAD of MSR to the cobalamin 
cofactor of MS through a large-scale movement of the FMN-binding domain of 
MSR.  
 Comparison of the FAD-binding sites of the diflavin family shows that the 
FAD-binding domain of CPR binds the FAD in an extended conformation. The 
isoalloxazine ring is positioned at the boundary of the FAD and NADPH binding 
domains. This structure is similar to that of MSR where the remainder of the FAD 
molecule lies at the interface of the FAD-binding domain and the connecting 
domain. The similarity of these two structures indicates that there are conserved 
residues that form a catalytic triad for hydride transfer in MSR (Cys
650
, Asp
695 
and 
Ser
454
) and in CPR (Cys
630
, Asp
675
 and Ser
454
). This similarity suggests that MSR 
and CPR have the same hydride transfer mechanism. In addition some differences 
exist in these two structures. One difference is the ribose group of FAD in MSR 
which is near the partially oxidized Cys
421
 and which can adopt difference positions. 
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Consequently, the orientation of this sugar in MSR is quite different from that of 
CPR. This dynamic character of the ribose in MSR suggests an increase in mobility 
of the adenine ring. Another difference is on the structure of Trp
697
. In MSR, Trp
677
 
is located on the re-side face of the FAD ring and Tyr
456
 at the si-side. The side chain 
of Tyr
491
 and Arg
454
 are responsible for the stabilization of the pyrophosphate group. 
The polypeptide from residues Cys
472
 to Tyr
478
 is almost parallel to the ribityl-
pyrophosphate chain, with the adenosine moiety exposed to the solvent and the 
phenolic ring of Tyr
478
 stacking on the other side of the adenine ring.  But in CPR, 
the corresponding Trp
677
 is oriented about 90 ° with only the benzyl moiety stacking 
against the isoalloxazine ring (Figure 3.15).  With respect to rat NOS, another 
member of this family, this protein contains 435 residues in the FAD binding domain 
with the first 10 amino acids disordered due to flexibility. The cofactor FAD binds 
the enzyme in an extended conformation and lies between the interface between the 
FAD binding domain and NADPH binding domains. The pyrophosphate group of 
FAD hydrogen bonds with Arg
1173
 and the isoalloxazine ring of FAD is stabilized by 
several hydrogen bonds with the pyrimidine side chains and water molecules. The 
O2 atom of the isoalloxazine ring forms hydrogen bonds between Ala
1193 
and 
Thr
1191
; the N3 atoms form hydrogen bonds with Thr
1191
; the N1 atom combine with 
the carbonyl oxygen of Ala
1193
 and Tyr
1175
 attach to the si-face of the FAD ring with 
Phe
1395
 on the re-face. 
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Figure 3.15 Superposition of the MSR and rat CPR FAD binding sites. (A). 
Superposition of FAD isoalloxazine-binding sites. FAD and residues are shown as 
atom-coloured sticks and lines, respectively. MSR and CPR carbons are shown as 
green and magenta atoms, respectively. (B). Superposition of AMP-binding sites 
FAD and residues are shown as atom-coloured sticks and lines, respectively. MSR 
and CPR carbons are shown as green and magenta atoms, respectively. The structure 
of CPR is from PDB entry: 1AMO 
 Comparison of the NADPH binding domain and NADPH binding site of this 
diflavin reductase family shows that the nNOS NADPH binding domain consists of 
an αβα structural motif with a five-stranded sheet sandwiched between α-helices. 
The nicotinamide moiety of the coenzyme NADPH is bound at the surface of the 
molecule in a bent conformation with the nicotinamide and adenine ring pointing to 
the same side. A conserved arginine is an important structural feature in the binding 
of NADPH of nNOS. A salt bridge is formed between the pyrophosphate group of 
NADPH with Arginine
1010
; Arg 
1314 
interacts with the 2‘-phosphate of AMP moiety 
and Arg
1284
 with phosphate. This motif occurs in the CPR structure, but not in the 
MSR structure. 
 These structural variations in the family also affect the binding ability of 
NADPH. Experimental results have shown that the binding energy of NADPH for 
MSR is 7 KJ/mol which is slightly greater than that of FNR [3, 168]. Because most 
of the binding energy of NADPH can be attributed to the 2‘-5‘-ADP moiety of 
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NADPH, the origin of the binding affinity for 2‘5‘-ADP is now the focus of further   
research (see chapter four). Experimental data suggests that the 2‘5‘-ADP has a 
similar binding affinity to CPR and NOS, but it is lower with MSR [3]. The reason 
for the low affinity for MSR could be related to its lower demand on physiological 
functions (MSR is only needed to reactivate human MS on an occasional basis), and 
it may be related to its structure. The crystal structure model of the FAD/NADPH-
binding domain shows that the binding pocket around the 2‘ phosphate group of 
NADPH carries a similar positive charge in both MSR and CPR, but the binding 
cavity around the 5‘-pyrophosphate group is more negatively charged in MSR 
compared to CPR. A residue, Asp
652, located between the 5‘-pyrophosphate group of 
NADPH and the isoalloxazine ring of FAD and exposed to the solvent is assumed to 
be a determinant on the binding ability of NADPH. The properties of mutant MSR 
proteins altered at residues of Asp
652
 and Asp
697
 are described in chapter 4 to probe 
in detail the roles of these residues in NADPH binding and catalysis. 
 Further structural variations across family members are likely also to change 
the mechanism of hydride transfer within members of the diflavin reductase family. 
In nNOS, the possible hydride transfer mechanism involves the phenyl ring of the 
Phe
1395
, which covers the re-face of the isoalloxazine ring of FAD and this residue 
swings away from the FAD on binding the nicotinamide moiety. The change in the 
monodihedral angle at the pyrophosphate linkage results in a bent conformation for 
the bound NADPH so that the nicotinamide ring can replace the position of the 
phenyl side chain of the Phe
1395
 and then direct the hydride transfer from NADPH to 
FAD. In CPR, Trp
677
 plays the same role as the Phe
1395
 in the nNOS. Similarly, in 
MSR, Trp
697
 is the corresponding residue.  The crystal structure of the FAD/NADPH 
binding domain of MSR has shown that the orientation for the aromatic stacking 
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residue in MSR and CPR is different. This apparent structural difference for Trp
697
in 
MSR and Trp
677 
in CPR prompts further questions the roles of these residues in 
hydride transfer. Mutagenesis of this residue in MSR is therefore a route to explore 
the role of this residue in catalysis, and these studies are described in later chapters.   
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CHAPTER FOUR  
COMPARISON OF WILD TYPE AND VARIANTS OF 
MSR PROTEINS  
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4.1 Introduction 
           MSR is a 78 kDa flavoprotein that is a member of the diflavin reductase 
family which includes MSR, NOS, CPR and NR1. Alignment of the primary 
sequences of these four members shows that MSR lacks some of the conserved 
sequences which are related to the binding of NADPH, however, in FNR, several 
conserved residues such as Ser
234
, Arg
235
 and Tyr
246
 form a network which makes 
electrostatic interaction with NADPH [75]. Some of these conserved residues have 
been confirmed as the determinants of coenzyme specificity by differentiating 
between NADPH and NADH. A further example, from work on the crystal structure 
of CPR, concerns two conserved residues, Ser
596 
and Tyr 
604
, which form a consensus 
sequence for the binding of the 2‘ phosphate group of NADPH [90]. MSR shows 
some structural variation in this consensus sequence motif for the binding of 2‘-
phosphate, with only three of the four binding determinants, Ser6
610
, Arg
611
 and 
Tyr
624
 being present and with a six amino acid insert between the Ser
610
/Arg
611
, 
Tyr
624
 to extend the distance between them. In the crystal structure of MSR, the six 
amino acids are disordered and possibly act as a mobile loop. In addition, there are 
two other important residues in MSR that are involved with the binding of NADPH, 
namely Asp
652
 and Trp
697
. 
The solvent-exposed residue Asp
652
 is located between the 5‘-pyrophosphate 
and the isoalloxazine ring of FAD. Comparison of the electrostatic surface of the 
FAD/NADPH-binding domain of MSR with the corresponding domain of CPR 
(Figure 4.1), shows that both are positively charged around the 2` phosphate group 
of the FAD isoalloxazine ring; but it is more negatively charged around the 5‘-
pyrophosphate group in the MSR structure than in CPR. Specifically, Asp 
652
 also 
has a large B factor value for its carboxylate side chain and is orientated in a 
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different direction compared to the corresponding residue Asp
632
 in CPR. Research 
on the mutant W677G of CPR identified a steric clash between the ribose of NADP
+
 
and the carboxylate group of Asp
632
 when the nicotinamide group stacks on the FAD 
isoalloxazine ring [90]. This result could suggest that the movement of the residue 
Asp
652 
in MSR is involved in the hydride transfer reaction. Although Asp
652 
is 4 to 5 
Å away from the pyrophosphate, the electrostatic repulsion and/or steric interference 
may be responsible for the rotation along the dihedral angles of the pyrophosphate 
bonds as NADPH binds in a productive mode for catalysis. The Asp
652
 residue 
possibly forces the equilibrium distribution of the conformation states towards states 
that are non-productive binding modes. Another residue, Trp
697
, is related to the 
destabilization of NADP
+
 binding. On the basis of structural analogies with the CPR 
protein, the indole ring of Trp
697 
is positioned over the re face of the FAD 
isoalloxazine ring. When NADPH binds, its nicotinamide ring must stack against the 
re face of the isoalloxazine to lead the C4 atom of NADPH close to the N5 atom of 
FAD for hydride transfer from NADPH to FAD. To avoid steric clashes with the 
nicotinamide ring, Trp
697
 must flip away from the FAD. The movement of the Trp
697
 
has been confirmed in stopped-flow fluorescence studies on MSR with a rate 
constant similar to the rate determined for hydride transfer in MSR [60]. However, 
the overlap of the Trp
697
 with the corresponding residue of CPR indicates a different 
direction for this tryptophan. The corresponding tryptophan in CPR has an 
approximately 90° rotation with only the benzyl moiety of it stacking against the 
isoalloxazine ring. So whilst the additional - interaction between the isoalloxazine 
ring and Trp
697
 increases the thermodynamic stability of this conformation, it 
weakens the binding of NADPH. In addition, the crystal structure of the complex of 
NADP
+
 with the FAD/NADPH domain of MSR showed that the binding of NADPH 
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does not change the orientation of the Trp
697
 residue. This result supports the 
hypothesis. In order to confirm the importance of Asp
652
 and Trp
697
 on the coenzyme 
binding affinity, mutagenesis experiments were designed and carried out.  
    
                       
Figure 4.1 The electrostatic surfaces of the NADP
+ 
binding pockets in MSR and 
CPR. NADP
+ 
and FAD are shown as green and yellow balls and sticks. The Asp
652
 
of MSR is labelled. The electrostatic surface is shown as blue for a positive potential 
and red for a negative potential. The CPR is from the PDB entry: 1AMO.  
  In this chapter, the design and outcome of the site-directed mutagenesis 
experiments which were undertaken on the two positions Asp
652
 and Trp
697
 are 
described. The Asp
652
 residue was replaced with asparagine, alanine and arginine. 
The product mutants D652A, D652R and D652N were cloned and expressed in E. 
coli BL21, a protease deficient host strain, in the FAD/NADPH binding domain of 
MSR and the full-length MSR.  The Trp
697
 residue was changed to alanine and 
histidine. The product mutants W697A and W697H were cloned and expressed in E. 
coli BL21 in full length MSR. The altered proteins were purified by affinity 
chromatography, followed by anion exchange and gel filtration chromatography. The 
kinetic properties of these mutant proteins were investigated in steady state turnover, 
steady state inhibition studies, stopped-flow pre-steady state kinetic and redox 
potential studies. The study results were compared with data obtained with the wild 
type MSR protein. 
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4.2.    Results 
4.2.1. Site-directed mutagenesis of the FAD/NADPH binding domain of MSR  
 All the plasmids of the mutants were confirmed by sequencing and the 
sequence results are shown in Table 4.1. These plasmids were transformed into 
strain BL21 of E. coli and single clones picked from LB plates containing ampicillin 
(100µg/mL) and grown in TB modicum at 28 °C, 200 rpm/min. After about 4 to 5 
hours, when the OD600nm of the culture reached approximately 1.0, IPTG was added 
to give a final concentration of 1 mM. The culture was incubated at 25 °C, 200 
rpm/min overnight to allow protein expression. The overnight cells were harvested 
by centrifugation at 4 °C. Finally, the cells were stored at -80 °C until they were 
required for purification. 
Name of mutant Mutant site sequence 
D652A gat→gct 
 
D652R gat→cgt 
 
D652N gat→aat 
 
D652A full-length gat→gct 
 
D652R full-length gat→cgt  
D652N full-length gat→aat 
 
W697A full-length tgg→gcg 
 
W697H full-length tgg→cac 
 
Table 4.1 Sequence results of plasmids of variants of MSR. 
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4.2.2. Purification of the mutant proteins  
4.2.2.1. The purification of the mutants D652A, D652R and D652N of the 
FAD/NADPH-binding domain of MSR         
 Three mutants of the FAD/NADPH binding domain of MSR, D652A, D652R 
and D652N were purified by the method described in Chapter two (section 2.4.3). 
After purification by affinity chromatography and anion chromatography, the 
proteins of interest were checked by 10-12% SDS PAGE electrophoresis. All of 
them exhibited only one major band on SDS-PAGE electrophoresis and were 
therefore seemed pure. The first purification step employed was an anion exchange 
Q-Sepharose high-performance column (145 x 25 mm), which was equilibrated in 50 
mM NaCl in 50 mM Tris-HCl buffer, pH 7.5 containing 50 mM NaCl. After loading 
the sample and washing to remove weakly bound proteins, the target protein was 
eluted using a linear gradient (50 mM to 500 mM NaCl) at a flow rate of 4 mL/min. 
The eluted fractions of the gradient at 40% to 60%, containing the target protein, 
were identified by the absorbance spectrum at 454 nm and 280 nm and the protein 
identity was confirmed by electrophoresis in a 10 % SDS-PAGE gel by comparison 
with a standard protein marker ladder. The elution profiles from chromatography and 
photograph of the SDS-PAGE electrophoresis are shown in Figure 4.2. 
 
 
 
 
115 
 
 
 
 
 
D652A 
 
Purification of D652 
(A) Purification of D652A using an AKTA HPLC on an anion-
exchange Q-sepharose column (54 × 30 mm). The spectrum in red is 
the absorbancce spectrum on 454 nm; the spetrum in blue is the 
absorbance spectrum on 280 nm; the green line is the gradient of anion 
concentration; the second peak was confirmed by SDS-PAGE 
electroporesis to be D652A. 
(B) 10% SDS-PAGE electrophoresis on D652A. Lane 1, LMW 
marker; lane 2, cell extract after sonification; lane 3, fraction after 
centrifugation; lane 4, fraction eluted from GST column; lane 5, 
mixture after incubation with thrombin; line 6, fraction after ion-
exchange column chromatography. 
 
 
 
 
D652R 
  
(A) Purification of D652R using an AKTA HPLC on an anion-
exchange Q-sepharose colmn(54× 30 mm). The spectrum in red is 
the absorbancce spectrum on 454 nm; the spetrum in blue is the 
absorbance spectrum on 280 nm; the green line is the gradient of 
anion concentration; the second peak was confirmed by SDS-
PAGE electroporesis to be D652R. 
(B) 10% SDS-PAGE electrophoresis on D652R. Lane 1, LMW marker; 
lane 2, cell extract after sonification; lane 3, mixture after 
incubation with thrombin; line 4, fraction after ion-exchange 
column chromatography.  
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D652N 
 
Purification of D652N  
(A). Purification of D652N using an AKTA HPLC on an anion-
exchange Q-sepharose column (54× 30 mm). The spectrum in red is the 
absorbance spectrum on 454 nm; the spetrum in blue is the absorbance 
spectrum on 280 nm; the green line is the gradient of anion 
concentration; the second peak was confirmed by SDS-PAGE 
electroporesis to be D652N. 
(B). 10% SDS-PAGE electrophoresis on D652N. Lane 1, LMW 
marker; lane 2, cell extract after sonification; lane 3, fraction after 
centrifugation; lane 4, fraction eluted from GST column; lane 5, 
mixture after incubation with thrombin; line 6, fraction after ion-
exchange column chromatography. 
Figure 4.2 Chromatography elution profiles and SDS PAGE electrophoresis of 
mutants of the FAD/NADPH binding domain during purification. 
4.2.2.2. Purification of the mutants D652A, D652R, D652N, W679A and W697H 
of the full-length MSR 
 Five full length MSR mutants D652A, D652R, D652N, W697A and W697H 
were purified by the procedures stated in Chapter two (section 2.4.3).  The MSR 
protein, which had undergone GST affinity chromatography and Q-Sepharose anion 
exchange chromatography, was loaded onto a Superdex 200 gel filtration column 
(volume 180 cm
3
), which had been equilibrated with 50 mM Tris-HCl buffer, pH 7.5 
containing 0.3 M NaCl. The protein was eluted in the same buffer at a flow rate 0.3 
mL/min. The MSR fraction in the elution profile was indicated by its absorbance at 
280 nm and 454 nm and the protein identity was confirmed by SDS-PAGE 
electrophoresis. The proteins of interest were checked by 10-12% SDS PAGE 
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electrophoresis. All of the proteins purified exhibited a single major band on SDS-
PAGE electrophoresis and were considered pure enough for further characterization. 
The purification plots of the chromatography and photographs of the electrophoresis 
gels are shown in Figure 4.3.        
D652A 
full 
MSR 
 
Purification of full-length MSR variant D652A.       
(A) Purification of D652A using an AKTA HPLC on an anion 
exchange Q-sepharose column (54 × 30 mm). The spectrum in red is the 
absorbance spectrum on 454 nm; the spectrum in blue is the absorbance 
spectrum on 280 nm; the green line is the gradient of anion concentration;  
the second peak was collected and confirmed by SDS-PAGE 
electroporesis to be D652A. 
(B) Purification of D652A using an AKTA HPLC on Q-sepharose 
column (145 × 25 mm). The spectrum in red is the absorbance spectrum 
on 454 nm; the spetrum in blue is the absorbance spectrum on 280 nm; the 
second peak is D652A. 
(C)  10% SDS-PAGE electrophoresis on D652A. Lane 1, LMW 
marker; lane 2, cell extract after sonification; lane 3, fraction after 
centrifugation; lane 4, fraction eluted from GST column; lane 5, mixture 
after incubation with thrombin; line 6, fraction after ion-exchange column. 
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D652R 
full 
MSR 
 
Purification of full-length MSR variant D652R.                                         
(A). Purification of D652R using an AKTA HPLC on an anion exchange 
Q-sepharose column (54 × 30 mm). The spectrum in red is the absorbance 
spectrum on 454 nm; the spetrum in blue is the absorbance spectrum on 
280 nm; the green line is the gradient of anion concentration; the second 
peak was collected and confirmed by SDS-PAGE electroporesis to be 
D652R.                                                                                                      
(B). Purification of D652R using an AKTA HPLC on Q-sepharose column 
(145 × 25 mm). The spectrum in red is the absorbance spectrum on 454 
nm; the spetrum in blue is the absorbance spectrum on 280 nm;; the 
second peak is D652.                                                                               
 (C). 10% SDS-PAGE electrophoresis on D652R. Lane 1, LMW marker; 
lane 2, cell extract after sonification; lane 3, fraction after centrifugation; 
lane 4, fraction eluted from GST column; lane 5, mixture after incubation 
with thrombin; line 6, fraction after ion-exchange column. 
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D652N 
full 
MSR 
 
Purification of full-length MSR variant D652R.                                     (A). 
Purification of D652N using an AKTA HPLC on an anion exchange Q-
sepharose column (54 × 30 mm). The spectrum in red is the absorbance 
spectrum on 454 nm; the spetrum in blue is the absorbance spectrum on 
280 nm; the green line is the gradient of anion concentration; the second 
peak was collected and confirmed by SDS-PAGE electroporesis to be 
D652N.                                                                                                     (B).  
10% SDS-PAGE electrophoresis on D652N. Lane 1, LMW marker; lane 
2, cell extract after sonification; lane 3, fraction after centrifugation; lane4, 
fraction eluted from GST column; lane 5, mixture after incubation with 
thrombin; line 6, fraction after ion-exchange column. 
W697A 
full 
MSR 
 
(A). Purification of W697A using an AKTA HPLC on an anion exchange 
Q-sepharose column (54 × 30 mm). The spectrum in red is the absorbance 
spectrum on 454 nm; the spetrum in blue is the absorbance spectrum on 
280 nm; the green line is the gradient of anion concentration; the second 
peak was collected and confirmed by SDS-PAGE electroporesis to be 
W697A.                                                                                                     
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(B). Purification of W697A using an AKTA HPLC on Q-sepharose 
column (145 × 25 mm). The spectrum in red is the absorbance spectrum 
on 454 nm; the spetrum in blue is the absorbance spectrum on 280 nm; the 
secondpeak was W697A                                                                          (C). 
10% SDS-PAGE electrophoresis on W697A. Lane 1, LMW marker; lane 
2, cell extract after sonification; lane 3, fraction eluted from GST column; 
lane 4, mixture after incubation with thrombin; line 5, fraction after ion-
exchange column. 
W697
H 
full 
MSR 
 
 
 
 
 
 
 
Purification of full-length MSR variant W697H.                                     
(A). Purification of W697H using an AKTA HPLC on an anion exchange 
Q-sepharose column (54 × 30 mm). The spectrum in red is the absorbance 
spectrum on 454 nm; the spetrum in blue is the absorbance spectrum on 
280 nm; the green line is the gradient of anion concentration; the second 
peak was collected and confirmed by SDS-PAGE electroporesis to  be 
W697H.                                                                                                    (B). 
Purification of D652R using an AKTA HPLC on Q-sepharose column 
(145 × 25 mm). The spectrum in red is the absorbancce spectrum on 454 
nm; the spetrum in blue is the absorbance spectrum on 280 nm; the second 
peak was W697H.                                                                                       
(C). 10% SDS-PAGE electrophoresis on W697H. Lane 1, LMW marker; 
lane 2, cell extract after sonification; lane 3, fraction after centrifugation; 
lane 4, fraction eluted from GST column; lane 5, mixture after incubation 
with thrombin; line 6, fraction after ion-exchange column. 
Figure 4.3 Chromatography elution profiles and SDS PAGE electrophoresis of 
mutants of the full length MSR mutants 
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4.2.3.    Kinetic studies on the mutants  
4.2.3.1. Kinetic studies on the mutants of the FAD/NADPH binding domain of 
MSR 
4.2.3.1.1. Steady-state kinetic studies on the FAD/NADPH binding domain 
mutants D652A, D652R, and D652N         
 Similar to the wild type FAD/NADPH binding domain of MSR, the variants of 
the FAD/NADPH binding domain of MSR, D652A, D652R, and D652N also have 
the ability to catalyze the NADPH-dependent reduction of FeCN. The apparent 
steady-state turnover rates for D652A, D652R, and D652N were determined under 
the conditions described in Chapter two as 1.4 s
-1
, 2.6 s
-1
 and 3.8 s
-1
 for FeCN 
reduction; the apparent Km for NADPH binding is 117 µM, 147 µM and 23 µM for 
D652A, D652R and D652N, respectively (data are shown in Figure 4.4 and Table 
4.2). Compared to the wild type FAD/NADPH binding domain of MSR, the relative 
catalytic ability is decreased about 560 fold, 239 fold and 25 fold, respectively. 
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Figure 4.4 Apparent steady-state turnover rates of the variants of the 
FAD/NADPH binding domain of MSR with variable NADPH concentration and 
using ferricyanide as artificial electron acceptor. Fitting to the Michaelis-Menten 
equation gave values for apparent kcat , Km (Table 4.2). 
 kcat (s
-1
) Km (µM) kcat / Km 
(µM
-1
.s
-1
) 
Wild-type 67.3 ± 0.1 10 ± 1 6.73 
D652A 1.4 ± 0.1 117 ± 26 0.012 
D652R 2.6 ± 0.1 147 ± 5 0.018 
D652N 5.8 ± 0.1 22.2 ± 2.0 0.26 
Table 4.2 Steady-state plots of the variants of the FAD/NADPH binding domain 
of MSR  
4.2.3.1.2 Steady-state inhibition studies on the FAD/NADPH binding domain 
mutants D652A, D652R, and D652N.   
Steady-state inhibition studies were carried out on selected variants of the 
MSR protein.  These included D652A of the FAD/NADPH binding domain and 
D652A and D652R of the full length MSR.  The reaction procedure and conditions 
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have been described previously in Chapter two (section 2.6.3). NADPH, FeCN and 
cytochrome c were the chosen substrates for the reactions.  2‘, 5‘-ADP and NADP+ 
were used as inhibitors of the reduction of FeCN and cytochrome c, catalyzed by the 
MSR or the FAD/NADPH binding domain, and used to determine the steady-state 
inhibition constants. The calculated inhibition constant data is listed in Table 4.3. 
The double-reciprocal plots of the initial velocity versus NADPH concentration with 
several fixed concentration of NADP
+ or 2‘, 5‘-ADP are shown in Figure 4.5. The 
data indicate that both 2‘, 5‘-ADP and NADP+ are competitive inhibitors for 
NADPH. Similar to the wild type of MSR, 2‘, 5‘-ADP is a relatively strong inhibitor 
for the variants of MSR and NADP
+
 is a relatively weak inhibitor. However, 
compared with the dissociation constants determined from ITC and pre-steady state 
stopped flow spectrophotometry experiments [3], the dissociation constants for 
D652A and D652R were lower and higher respectively. 
D652A 
 
Steady state inhibition of D652A 
(A) Double-reciprocal plots of 2‘, 5‘-ADP as inhibitors of D652 
catalyzed reduction of FeCN by NADPH. The steady-state inhibition 
constant (Ki) was determined by the initial velocity versus NADPH 
concentration at several fixed concentration of 2‘, 5‘-ADP. The inhibition 
data fitted to equation 2.4. Data are shown in Table 4.3. 
(B) Double-reciprocal plots of NADH as inhibitors of D652 catalyzed 
reduction of FeCN by NADPH. The steady-state inhibition constant (Ki) 
was determined by the initial velocity versus NADPH concentration at 
several fixed concentration of NADH. The inhibition data are fitted to 
equation 2.4. Data are shown in Table 4.3. 
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Full 
length 
D652A 
 
Steady state inhibition of full length D652A 
(A) Double-reciprocal plots of 2‘, 5‘-ADP as inhibitors of full length 
D652A catalyzed reduction of FeCN by NADPH. The steady-state 
inhibition constant (Ki) was determined by the initial velocity versus 
NADPH concentration at several fixed concentration of 2‘, 5‘-ADP. The 
inhibition data fitted to equation 2.4. Data is shown on Table 4.3. 
 (B) Double-reciprocal plots of NADH as inhibitors of D652 catalyzed 
reduction of FeCN by NADPH. The steady-state inhibition constant (Ki) 
was determined by the initial velocity versus NADPH concentration at 
several fixed concentration of NADH. The inhibition data are fitted to 
equation 2.4. Data are shown in Table 4.3. 
Full 
length 
D652R 
 
Steady state inhibition of full length D652R 
(A) Double-reciprocal plots of 2‘, 5‘-ADP as inhibitors of full length 
D652R catalyzed reduction of FeCN by NADPH. The steady-state 
inhibition constant (Ki) was determined by the initial velocity versus 
NADPH concentration at several fixed concentration of 2‘, 5‘-ADP. The 
inhibition data fitted to equation 2.4. Data is shown on Table 4.3. 
(B) Double-reciprocal plots of NADH as inhibitors of D652R catalyzed 
reduction of FeCN by NADPH. The steady-state inhibition constant (Ki) 
was determined by the initial velocity versus NADPH concentration at 
several fixed concentration of NADH. The inhibition data are fitted to 
equation 2.4. Data are shown in Table 4.3. 
Figure 4.5 Steady-state inhibition plots of the variants of the FAD/NADPH 
binding domain of MSR. 
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 Ki for 2’5’-ADP (µM) Ki for NADP
+ 
 (µM) 
D652A 10.34 ± 0.01 549 ± 1 
D652A full 8.81 ± 0.01 20.43 ± 0.01 
D652R full 1.13 ± 0.01 13.95 ± 0.01 
Wild type full 1.44 ± 0.01 36 ± 0.01 
Table 4.3 Steady-state inhibition results for the variants of MSR  
4.2.3.1.3 Pre- steady-state kinetic studies on the FAD/NADPH binding domain 
mutants D652A, D652R, and D652N.   
Studies of the reductive half reaction of the variants of the FAD/NADPH 
binding domain of MSR were carried out to investigate the pre-steady state kinetics 
of these proteins. Reactions were performed at 25 °C under pseudo first-order 
conditions, in a stopped-flow spectrophotometer housed inside a Belle anaerobic 
cabinet, with a 20 fold excess of NADPH over enzyme. The enzyme sample was 
mixed with NADPH and the absorbance spectrum change followed for 5 seconds. In 
this time period, the reduction of the fully oxidized enzyme sample was completed. 
Figure 4.6 shows the resulting spectra which demonstrate a characteristic peak at 
454 nm. These spectra were globally fitted by SVD analysis to a one step reversible 
model to obtain the rate constant for electron transfer to the oxidised enzyme. In 
addition, single wavelength stopped-flow spectrophotometry at 454 nm was 
performed to determine the rate constant for the spectral intermediate formed in the 
PDA experiment. Compared with the wild-type FAD/NADPH binding domain of 
MSR, the variants D652A, D652R, and D652N had the same pattern spectra but with 
decreased rate constants. The data of the rate constants for these variants are listed in 
Figure 4.6 and Table 4.4. 
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D652A 
 
Reaction D652A of the FAD/NADPH-binding domain of MSR with 
NADPH followed by stopped-flow photodiode array spectroscopy. (A) 
Time-dependent spectral changes (recorded over 1 second) shown after 
rapid mixing the D652A and NADPH. (B) Deconvoluted spectra of the 
intermediates generated by global SVD analysis of the reaction depicted 
with spectra in panel (A). The data in (A) were fitted globally to a reversible 
one step A⇄B model.  
D652R 
 
Reaction D652R of the FAD/NADPH-binding domain of MSR with 
NADPH followed by stopped-flow photodiode array spectroscopy. 
(A) Time-dependent spectral changes (recorded over 1 second) shown 
after rapid mixing the D652R and NADPH. (B) Deconvoluted spectra of 
the intermediates generated by global SVD analysis of the reaction 
depicted with spectra in panel (A). The data in (A) were fitted globally to 
a reversible one step A⇄B model. The insert plot shows the concentration 
profile of intermediates in the reaction of the D652R with NADPH. 
D652N 
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Reaction D652N of the FAD/NADPH-binding domain of MSR with 
NADPH followed by stopped-flow photodiode array spectroscopy.  
(A) Time-dependent spectral changes (recorded over 1 second) shown after 
rapid mixing the D652N and NADPH. (B) Deconvoluted spectra of the 
intermediates generated by global SVD analysis of the reaction depicted 
with spectra in panel (A). The data in (A) were fitted globally to a 
reversible one step A⇄B model. He insert plot shows the concentration 
profile of intermediates in the reaction of the D652N with NADPH. 
Figure 4.6 Stopped-flow spectrophotometry plots of the variants of the 
FAD/NADPH binding domain of MSR 
  Data (s
-1
) St. Error 
Wild-type k+1 20.01 ±0.01 
D652A k+1 0.156 ±4.562E-03 
D652R k+1 0.061 ±7.564E-05 
D652N k+1 1.344 ±3.897E-03 
Table 4.4 The stopped-flow date of the variants of the FAD/NADPH binding 
domain of MSR. 
4.2.3.1.4. Redox potential studies on the FAD/NADPH binding domain mutants 
D652A, D652R, and D652N. 
Anaerobic spectroelectrochemical titration experiments were used to 
determine the midpoint potentials for the cofactor FAD on the variants D652A, 
D652R, and D652N of the FAD/NADPH binding domain. The reaction protocol and 
conditions have been described in detail in Chapter two (section 2.6.5). During the 
titration process, the fully oxidized enzyme sample was gradually reduced by the 
addition of small volumes of sodium dithionite which is freshly prepared in solution 
just prior to the experiment. To allow the reaction to reach equilibrium before the 
absorption spectrum was recorded, several minutes were allowed after each addition 
of the reducing agent until a stable voltage reading was achieved. These procedures 
were repeated until the half reduction reaction was finished. After changing to 
potassium ferricyanide, the reduced reaction sample was reoxidized and the 
experimental process repeated using the same procedure as used for the reductive 
half reaction. Most of the variants of the FAD/NADPH binding domain of MSR are 
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generally stable during the reduction reaction by dithionite. Some minor spectral 
drifts can be corrected by simple baseline subtraction. The reduction process of the 
variants D652A, D652R, and D652N consist of two phases as shown in the redox 
absorption spectra in Figure 4.7. The first phase is a result of the blue semiquinone 
species FADH, which is shown as a broad feature absorbance band near 600 nm. In 
the second phase, after the addition of more sodium dithionite, the blue semiquinone 
FADH is gradually reduced to the colourless FADH2 with the bleaching of the 
shoulder around 600 nm on the spectrum. Two isosbestic points at 500 nm and 360 
nm are visible on the absorbance spectra. The absorbance data obtained at 454nm 
and 600 nm were plotted versus the redox potential data and are shown in Table 4.5. 
The bell-shape curve at 600 nm indicates the redox potential of two semiquinone 
species, the high potential FADox/FADsq in the right-hand region and the low 
potential FADsq/FADhq at the left side of the curve.  Based on equation 2.6, the data 
in these two plots were calculated to obtain the midpoint potentials of the 
FADox/FADsq, and FADsq/FADhq redox couples, which are shown in Table 4.4. 
Compared to the two midpoint potentials of FADox/FADsq, and FADsq/FADhq of the 
wild-type FAD/NADPH binding domain (-222 mV and -288 mV), most of the 
midpoint potentials of the variants D652A (-123 mV, 233 mV), D652R (-124 mV, -
306 mV), and D652N (-178 mV, -279 mV) exhibited a positive shift, which is 
consistent with the decrease in the steady-state turnover numbers for these variant 
proteins. The catalytic ability of these variants is severely reduced. 
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D652A 
 
Redox potentials of D652A.  
(A) Absorption spectra of the redox titration of D652A. The spectra were obtained 
after each addition of dithionite as described in section (2.1).Two isosbestic points 
appear at 501 nm and 425 nm.  
(B) & (C). Plots of absorbance at 600 nm and 454 nm versus potential of D652A. 
Both data were fitted to equation 2.6 and the resultant values for the redox potential for 
the ox/sq and sq/hq couples of FAD are shown in Table 4.5. 
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D652R 
  
(A) Absorption spectra of the redox titration of D652R. The spectra were obtained after 
each addition of dithionite as described in section 2.1. Two isosbestic points appear at 
501 nm and 425 nm.  
(B) & (C) Plots of absorbance at 600 nm and 454 nm versus potential of D652R. Both 
data were fitted to equation 2.6 and the resultant values for the redox potential for the 
ox/sq and sq/hq couples of FAD are shown in Table 4.5. 
D652N 
  
(A) Absorption spectra of the redox titration of D652N after each addition of dithionite 
as described in section 2.1.Two isosbestic points appear at 501 nm and 425 nm.  
(B)  Plots of absorbance at 600 nm versus potential of D652N. Both data were fitted to 
equation 2.6 and the resultant values for the redox D652N. The spectra were obtained 
potential for the ox/sq and sq/hq couples of FAD are shown in Table 4.5. 
Figure 4.7 Redox potentials of the variants of the FAD/NADPH binding domain 
of MSR  
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 ox/sq (mV) sq/hq (mV) 
Wild-type -222 ± 4 -288 ± 7 
D652A -123 ± 7 -233 ± 23 
D652R -124 ± 5 -306 ± 16 
D652N -178 ± 7 -279 ± 10 
Table 4.5 Redox potential data of the variants of the FAD/NADPH binding 
domain of MSR  
4.2.3.2. Kinetic studies on the full length MSR mutants D652A, D652R, 
D652N, W697A and W697H 
4.2.3.2.1. Steady-state kinetic studies on the full length MSR mutants D652A, 
D652R, D652N, W697A and W697H  
 As with wild type full length MSR, the variants of full length MSR, D652A, 
D652R, D652N, W697A and W697H also have the ability to catalyze the NADPH-
dependent reduction of cytochrome c. The apparent steady-state turnover rates for 
D652A, D652R, W697A and W697H were determined under the conditions 
described in chapter two. The kcat values were 3.12 s
-1, 
0.50 s
-1
, 0.29 s
-1 
0.154 s
-1
 for 
cytochrome c reduction and the apparent Km values for NADPH are 8.12 µM, 7.98 
µM, 7.75µM and 6.75 μM for D652A, D652R, W697A and W697H. The kcat values 
were 0.60 s
-1
 and 0.09 s
-1
 and the Km values were 3117 μM, 184.3 µM for full length 
and D652N with NADH and cytochrome c as substrates. Compared to the data of 
wild type of full length MSR (kcat/Km is 1.315 ± 0.088 s
-1
M
-1
 for NADPH and 6.78 × 
10
-5 
s
-1
M
-1
 for NADH. [3]), the catalytic ability decreased 34.5 fold, 56.6 fold, 2.4 
fold and 19.8 fold for W697A, W697H, D652A and D652R with NADPH as 
electron provider and increased 6 fold and 1.8 fold for W697H and D652N with 
NADH as electron provider.  
 
 
132 
 
 
Figure 4.8. The apparent steady-state turnover rates of the variants of the full 
length MSR with variable NADPH concentration and using cytochrome c as 
artificial electron acceptor.(A) Full-length D652A.(B). Full length D652R.(C) Full-
length W697A. (D) Full length W697H. Fitting to the Michaelis-Menten equation 
gave values for apparent kcat , Km (Table 4.6.1) 
  
Figure 4.9 The steady-state plots of the variants of the full length MSR with 
variable NADH concentration and using cytochrome c as artificial electron 
acceptor.(A) Full length D652N. (B). Full length W697H. Fitting to the Michaelis-
Menten equation gave values for apparent kcat , Km (Table 4.6.2) 
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 W697A W697H D652A D652R 
kcat(s
-1
) 0.29 ± 0.01 0.154 ± 0.01 3.12 ± 0.06 0.50 ± 0.01 
Km(µM) 7.75 ± 0.01 6.75 ± 0.66 8.12 ± 0.7 7.98 ± 0.18 
kcat/ Km 0.037 0.0228 0.384 0.063 
Table 4.6.1 Steady state turnover number of W697A, W697H, D652A and 
D652R with NADPH as substrate. 
 W697H D652N Wild-type 
kcat (s
-1
) 0.09 ± 0.01 0.60 ± 0.01 0.24 ± 0.03 
Km (µM) 184.3 ± 33 3117 ± 460 3540 ±560 
kcat/ Km (s
-1
M
-1 
× 10
-3
) 0.483 ± 0.0001 0.1925 ± 0.001 0.0678 ± 0.0137 
Table 4.6.2 Steady state turnover number of W697H, D652N with NADH as 
substrate. 
 
4.2.3.2.2. Pre-steady-state kinetic studies on the full length MSR mutants D652 
A, W697A and W697H 
           Studies of the reductive half reaction of the variants of full length MSR were 
carried out to investigate the pre-steady state kinetic behaviour of these proteins. 
Reactions were performed at 25 °C under pseudo first-order conditions, in a stopped-
flow spectrophotometer contained inside an anaerobic Belle glove box, using a 20 
fold molar excess of NADPH over the enzyme. The enzyme sample was mixed with 
NADPH and the absorbance spectrum change monitored for 200 seconds during 
which time the reduction of the fully oxidized enzyme sample was completed. The 
resulting spectra are shown in Figure 4.10 with a characteristic peak at 454 nm. This 
spectrum was globally fitted by SVD analysis to a three step reversible model. 
Semiquinone can be detected in these spectra. In addition, single wavelength stopped 
flow spectrophotometric experiments at 454 nm were performed to determine the 
rate constant for the spectral intermediate formed in the PDA experiment. Compared 
with the full length wild type MSR, the variants D652A, D652R, D652N, W697A, 
and W697H had the same spectral features, but with decreased rate constants.  The 
rate constants on the single wavelength 454 nm were fitted with a double electron 
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transfer model A→B→C. The rate constants are listed in Table 4.7. The D652A has 
the fastest rate constant of the three mutants. 
D652A 
 
Reaction of full length MSR variant D652A with NADPH followed by 
stopped-flow photodiode array spectroscopy. 
 (A).Time-dependent spectral changes (recorded over 1 second) shown 
after rapid mixing the D652A and NADPH. Insert plot is the single wave 
length absorbance plot at 454 nm.  
(B) Deconvoluted spectral of the intermediates generated by global SVD 
analysis of the reaction. The data were fitted to a reversible A⇄B⇄C⇄D 
mode. Insert plot is the calculated concentration profile of intermediate. 
W697A 
 
Reaction of full length MSR variant W697A with NADPH followed by 
stopped-flow photodiode array spectroscopy. 
 (A).Time-dependent spectral changes (recorded over 1 second) shown 
after rapid mixing the W697A and NADPH. Insert plot is the single 
wave length absorbance plot at 454 nm.  
(B) Deconvoluted spectral of the intermediates generated by global SVD 
analysis of the reaction. The data were fitted to a reversible A⇄B⇄C⇄D 
mode. Insert plot is the calculated concentration profile of intermediate. 
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W697H 
 
Reaction of full length MSR variant W697H with NADPH followed by 
stopped-flow photodiode array spectroscopy. 
 (A).Time-dependent spectral changes (recorded over 1 second) shown 
after rapid mixing the W697H and NADPH. Insert plot is the single 
wave length absorbance plot at 454 nm.  
(B) Deconvoluted spectral of the intermediates generated by global SVD 
analysis of the reaction. The data were fitted to a reversible A⇄B⇄C⇄D 
mode. Insert plot is the calculated concentration profile of intermediate. 
Figure 4.10 Stopped-flow plots of the variants of the full length MSR        
   W697A W697H D652A 
k+1 0.1400 ± 0.0007 0.1130 ± 0.004 0. 3691 ± 0.022 
k+2 0.0170 ± 0.0003 0.0117  ± 0.0001 0.0095 ± 0.0001 
Table 4.7 Stopped flow experiment data on the variants of full length MSR 
 
4.2.3.3.    Fluorescence studies on the wild-type MSR protein and one variant of 
 full-length MSR 
 
 Tryptophan fluorescence-monitored stopped flow spectroscopy was employed 
to investigate the change in intensity of the fluorescence of the tryptophan in the 
reaction after mixing wild type full length MSR with NADPH, and the variant 
W697A of full-length MSR with NADPH (Figure 4.9.). The crystal structure of the 
FAD/NADPH binding domain of MSR confirms that tryptophan
697
 covers the re-
face of the isoalloxazine ring of the cofactor FAD and moves away when the hydride 
is transferred from NADPH to FAD. It was thought that the movement of the 
hydride could be accompanied by a change in the intensity of tryptophan
697
 
fluorescence. In this experiment, the wild type full length MSR (10 µM) was rapidly 
mixed with a 20 fold excess of NADPH and the tryptophan fluorescence monitored 
as a monophasic reaction transient. Using the same reaction conditions, after the 
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rapid mixing of the W697A protein with a 20 fold excess of NADPH, no 
fluorescence could be detected. This result confirms that tryptophan
697
 has been 
substituted by alanine and that the tryptophan fluorescence signal seen in wild-type 
MSR is attributed to W697.  
Wild type MSR 
 
Full length 
W697A 
 
Figure 4.11. Tryptophan fluorescence-monitored stopped flow spectroscopy on 
wild-type MSR and mutant W697A.The increase in tryptophan fluorescence 
(excitation at 295 nm) after rapid mixing of the wild type MSR or W697A (10 μM) 
with NADPH (200 µM) was monophasic and was fitted to a single-exponential 
function. 
 4.3.   Discussion 
 Research on the mutants of MSR focused on two conserved residues, namely 
Asp
652
 and Trp
697
, and included steady state kinetic studies, pre-steady-state kinetic 
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studies, steady-state substrate inhibition studies, and redox potential studies. The 
results of these studies demonstrated that these two conserved residues play a key 
role in coenzyme binding, the electron transfer mechanism and in maintaining the 
integrity of the environment around the FAD cofactor. 
Steady-state kinetic data indicated that the kinetic parameters kcat and kcat/Km 
for the mutants D652A, D652N, and D652R were decreased while the Km values 
obtained were increased compared with the wild type FAD/NADPH binding domain 
of MSR. This result illustrates that the change on the electrostatic charge and space 
volume on Asp
652
, substantially affects the binding affinity of NADPH and 
furthermore lowers the rate of the hydride transfer from NADPH to FAD. The 
variants obtained by changing another residue, namely Trp
697
 which is stacked on the 
re-face of the isoalloxazine ring of FAD, also exhibit a decreased kcat and kcat/Km and 
increased Km with respect to the data determined with wild type full length MSR. 
This result confirms that the binding efficiency of NADPH with the enzyme was 
decreased. Additionally, although Asp
652
 and Trp
697
 do not directly form the binding 
site for the 2‘-phosphate of NADPH, these residues have the potential to influence 
discrimination between NADPH and NADH. The observed preference for NADH 
binding by the mutant containing the Asp
652
 substitution is consistent with this 
hypothesis. For example, on study of the mutant D652N of the full-length MSR was 
not able to bind NADPH and only NADH could be used as a suitable electron donor. 
The Ki for 2‘5‘-ADP determined from steady state inhibition studies with the D625A 
mutant on the FAD/NADPH binding domain was increased compared to that 
measured with the wild type MSR. These data are consistent with the deceased kcat 
and the increased Km. This phenomenon can be explained by a decrease in the ability 
of the mutant to identify the 2‘-phosphate of NADPH.  This recognition controls the 
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binding affinity of NADPH, so the decreased binding of NADPH will trigger the 
decreased catalytic ability of the mutant. In addition, the variant D652N of full-
length MSR exhibits a change in coenzyme specificity with only NADH being 
capable of driving turnover. This result is direct evidence to confirm that Asp
652
 is a 
key   binding residue for NADPH on MSR. 
 Another residue Trp
697
 is believed to be involved in the electron transfer 
reaction of MSR. Two mutants, W697A and W697H, were produced to probe the 
importance of this position and investigate whether these changes were reflected in 
the steady-state and pre-steady-state kinetic experiments. Comparison with the data 
obtained from the wild-type full-length MSR, the kcat for W697A and W697H 
decreased about 10 fold and 24 fold and the Km increased about 1.6 fold and 1.3 fold. 
These results show that both the binding affinity of NADPH and the catalytic ability 
of these two mutants have been affected. These results were confirmed by stopped-
flow spectrophotometry experiments on W697A and W697H where the rate for 
electron transfer was decreased about 2 fold. One possible explanation is the variant 
of MSR forms a stable complex with NADP
+
 and increases the inhibition of NADP
+
, 
so the catalytic ability is decreased. 
 The redox potential is an important factor in the electron transfer reaction of 
MSR. Compared with the redox potential data with the wild type protein of the 
FAD/NADPH binding domain, the redox potentials of the FAD of the mutants 
D652A, D652R and D652N are more positive with shifts of about 90 to 100 mV for 
the ox/sq FAD and about 50 mV for sq/hq FAD. This result is consistent with the 
stopped-flow experimental data which showed a slow hydride transfer rate for these 
two mutants. In addition, these results reveal that the environment of FAD has been 
disturbed by performing site directed mutagenesis. However, the PDA spectrum of 
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the mutants in the stopped-flow experiments also demonstrates the electron transfer 
mode for the mutants is similar to that of the wild type protein. It consists of three 
steps: A⇄B⇄C⇄D for the full- length MSR and mutants (D652A, W697A, and 
W697H) and one step mode for the FAD/NADPH binding domain of MSR with 
mutants D652A, D652R, and D652N. In addition, the semiquinone FAD and 
semiquinone FMN were detected in the stopped-flow experiments for full- length 
MSR and its mutant, but no semiquinone FAD was found in the stopped-flow kinetic 
studies on the wild-type FAD/NADPH binding domain of MSR and its mutants. 
          The mutants on the residue Asp
652 
of MSR consists of two groups. One group 
includes D652A, D652R, D652N of the FAD/NADPH binding domain of MSR; 
another group has D652A, D652R, D652N of the full length MSR. Although all 
these mutants are focused on residue Asp
652
, the purification of the mutants D652A, 
D652R, D652Nof the full length MSR were more complicated and difficult. So some 
experiments were not designed to complete. 
Collectively, these results suggested that the mutagenesis on these two 
residues Asp
652
, Trp
697
, results in some change in the protein structure but not 
enough to abolish the catalytic ability and electron transfer ability of MSR. Some 
kinetic, pre steady-state kinetic and thermodynamic changes were observed. These 
changes provide good evidence to support Asp
652
 and Trp
697 
as
 
being pivotal 
determinants in the structure and function for MSR. Clearly, the observed effects on 
catalysis might arise for changes in electrostatics and/or conformational differences. 
The next logical phase of the study would be to determine the crystal structures of 
the mutant proteins to offer further insight into the observed effects. 
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               5.1 Introduction 
 The redox potentials of the FMN and FAD cofactors of MSR allow for the 
formation of one electron and two electron reduced states containing the FMN 
semiquinone, and FMN and FAD semiquinones respectively. Flavin semiquinones 
bear an unpaired electron and can therefore be studied using EPR spectroscopy and 
the related techniques of pulsed ENDOR, ESEEM and pulsed ELDOR spectroscopy 
(see Chapter two section 2.8). These techniques provided data on the environment of 
the flavin cofactors and the change in inter-flavin distance caused by the binding of 
effectors such as NADP
+
 and the isolated activation domain of methionine synthase 
(AD). The latter is relevant to the conformational sampling mechanism proposed to 
operate in diflavin reductases including P450 reductase (CPR) and nitric oxide 
synthase (NOS), as described in Chapter one Sections 1.3 and Section 1.4. 
5.2.    Results 
5.2.1. EPR spectroscopy 
 X-band continuous wave EPR spectra of dithionite reduced MSR are shown in 
Figure 5.1. The first four spectra (a, b, c, d) show ‗one electron reduced‘ MSR 
containing a proportion of FMN semiquinone; the second four spectra (e, f, g, h) 
show the ‗two electron reduced‘ state of MSR, which contains FMN semiquinone 
and FAD semiquinone. The midpoint potential of the two electron reduced state 
determined that there is an equilibrium between the semiquinone FMN and 
semiquinone FAD rather than the formation of 100% semiquinone at either cofactor. 
The spectra b, c, d, and f, g, h, show the EPR of the complexes of MSR with 2‘ ,5‘-
ADP, NADP
+
 and the isolated activation domain of MS (AD) respectively. These 
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complexes were designed to form a 1:1 complex based on the dissociation constants 
of every component in every complex. 
 The X-band EPR spectrum of one electron reduced MSR (spectra a, b, c, d) is 
characterized by a single line with g=2.0035 and a peak to trough width of 20.1 G. 
This is a typical spectrum for the neutral flavin semiquinone radical. These 
parameters were not changed in the complex of MSR with 2‘, 5‘-ADP, NADP+ and 
AD.  The EPR spectrum of the two electron reduced MSR showed the same feature 
at g=2.0035 with a peak to trough line width of 20.5 G. This spectrum confirms the 
formation of flavin semiquinone, and it also suggests that the line width of the EPR 
spectrum of the FAD semiquinone is slightly wider than that of the FMN 
semiquinone. As is observed in one electron reduced MSR, the formation of a 
complex of MSR with 2‘, 5‘-ADP, NADP+ does not affect the EPR spectrum. 
 
Figure 5.1 X-band continuous wave EPR spectra of dithionite reduced MSR:  
a) one electron reduced: b) one electron reduced + 2‘, 5‘-ADP: c)  one electron 
reduced + NADP+: d) one electron reduced + AD: e) two electron reduced: f) two 
electron reduced + 2‘, 5‘-ADP: g) two electron reduced + NADP+: h) two electron 
reduced + AD. Experimental parameters: microwave power 10 μW; modulation 
amplitude 1 G; modulation frequency 100 KHz; temperature 80 K.   
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 In addition, these EPR spectra also show several other features of neutral 
flavin semiquinones. Firstly, ‗tails‘ to high and low field of the central line appear 
where the spectrum deviated from what might be expected of the first derivative of a 
Gaussian line and there is a small ‗step‘ in the maximum at approximately 3338G. 
Both of these features arise from the partially resolved hyperfine coupling to H
1
 and 
14
N atoms of the flavin, mostly N(5)H, N(5) and C(8)-methyl atoms. Unfortunately, 
the resolution of the EPR spectrum does not permit accurate measurement and 
assignment of these hyperfine coupling constants.  
 In summary, EPR spectra confirm the formation of semiquinone FMN and 
FAD at low temperature and it is consistent with the same formation at room 
temperature observed using optical spectroscopy. 
5.2.2. ESEEM spectroscopy  
ESEEM spectroscopy is a method of measuring the hyperfine coupling 
between atomic nuclei and unpaired electrons. ESEEM spectra are produced by the 
Fourier transformation of the modulation of spin echoes and ESEEM is particularly 
sensitive to small hyperfine coupling to nuclei with low Larmor frequencies and 
nuclear spin greater than ½ (I >½) such as 
14
N or 
2
H .  
 The X-band two pulse ESEEM spectra of dithionite reduced MSR are shown 
in Figure 5.2. Each spectrum is split into three regions. The first region, from 0 to 5 
MHz, provides the information on the quadrupole and hyperfine coupling of 
14
N 
atoms weakly coupled to the unpaired flavin semiquinone electron; the second 
region, from 6 to 9 MHZ provides the information on the hyperfine coupling of 
14
N 
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atoms to the unpaired flavin semiquinone electron; the third region, from 14 to 16 
MHz provides information on the weak hyperfine coupling of 
1
H atoms to the 
unpaired flavin semiquinone electron. Previous ESEEM studies of other 
flavoproteins have shown that the 0 to 6 MHz region is dominated by contributions 
from the flavin semiquinone N(1) and N(3) atoms with 
14
N hyperfine coupling 
constants of 1-2 MHz.  The 6 to 9 MHz region is dominated by a peak at 7.3 MHz 
which is assigned to the hyperfine constant to N(10) 
14
N hyperfine coupling. The 
small feature in the 14 to 16 MHz region at 14.7 MHz arises from weakly coupled 
1
H atom, which is possibly assigned to N(3)H. Since ESEEM is not particularly good 
at detecting large hyperfine coupling to nuclei with spin of ½ (I=½), only this weak 
feature is observed for 
1
H nuclei. Although there are some limitations to the ESEEM 
method, the identical ESEEM spectra suggest that the environments of N(1), N(3) 
and N(10) are identical for both the FMN and FAD flavin semiquinones and also that 
all of these atoms are not affected by the binding of 2‘, 5‘-ADP, NADP+ and AD. 
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Figure 5.2. X-band two pulse ESEEM spectra of dithionite reduced MSR:  
a) one electron reduced: b) one electron reduced + 2‘, 5‘-ADP:c)  one electron 
reduced + NADP+: d) one electron reduced + AD: e) two electron reduced: f) two 
electron reduced + 2‘, 5‘-ADP: g) two electron reduced + NADP+: h) two electron 
reduced + AD. Experimental parameters: see Materials and Methods for pulse 
sequence; temperature 80 K; 60 scans were concatenated. 
 
5.2.3. ENDOR spectroscopy 
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Electron Nuclear Double Resonance (ENDOR) spectroscopy can be used to 
measure the hyperfine coupling between atomic nuclei and unpaired electrons. 
Compared to ESEEM, ENDOR allows the detection of large hyperfine couplings to 
nuclei with nuclear spin ½ (I=½), such as 
1
H.  Figure 5.3 shows the X-band echo 
detected Davies ENDOR spectra of MSR. The hyperfine coupling to 
1
H and 
unpaired electron are symmetrical around the central matrix feature which occurs at 
the nuclear Larmor frequency for 
1H, νH, at 14.7 MHz under the conditions 
employed in these experiments. Three hyperfine couplings are observed and their 
assignments to flavin semiquinone protons are listed in Table 5.1. The most 
prominent lines in these spectra, (2, and 2‘), arise from the 8-methyl group of the 
flavin semiquinone dimethylbenzene ring. These lines also show the most variation 
in the complexes of MSR with 2‘, 5‘-ADP, NADP+  and AD and the addition of a 
second electron to MSR. The high frequency lines for pair 2, were therefore plotted 
on an expanded scale to make their line shape more easily discernable, Figure 5.4. 
The 8-methyl group lines consist of two components, an intense A┴ component and a 
weaker A║ component. The A║ component gives rise to a shoulder and a slightly 
larger hyperfine coupling than A┴. These two components are a consequence of the 
cylindrical symmetry of the 8-methyl group hyperfine coupling, the axis of 
symmetry being the C (8) to methyl group bond. The difference between the A┴ and 
A║ can be indicative of the rate of methyl group rotation with a faster rotation rate 
making the difference smaller. The 
1
H hyperfine couplings are proportional to the 
share of the unpaired electron, the ‗unpaired electron spin density‘, at the attached 
carbon in the singly occupied molecular orbital (SOMO) of the flavin semiquinone. 
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Figure 5.3. X-band pulsed Davies ENDOR spectra of dithionite reduced MSR: 
a) one electron reduced: b) one electron reduced + 2‘, 5‘-ADP: c) one electron 
reduced + NADP+: d) one electron reduced + AD: e) two electron reduced: f) two 
electron reduced + 2‘, 5‘-ADP: g) two electron reduced + NADP+: h) two electron 
reduced + AD. Experimental parameters: see Materials and Methods for pulse 
sequence; temperature 80 K; 100 scans were concatenated. 
 
Hyperfine coupling constants (MHz) 1 2        A┴/A|| 3 
a) 1 electron reduced 11.5 8.5/9.2 5.1 
b)  1 electron reduced + 2’, 5’-ADP 11.5 8.5/9.2 5.1 
c) 1 electron reduced + NADP
+
 11.5 8.6/9.1 5.1 
d) 1 electron reduced + AD 11.5 8.5/9.2 5.1 
e) 2 electron reduced 12.0 8.7/9.5 5.1 
f) 2 electron reduced + 2’, 5’-ADP 12.0 8.7/9.5 5.1 
g) 2 electron reduced + NADP
+
 12.0 8.7/9.5 5.1 
h) 2 electron reduced + AD 12.0 8.6/9.6 5.1 
Assignment C(1‘)H 8-methyl C(6)H 
Table 5.1. The data of three observed hyperfine couplings and their assignments 
to flavin semiquinone protons. 
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Figure 5.4, an expansion of the high frequency methyl lines, 2’, of Figure 5.3. 
 Comparing the hyperfine coupling constants, it was found that in the one 
electron reduced state the unpaired electron spin densities at C (8), C (6) and C (1‘) 
of the FMN flavin semiquinone are identical in MSR and in its 2‘, 5‘-ADP and AD 
complexes. However, there is a small change in the complex with NADP
+
 in the 8-
methyl anisotropy which suggests the methyl group may rotate more freely in this 
complex. In two electron reduced MSR, (Figure 5.3 and Figure 5.4, e-h), there are 
slightly different 8-methyl group hyperfine couplings. This phenomenon can be 
explained by the presence of two overlapping 8-methyl group lines; one line arises 
from the FMN semiquinone which occurs in the EPR spectra of the one electron 
reduced MSR and the other new line originates from the FAD cofactor. The 
observed increase in the 8-methyl hyperfine coupling constants of the two electron 
reduced MSR samples suggests that the 8-methyl hyperfine coupling of the FAD 
semiquinone is larger than that of the FMN cofactor, so moving the overlapped 
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combination of FMN and FAD lines to a higher apparent hyperfine coupling. In 
addition, a more pronounced ‗apparent‘ anisotropy of the 8-methyl coupling is 
shown, i.e. this line becomes wider while the A┴ moves towards that observed for 
the FMN flavin semiquinone. This suggests that the binding of AD to the two 
electron reduced states increases the separation between the 8-methyl hyperfine 
coupling constants of the FMN and FAD flavin semiquinones, with the increasing of 
the FAD 8-methyl hyperfine coupling. 
 Throughout this study, the hyperfine coupling for the C(1‘) and C (6) remained 
relatively constant. The hyperfine coupling for the C(1‘) on the second electron 
reduced MSR increased, but the line associated with it was broad and difficult to 
measure. This increase probably indicates an overlap between the C(1‘)H line of the 
FMN and the FAD flavin semiquinones. Since the hyperfine coupling for the C(6)H 
remained constant, there is little change in the overall unpaired electron spin density 
on the dimethylbenzene ring for either of the cofactors on binding of 2‘, 5‘-ADP, 
NADP
+
 or AD. This result suggests that the observed changes in the 8-methyl group 
hyperfine couplings come from the 8-methyl group‘s dynamics.  
5.2.4. ELDOR 
 Electron electron double resonance (ELDOR or DEER), can be used to 
measure the distance between two unpaired electrons. The X-band four pulse 
ELDOR spectra on the two electron reduced MSR, and the complexes of MSR and 
2‘, 5‘ -ADP, NADP+ and AD were collected and are shown in Figure 5.5. These 
spectra were obtained from the Fourier transform of the spin echo from the four 
pulse ELDOR experiment. The x axis provides a measure of the dipolar coupling, 
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νDD, between two unpaired electrons. νDD is related to the distance between the two 
electrons, r.  
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Where νDD is in MHz and r is in nm.  
 The distances between the FAD and FMN flavin semiquinone in the two 
electron reduced state of MSR obtained from the ELDOR spectra are shown in 
Table 5.2. Several inter-flavin distances were determined from each of the ELDOR 
spectra. The relative integrals of lines in the spectrum are important as they provide 
an indication of the number of molecules in each conformation. Consideration of the 
distance data along with the relative integrals shows that there are always multiple 
conformations of MSR and these conformations and their relative proportions 
change with substrate binding. 
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Figure 5.5  X-band continuous wave EPR spectra of dithionite reduced MSR:  
a) two electron reduced: b) two electron reduced + 2,5-ADP: c) two electron reduced 
+ NADP+: d) two electron reduced + AD. Experimental parameters: pulse sequence 
given in Materials and Methods; temperature 80 K; 400 scans were concatenated. 
 
 νDD (MHz) Distance, r (nm) Relative integral 
2 electron reduced 0.8, 2.8, 4.0, 5.2 3.9, 2.7, 2.3, 2.1 0.55, 0.24, 0.09, 0.12 
2 electron reduced + 
2’, 5’-ADP 
1.1, 3.3 3.6, 2.5 0.77, 0.23 
2 electron reduced + 
NADP
+
 
0.7, 1.8, 3.0, 4.6, 
6.0, 7.9 
4.2, 3.1, 2.6, 2.2, 
2.0, 1.9 
0.23, 0.10, 0.14, 0.23, 
0.19, 0.11 
2 electron reduced + 
+AD 
1.6, 2.6, 4.0, 
5.1 
3.2, 2.7, 2.3, 2.1 0.20, 0.26, 0.24, 0.3 
Table 5.2 The distances data between the FAD and FMN flavin semiquinone in 
the two electron reduced state of MSR obtained from the ELDOR spectra. 
 
5.3.    Discussion 
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 Continuous wave EPR spectra show the formation of neutral `blue` flavin 
semiquinones in both the FMN and FAD cofactors of MSR under all the conditions 
tested. MSR has been shown to form neutral flavin semiquinones in optical 
spectroscopy at room temperature. It is therefore evident that in EPR experiments 
carried out at a temperature of 80 K the protonation state of the flavin is unaffected 
and can be compared with the data obtained at room temperature.  
 ESEEM spectra report hyperfine coupling to 
14
N atoms of the flavin cofactors. 
These 
14
N atoms are located within the isoalloxazine end of the cofactor. The 
hyperfine coupling is a measure of the unpaired electron spin density at these 
nitrogen atoms and it is affected by the hydrogen bonding to the isoalloxazine end of 
flavin. The ESEEM spectra on MSR show that binding of 2‘, 5‘-ADP, NADP+  and 
AD do not change the hydrogen bonding to the isoalloxazine end of the FMN and 
FAD cofactors. 
 ENDOR spectra of one electron and two electrons reduced MSR are similar. 
However, the difference between the 8-methyl hyperfine couplings of the FMN and 
FAD cofactors can be discerned. The significance of this difference is not clear and 
probably reflects the difference in the structures of FMN and FAD binding sites. In 
addition, the unpaired electron spin density distribution is also influenced by 
hydrogen bonding to the flavin cofactor reflecting part of the pattern of hydrogen 
bonding between the protein and the cofactor.  
 The 8-methyl hyperfine coupling of one electron reduced MSR, which 
contains the FMN flavin semiquinone, is affected by the binding of NADP
+
. This 
suggests that the environment of the FMN cofactor is changed by the binding of 
NADP
+
. The 8-methyl line becomes narrower, i.e there is a smaller anisotropy, 
153 
 
indicating an increase in the rotation of the 8-methyl group, although the actual rate 
of rotation cannot be determined quantitatively from the spectra. This suggests there 
is a change in the arrangement of the protein around the dimethylbenzene portion of 
the FMN cofactor, possibly increasing the solvent accessibility and leading to less 
steric hindrance at the methyl group. These data are consistent with and indicative of 
the movement of the FMN-binding domain within the diflavin reductase structure 
and function model. 
The 8-methyl hyperfine coupling of the two electron reduced MSR, which 
contains FMN semiquinone and FAD semiquinone, is changed by the binding of 
AD. Compared to the data from the one electron reduced MSR, this change can be 
attributed to the FAD semiquinone. This suggests that the binding of AD affects the 
environment of the FAD cofactor. This data does not exclude the possibility of the 
change in the environment around the FMN cofactor while binding with AD, 
however, this change cannot be detected by ENDOR spectroscopy.          
 The ELDOR spectra of the two electron reduced MSR show the changes in the 
distance between FMN and FAD semiquinone with the binding of 2‘, 5‘-ADP, 
NADP
+
 and AD. The data clearly show that there are several inter-flavin distances 
measured from each ELDOR spectra. This suggests that MSR exist in several 
conformations at 80K. Each conformation represents an energy minimum and a 
‗frustrated‘ energy landscape where the lack of thermal energy at 80 K maintains the 
protein in a number of separate conformations which cannot convert at that 
temperature. The isolated MSR mainly exists in the conformations in which the two 
flavins are located far apart, 3.6-2.7 nm. The addition of 2‘, 5‘-ADP maintains the 
equilibrium and possibly increases the distance between FAD and FMN cofactors. 
However, the binding of the NADP
+
 moves the conformational equilibrium towards 
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shorter inter-flavin distances, between 2.7 and 1.8 nm. The binding of AD also 
moves the equilibrium towards short inter-flavin distances, but with a pattern of 
conformations that differ from that exhibited by NADP
+
 bound MSR.  
 These results are consistent with the currently accepted model of diflavin 
reductase action in which the binding of substrates triggers the movements of the 
FMN-binding domain. In the case of the binding of NADP
+
 and MS, it enables the 
FMN-binding domain to accept electrons from the FAD-binding domain and then 
donate to MS. The current model for electron transfer in the human MS-MSR system 
[118] suggests that the major interaction stabilising the MS-MSR complex occurs 
between the MS activation domain, AD, and the FMN binding domain. The nature of 
the equilibrium that governs conformation change in MSR has not previously been 
investigated. The ELDOR data presented in Section 5.2.4 suggests that the 
equilibrium is not a simple ‗binary‘ one, having two states ‗free‘ and ‗bound‘, but 
rather several conformational states can be identified suggesting that a 
conformational sampling mechanism may be operating. Surprisingly, given the 
models for the MS-MSR interaction exemplified by Figure 9 in [118], the ELDOR 
data shows that the FAD to FMN distance decreases on binding to AD, relative to 
the distance between the flavin cofactors in the ‗resting‘ enzyme with no effectors 
bound. This suggests that some revision of the current model of MS-MSR 
interactions is required, with consideration given to the location of the FAD domain 
within the MS-MSR complex. The MSR:AD complex has been shown to be less 
stable than the MSR-FMN-binding domain:AD complex [118] and this may be 
explained by the presence of the FAD domain in relatively close proximity to the 
FMN-binding domain in the MSR:AD complex (see Section 1.4.4). Moreover the 
presence of the FAD-binding domain of MSR affects the AD binding stoichiometry 
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[118], it being two AD to one MSR, but a one to one stoichiometry when only the 
FMN-binding domain of MSR was used. This also suggests that the FAD-binding 
domain of MSR plays a role in MSR-AD, and therefore MSR-MS, interactions, in 
keeping with the ELDOR data showing that the binding of AD shortens the distance 
between the FAD and FMN binding domains of MSR.  
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CHAPTER SIX 
CRYSTALLOGRAPHY OF THE ACTIVATION DOMAIN OF 
METHIONINE SYNTHASE 
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 6.1.   Introduction 
Human MSR is a 78 kDa flavoprotein and its physiological function is to 
regenerate the active form of cobalamin-dependent methionine synthase by passing 
one electron from FMN, a cofactor of MSR, to cobalamin, the cofactor of MS. 
Structural studies on MS have suggested that MS is a multi-domain cobalamin-
dependent enzyme which consists of four domains: from N to C terminus, a 
homocysteine binding domain, a CH3-H4folate binding domain, a cobalamin binding 
domain and a S-adenosylmethionine binding domain, which is also termed the 
activation domain of MS [30]. The activation domain of MS interacts with the FMN- 
binding domain of MSR. Research on the complex of these two domains has shown 
that mutagenesis of putative interface residues of human MS and MSR, Lys
1071
 and 
Lys
987
, decreases the binding affinity between these two domains. High ionic 
strength conditions can also lower the binding affinity [118]. These results illustrate 
that the electrostatic interaction heavily affects the binding affinity of the complex 
between MS and MSR. In addition, isothermal titration calorimetry measurements of 
the binding stoichiometry of the FMN binding domain with the activation domain of 
MS revealed a stoichiometry of 1:2, and the midpoint reduction potential of the 
complex was not affected relative to the MSR on binding activation domain [118]. 
Also, kinetic data for electron transfer in MSR was similar for MSR alone and the 
MSR-MS complex [118]. Currently, most of the structural information for human 
MS has been inferred based on the structure of E. coli MetH [30], but the structure of 
the activation domain of human MS was successfully solved in the Scrutton group 
[2]. The crystal structure of the activation domain of MS solved at 1.6 Å resolution 
consists of one C-shaped structure with an α and β region mixed core which are 
mainly dominated by a twisted β-sheet with a β-mender region. This structure is 
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similar to the structure of MetH, however, the distinct difference between the human 
MS and MetH is that there is an extended 310-containing loop in human MS. This 
structure is perhaps related to their different binding stoichiometry.  
 In an attempt to clearly understand the structural relationship between MS and 
MSR a structure for the complex of the two proteins is required. After purification of 
the activation domain of MS and full-length MSR, these two domains were mixed in 
a 2:1 stoichiometry to perform crystallization of the complex of the activation 
domain of MS and MSR. In an attempt to determine the structure of the full length 
MSR and to overcome the difficulties met in the purification of MSR, two 
expression plasmids were constructed: the first plasmid contains one GST tag, cDNA 
of MSR and one (His)6 tag. The MSR protein which was expressed by this plasmid 
in E. coli BL21(DE3) can potentially be purified by two affinity chromatography 
procedures, using the GST tag and (His)6 tag on the MSR protein. The glutathione-
Sepharose 4B column binds the MSR-GST fusion protein.  After incubation with 
thrombin, the GST tag is cleaved from MSR; thereafter the Ni-NTA His resin 
column can be used to purify the MSR protein via the (His)6 tag. This two-step 
affinity chromatography method quickly accomplishes the purification of MSR and 
should avoid the problem of proteolysis which has been observed in previous 
purifications of MSR. The second expression plasmid is designed to express MSR in 
Pichia Pastoris, which is a yeast-expression system that combines the advantages of 
both prokaryotic and eukaryotic expression systems [154].  As an example, the 
methylotrophic yeast Pichia pastoris provides high yield of recombinant proteins 
which can be grown in high cell densities using minimal media and offers a cost-
effective method for 
13
C-labelled protein production for NMR structural analyses. 
The gene of the target protein expressed in Pichia pastoris can be regulated strongly 
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and tightly by the alcohol oxidase1 (AOX1) promoter. The construction of these two 
plasmids was confirmed by sequencing of the expression plasmids and Western Blot 
analysis of the expressed protein.  
  In this chapter, the results of the purification and crystallization of the 
activation domain of MS and the construction of the two MSR expression plasmids 
are demonstrated and discussed. 
6.2.    Results 
6.2.1. Expression and purification of the activation domain of MS 
 The activation domain of MS was previously cloned in plasmid pET23d with a 
C-terminal His-tag. This plasmid was transformed to BL21(DE3) and the protein of 
the activation domain of MS was expressed. The expressed protein was purified 
according to the method of Wolthers et al [2]. The purified protein was analysed by 
10% SDS-PAGE electrophoresis. Compared to the protein marker ladder, the 
molecular mass of the sample was consistent with the molecular mass deduced from 
the amino acid sequences of the activation domain of MS confirming that the 
purified sample was the activation domain of MS with the purity of a single band in 
10% SDS-PAGE electrophoresis. This purified protein was dialysed against buffer 
overnight and stored -80 °C with 10 % glycerol for use in crystallography 
experiments. 
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Figure 6.1 10 % SDS/PAGE electrophoresis of the activation domain of MS. 
Lane 1: molecular marker with molecular weight of 97.0, 66.0, 45.0, 36.0, 20.1 and 
14.4 kDa. Lane 2: the cell lysates after sonification; Lane 3: the protein collected 
from the Ni-NTA resin column; Lane 4: the protein collected from the Q-Sepharose 
column.  
 6.2.2.Crystallography of the activation domain of MS 
  The previously determined crystal structure for activation was that of a mutant 
form which aided crystallogenesis. In this work attempts were made to grow crystals 
of the wild-type activation domain. A crystallography experiment on the activation 
domain of MS was carried out using the sitting drop vapour diffusion method at 19 
°C. The protein sample at a concentration of 15 mg/mL was mixed with the 
detergents in PEG/Ion Screen Solution for Crystal Growth of HAMPTON 
RESEARCH Corp on the Mosquito robot machine. The sealed crystal screening 
plates were stored in the 19 °C fridge for about one week. One week later, needle-
like crystals had grown under three conditions. 1).0.1 mM tris-sodium citrate pH5.5, 
20% w/v PEG3000; 2). 0.1 M tris-sodium citrate 15% w/v PEG3000 and 3). 0.2 M 
sodium malonate 20% w/v PEG 3350. Some crystals were picked out with a loop 
and washed with buffer in the reservoir and ddH2O. The crystals were then dissolved 
and run on a 12% SDS-PAGE gel. The resulting electrophoresis gel was developed 
with a silver staining kit. The band of the dissolved crystals in the SDS 
electrophoresis gel have a molecular mass of  ~38 kDa, which is consistent with the 
161 
 
calculated molecular mass of the activation domain of MS, so these crystals were the 
protein crystal of the wild type activation domain of MS (Figure 6.2). Despite 
obtaining crystals, they were not suitable for diffraction analysis and future work 
will need to refine conditions to obtain crystals of diffraction quality. 
 
Figure 6.2 The crystals of the activation domain of MS. (A) & (B): photographs 
of the crystals of the activation domain of MS. (C). SDS-PAGE gel of the dissolved 
crystal of MS. Lane 1 is a low molecular weight marker (Amersham) comprised of 
proteins with the molecular weight of 97.0, 66.0, 45.0, 36.0, 20.1 and 14.4 kDa 
respectively. Lane 2 is the dissolved crystal protein. 
 6.2.3. The construction of two MSR expression plasmids. 
In this chapter two new plasmid constructs were made: the first pET41aMSR 
was created to encode a N-terminal GST and a C-terminal His tag in an attempt to 
aid rapid purification of MSR, thereby preventing proteolysis. Expression from this 
construct is described in section 6.2.3.1. The second plasmid (pMSRGST) was 
created to facilitate expression in Pichia pastoris. Given the time available it was not 
possible to analyse extensively expression of MSR from each of these constructs. A 
preliminary analysis is reported for pET41aMSR (Figure 6.3); although the 
construction of pMSRGST is reported there was insufficient time to explore 
expression in Pichia pastoris. 
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6.2.3.1. The construction of pET41a and its expression of MSR. 
  The plasmid, containing MSR cDNA, GST tag and (His)6 tag (Figure 2.1) 
was verified by restriction enzyme digestion. The plasmid was transformed into E. 
coli BL21 to express MSR. A Western blot experiment validated the expression of 
the MSR protein (Figure 6.3). From the result of the Western blot analysis some 
bands below the MSR-GST band suggest that proteolysis of MSR-GST has occurred 
at some period during the cell growth. Further analysis of purified MSR expressed 
from this construct will now need to be performed to ascertain the level (if any) of 
proteolysis in the final purified protein product. Preliminary attempts to express the 
double tagged protein indicated that the level of recombinant protein expression was 
much lower than that for the GST-MSR fusion protein used for studies reported 
elsewhere in this thesis. 
 
Figure 6.3: Western Blot analysis for the expression of MSR containing two tags 
produced in E. coli BL21. Lane 1 protein marker; Lane 2 and Lane 7 are the 
plasmid pET41a without IPTG at 16 hours and 3 hours; Lane 3, Lane 4, Lane 5 and 
Lane 6 are the cell lysate at 16 hours after the adding IPTG to a final concentration 
of 0 mM, 0.1 mM, 0.5mM, 1 mM; Lane 8, Lane 9, Lane 10 and Lane 11  are the cell 
lysate at 3 hours after the adding IPTG to a final concentration at 0 mM, 0.1 mM, 0.5 
mM, 1 mM.. 
6.2.3.2. The construction of pMSRGST  
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 The newly constructed plasmid pMSRGST (Figure 2.2) was verified by the 
restriction enzymes digestion reaction with NotI and NcoI, or PmeI alone, at 37 ºC 
for 2 hours. The size of the restriction fragments observed by 1 % agarose 
electrophoresis confirmed that the clone was consistent in design. The sequencing 
result (Figure 6.4) from Company MWG confirmed the sequence integrity of this 
plasmid. Restriction digest analysis and DNA sequencing indicated that the new 
construct had been made successfully. Future work will now need to explore if the 
GST-MSR fusion protein can be synthesised in active form in Pichia pastoris. 
                                   
 
Figure 6.4: The digestion result of the construct expression vector containing 
GST tag, 6×His tag and MSR cDNA. Lane 1: 1 Kb DNA ladder with molecular 
weight of 10.0, 8.0, 6.0, 5.0, 4.0, 3.0, 2.0, 1.5, 1.0 and 0.5 Kb; Lane 2: the  construct 
plasmid, Lane 3: plasmid digested by NotI, Lane 4: plasmid digested by NotI and 
NcoI. 
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Figure 6.4 The sequencing result of the construction expression vector of MSR 
with GST tag and (His)6 tag. 
6.3.    Discussion 
 The activation domain of MS is one constituent of the multidomain human 
MS:MSR complex. Although the crystal structure of one mutant form of the human 
activation domain of MS has been solved, because of problems related to twinning of 
crystals, the crystal structure could not be solved for the wild-type activation domain 
of MS [2]. Despite this, it has been demonstrated that pure wild-type activation 
domain can be obtained. Crystallisation attempts are a useful addition to on going 
work as the work in this chapter has identified conditions for obtaining crystals of 
the protein. In the longer term it is hoped that conditions will be found to co-
crystallise the activation domain and full length MSR so that details of the protein 
complex can be elucidated. This would be an important initial step in the 
understanding of the impact of clinical mutations and polymorphisms on this 
complex. 
 In addition to the construction of the two MSR expression plasmids, the 
purpose of the research was to solve the proteolysis problem identified previously 
with MSR by gene manipulation. The addition of new affinity tags to aid rapid 
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purification was completed and confirmed. Further research is now needed in the 
area of protein expression, to identify a new purification protocol and the production 
of full length MSR crystals.  
 The work described in this chapter therefore supports further on-going studies 
of MSR and the MS-MSR complex. A key challenge is to build a more detailed 
structural picture of the complex and its component domains. This will require 
provision of highly purified proteins in a form suitable for structural determination. 
It is hoped that the progress on crystallogenesis and plasmid construct development 
will assist in this long term goal. 
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DISCUSSION 
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7.1.    Discussion      
 This PhD research program on MSR includes research on the crystal structure 
of the FAD/NADPH binding domain of MSR, kinetic and thermodynamic studies on 
the mutants of the FAD/NADPH binding domain of MSR and full-length MSR and 
the electron magnetic resonance spectroscopy, EPR, ENDOR, ESEEM and ELDOR 
on full-length MSR. 
 In studies of the crystal structure of the FAD/NADPH binding domain of 
MSR, the expressed recombinant protein was purified by affinity and anion-
exchange chromatography to produce a protein that crystallized and diffracted to 1.9 
Å. This protein crystal was subjected to X-ray diffraction studies, and the crystal 
structure was built. The study identified the binding sites for cofactors NADPH and 
FAD. As with other members in the diflavin reductase, MSR consists of two 
domains: the FMN binding domain in the N-terminal region and the FAD/NADPH 
binding domain on the C- terminal. One important structural feature of MSR is the 
extended hinge region which includes 82 residues. It is suggested that this long hinge 
region is involved in the large scale motion of the FMN binding domain of MSR, 
which is believed to play a part in the transfer of electrons from FAD to MS. The 
expected interflavin electron transfer rate for this diflavin reductase family is about 
10
7
 to 10
8
 s
-1
 if one uses the crystal structure of CPR or NOS to calculate theoretical 
values for electron transfer based on Marcus theory. However, the interflavin 
electron transfer rate for MSR is only 0.2 s
-1 
[68], suggesting that electron transfer is 
not rate limiting and that conformational motion controls the rate of interflavin 
electron transfer. This idea is consistent with the ELDOR studies reported in Chapter 
five that indicate the FMN domain of MSR is mobile with respect to the FAD 
domain supporting the idea that conformational motion is an important part of the 
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interflavin electron transfer mechanism. These dynamic features are believed to be 
related to the physiological function of MSR. MSR only functions to regenerate the 
inert MS every 200 to 1000 catalytic cycles, and therefore catalysis can be slow. The 
rate of hydride transfer from NADPH to FAD in MSR is also relatively slow 
suggesting that high catalytic turnover is not important for physiological function. 
Based on the crystal structure of the FAD/NADPH binding domain of MSR, 
the kinetic and thermodynamic studies on mutants of the FAD/NADPH binding 
domain and full- length MSR were completed. The mutants of MSR focus on two 
residues Asp
652
 and Trp
697
. The Asp
652
 is only 4-5Å distance to the pyrophosphate 
moiety of the substrate NADPH. The mutants at this position were designed to 
change the electrostatic charge and residue volume at this position by converting the 
natural residue to a series of variants (D652A, D652R and D652N). These mutants 
strongly decreased both the binding affinity of NADPH and the turnover numbers. 
The positive shift in the redox potentials of the FAD of the mutants was attributed to 
the slowness of the electron transfer rate from NADPH to FAD. Another residue 
Trp
697
, which is a conserved residue in the diflavin reductase family, packs on the 
face of isoalloxazine ring of FAD to form π-π interaction with FAD. Combined with 
the binding residues for the 2
‘
-phosphate of NADPH, this Trp
697
 involves the 
stabilization of the binding of NADPH and also affects the selectivity with different 
coenzymes, such as NADPH and NADH. The mutants possessing changes at this 
position showed decreased catalytic ability of MSR and the emission of tryptophan 
fluorescence consistent with removal of the tryptophan side chain. This perhaps can 
be explained by the fact that the replacements from tryptophan to alanine and 
histidine have the isoalloxazine ring more exposed to water which further triggers 
the change of redox potential of FAD, resulting in a greater energy cost on the 
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electron transfer to the physiological electron accepter. All these results verify that 
these two residues Asp
652
 and Trp 
697
 are key determinants in the reductive half 
reaction of MSR. 
 Recent studies in structural biology have revealed that conformational change 
plays a significant role on the catalysis on the diflavin reductase family. To 
investigate the effect of conformational change on full length MSR, EPR, ENDOR, 
ESEEM and ELDOR techniques were applied to the wild type full-length MSR and 
to complexes of MSR-NADP, MSR-2‘5‘ADP, MSR-the activation domain of MS. 
The results of EPR, ENDOR, and ESEEM all confirmed the existence of the 
semiquinone form of FAD and FMN during the catalytic turnover. ELDOR provided 
the distance change between the two semiquinones which is a reliable indication for 
the conformational change of MSR. Combined data indicate the highly dynamic 
properties of MSR as inferred from the presence of the long interdomain linker 
between the FAD and FMN binding domains. 
7.2. Further investigation 
In order to clearly understand the relationship between the structure and 
function of MSR, more biochemical experiments need to be carried out in future. 
 Using the crystallization conditions developed for the successful 
crystallization on the FAD/NADPH binding domain of MSR, the FMN binding 
domain of MSR and the full length MSR can be considered. To solve the difficulty 
in the full length MSR, the new expression plasmids which contain GST tag and 
(His)6 tag together, can be expressed in E.coli system and  Pichia Pastoris, further 
improvement on the purification and crystallization can be completed. Another 
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crystallization experiment on the complex of MSR-AD of MS is also suggested in 
future.  
 Based on the electronic structural research on MSR, using techniques such as 
EPR, ENDOR, ESEEM and ELDOR, more advanced interdisciplinary experiments 
on the dynamics structure of MSR should be carried out. The measurement of the 
relaxation time to determine the distance between the FMN semiquinone and FAD 
semiquinone has been finished, so the same method can be applied to measure the 
distance between the FMN semiquinone of MSR with the Co(II) cofactor of MS. 
Also, measurement of the distance change on these two cofactors with the addition 
of ligands such as NADP
+
 will provide some new illustration on the conformational 
change of the MS-MSR complex.  
  Focusing on the dynamic studies on the enzyme, the time dependent structural 
change in the MS-MSR catalysis process also could be researched. An advanced 
technology, fluorescence resonance energy transfer, FRET, could also be considered. 
FRET is a powerful technique used to measure the distance for 10Å to 75Å of two 
dyes [155]. At the single molecule level, single pair fluorescence resonance energy 
transfer, spFRET, has been successfully applied to the kinetic and conformational 
change of single domain proteins [156]. If spFRET were to be  applied to the 
complex of MS-MSR, it could assist in completing the interprotein dynamic research 
on the larger protein complex. 
 
 
 
171 
 
 
 
 
 
 
REFERENCES 
 
 
 
 
 
 
 
 
 
 
 
172 
 
1 Wolthers, K. R., Basran, J., Munro, A. W. and Scrutton, N. S. (2003) Molecular 
dissection of human methionine synthase reductase: Determination of the flavin redox 
potentials in full-length enzyme and isolated flavin-binding domains. Biochemistry. 42, 3911-
3920 
2 Wolthers, K. R., Toogood, H. S., Jowitt, T. A., Marshall, K. R., Leys, D. and Scrutton, 
N. S. (2007) Crystal structure and solution characterization of the activation domain of human 
methionine synthase. Febs J. 274, 738-750 
3 Wolthers, K. R., Lou, X. D., Toogood, H. S., Leys, D. and Scrutton, N. S. (2007) 
Mechanism of coenzyme binding to human methionine synthase reductase revealed through 
the crystal structure of the FNR-like module and isothermal titration calorimetry. 
Biochemistry. 46, 11833-11844 
4 Navaza, J. (2001) Implementation of molecular replacement in AMoRe. Acta 
Crystallogr D. 57, 1367-1372 
5 Galli, C., MacArthur, R., AbuSoud, H. M., Clark, P., Stuehr, D. J. and Brudvig, G. W. 
(1996) EPR spectroscopic characterization of neuronal NO synthase (vol 35, pg 2804, 1996). 
Biochemistry. 35, 7298-7298 
6 Schweiger, A. and Jeschke, G. (2001) Principles of Pulse Electron Paramagnetic 
Resonance Spectroscopy 
7 Kay, C. W. M., Elsasser, C., Bittl, R., Farrell, S. R. and Thorpe, C. (2006) 
Determination of the distance between the two neutral flavin radicals in augmenter of liver 
regeneration by pulsed ELDOR. J Am Chem Soc. 128, 76-77 
8 Hay, S., Brenner, S., Khara, B., Quinn, A. M., Rigby, S. E. J. and Scrutton, N. S. 
(2010) Nature of the Energy Landscape for Gated Electron Transfer in a Dynamic Redox 
Protein. J Am Chem Soc. 132, 9738-9745 
9 http://academic.brooklyn.cuny.edu/biology/bio4fv/page/coenzy_.htm. coenzymes and 
cofactors.  
10 Jordan, F., Patel, M. S. and Editors. (2004) Thiamine: Catalytic Mechanisms in 
Normal and Disease States. [In: Oxid. Stress Dis., 2004; 11] 
11 http://www.elmhurst.edu/~chm/vchembook/571cofactor.html. coenzymes.  
12 Palmer, T. (1981) Understanding Enzymes 
13 Metzler, D. E. (2001) Biochemistry: The Chemical Reactions of Living Cells, Volume 
1; Second Edition 
14 Bryce, C. F. A. (1979) SAM - semantics and misunderstandings. Trends Biochem. Sci. 
(Pers. Ed.). 4, N62-N63 
15 Sigel, H. (1973) Metal Ions in Biological Systems, Vol. 2: Mixed-Ligand Complexes 
173 
 
16 Aggett, P. J. (1985) Physiology and Metabolism of Essential Trace-Elements - an 
Outline. Clin Endocrinol Meta. 14, 513-543 
17 Li, H. Y. and Poulos, T. L. (2005) Structure-function studies on nitric oxide synthases. 
J Inorg Biochem. 99, 293-305 
18 Prohaska, J. R. (2008) Role of copper transporters in copper homeostasis. Am J Clin 
Nutr. 88, 826s-829s 
19 Brugna, M., Tasse, L. and Hederstedt, L. (2010) In vivo production of catalase 
containing haem analogues. Febs J. 277, 2663-2672 
20 Doleh, L. and Romani, A. (2007) Biphasic effect of extra-reticular Mg2+ on hepatic 
G6P transport and hydrolysis. Arch Biochem Biophys. 467, 283-290 
21 Ilies, M., Di Costanzo, L., North, M. L., Scott, J. A. and Christianson, D. W. (2010) 2-
Aminoimidazole Amino Acids as Inhibitors of the Binuclear Manganese Metalloenzyme 
Human Arginase I. J Med Chem. 53, 4266-4276 
22 Cerqueira, N. M. F. S. A., Gonzalez, P. J., Brondino, C. D., Romao, M. J., Romao, C. 
C., Moura, I. and Moura, J. J. G. (2009) The Effect of the Sixth Sulfur Ligand in the Catalytic 
Mechanism of Periplasmic Nitrate Reductase. J Comput Chem. 30, 2466-2484 
23 Kaluarachchi, H., Chan-Chung, K. C. and Zamble, D. B. Microbial nickel proteins. 
Natural Product Reports. 27, 681-694 
24 Akil, M., Gurbuz, U., Bicer, M.,  Sivrikaya, A.,Mogulkoc, R., Baltaci, A.K. (2010) 
Effect of Selenium Supplementation on Lipid Peroxidation, Antioxidant Enzymes, and 
Lactate Levels in Rats Immediately After Acute Swimming Exercise Biological Trace 
Element Research  
25 Maurmann, L. and Bose, R. N. (2010) Unwinding of zinc finger domain of DNA 
polymerase I by cis-diamminedichloroplatinum(II). Dalton T. 39, 7968-7979 
26 Muller Ingrid, B., Bergmann, B., Groves Matthew, R., Couto, I., Amaral, L., Begley 
Tadhg, P., Walter Rolf, D. and Wrenger, C. (2009) The vitamin B1 metabolism of 
Staphylococcus aureus is controlled at enzymatic and transcriptional levels. PloS one. 4, 
e7656 
27 Kirkland, J. B. (2003) Niacin and carcinogenesis. Nutrition and Cancer. 46, 110-118 
28 Kanouchi, H., Shibuya, M., Tsukamoto, S., Fujimura, Y., Tachibana, H., Yamada, K. 
and Oka, T. (2010) Comparisons of uptake and cell surface binding among pyridoxal, 
pyridoxine, and pyridoxamine in RAW264.7 cells. Nutrition. 26, 648-652 
29 Bryk, R., Arango, N., Venugopal, A., Warren, J. D., Park, Y. H., Patel, M. S., Lima, C. 
D. and Nathan, C. (2010) Triazaspirodimethoxybenzoyls as Selective Inhibitors of 
Mycobacterial Lipoamide Dehydrogenase. Biochemistry. 49, 1616-1627 
174 
 
30 Ludwig, M. L. and Matthews, R. G. (1997) Structure-based perspectives on B-12-
dependent enzymes. Annu Rev Biochem. 66, 269-313 
31 Gasser, B., Dragosits, M. and Mattanovich, D. (2010) Engineering of biotin-
prototrophy in Pichia pastoris for robust production processes. Metabolic Engineering. In 
Press, Corrected Proof 
32 Leonardi, R., Zhang, Y. M., Rock, C. O. and Jackowski, S. (2005) Coenzyme A: Back 
in action. Prog Lipid Res. 44, 125-153 
33 Joosten, V. and van Berkel, W. J. H. (2007) Flavoenzymes. Curr Opin Chem Biol. 11, 
195-202 
34 Mack, M. and Grill, S. (2006) Riboflavin analogs and inhibitors of riboflavin 
biosynthesis. Appl Microbiol Biot. 71, 265-275 
35 Bugg, T. and Editor. (1996) Introduction to Enzyme and Coenzyme Chemistry 
36 Chiang, P. K., Gordon, R. K., Tal, J., Zeng, G. C., Doctor, B. P., Pardhasaradhi, K. 
and McCann, P. P. (1996) S-adenosylmethionine and methylation. Faseb J. 10, 471-480 
37 Noll, K. M., Rinehart, K. L., Tanner, R. S. and Wolfe, R. S. (1986) Structure of 
Component-B (7-Mercaptoheptanoylthreonine Phosphate) of the Methylcoenzyme-M 
Methylreductase System of Methanobacterium-Thermoautotrophicum. P Natl Acad Sci USA. 
83, 4238-4242 
38 Balch, W. E. and Wolfe, R. S. (1979) Specificity and Biological Distribution of 
Coenzyme M (2-Mercaptoethanesulfonic Acid). J Bacteriol. 137, 256-263 
39 Crane, F. L. (2001) Biochemical functions of coenzyme Q10. Journal of the American 
College of Nutrition. 20, 591-598 
40 Wijayanti, N., Katz, N. and Immenschuh, S. (2004) Biology of heme in health and 
disease. Curr Med Chem. 11, 981-986 
41 Meister, A. and Anderson, M. E. (1983) Glutathione. Annu Rev Biochem. 52, 711-
760 
42 Mendel, R. R. and Bittner, F. (2006) Cell biology of molybdenum. Bba-Mol Cell Res. 
1763, 621-635 
43 Pai, E. F., Karplus, P. A. and Schulz, G. E. (1988) Crystallographic Analysis of the 
Binding of Nadph, Nadph Fragments, and Nadph Analogues to Glutathione-Reductase. 
Biochemistry. 27, 4465-4474 
44 Medina, M. (2009) Structural and mechanistic aspects of flavoproteins: photosynthetic 
electron transfer from photosystem I to NADP(+). Febs J. 276, 3942-3958 
175 
 
45 Berg, I. A., Kockelkorn, D., Ramos-Vera, W. H., Say, R. F., Zarzycki, J., Hugler, M., 
Alber, B. E. and Fuchs, G. (2010) Autotrophic carbon fixation in archaea. Nat Rev Microbiol. 
8, 447-460 
46 Brutnell, T. P., Wang, L., Swartwood, K., Goldschmidt, A.,  Jackson, D., Zhu, X., 
Kellogg, E., and Van Ecka, J. (2010) Setaria viridis: A Model for C4 Photosynthesis. The 
Plant Cell 
47 Cabezas, H., Raposo, R. R. and Melendez-Hevia, E. (1999) Activity and metabolic 
roles of the pentose phosphate cycle in several rat tissues. Mol Cell Biochem. 201, 57-63 
48 Sassi, N., Paul, C., Martin, A., Bettaieb, A. and Jeannin, J.-F. (2010) Lipid a-induced 
responses in vivo. Advances in experimental medicine and biology. 667, 69-80 
49 Wei, C.-C., Motl, N., Levek, K., Chen, L. Q., Yang, Y.-P., Johnson, T., Hamilton, L. 
and Stuehr, D. J. (2010) Conformational states and kinetics of the calcium binding domain of 
NADPH oxidase 5. Open Biochemistry Journal. 4, 59-67 
50 Myasoedova, K. N. and Timofeev, K. N. (2010) Conformational Changes near the 
Cytochrome P450 Active Site upon Binding of Two Different Ligands. Biochemistry-
Moscow. 75, 899-904 
51 Rather, L. J., Knapp, B., Haehnel, W. and Fuchs, G. (2010) Coenzyme A-dependent 
Aerobic Metabolism of Benzoate via Epoxide Formation. J Biol Chem. 285, 20615-20624 
52 Hatanosa.F, Takagi, Y. and Shikita, M. (1973) Hydrogen Transfer from Nadph to 
Steroid by Testicular 20-Alpha-Hydroxysteroid Dehydrogenase - Stereospecificity and 
Isotope-Effect. J Biochem-Tokyo. 74, 1065-1067 
53 Kono, H., Rusyn, I., Yin, M., Gabele, E., Yamashina, S., Dikalova, A., Kadiiska, M. 
B., Connor, H. D., Mason, R. P., Segal, B. H., Bradford, B. U., Holland, S. M. and Thurman, 
R. G. (2000) NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver 
disease. J Clin Invest. 106, 867-872 
54 Hoban, P. R., Walton, M. I., Robson, C. N., Godden, J., Stratford, I. J., Workman, P., 
Harris, A. L. and Hickson, I. D. (1990) Decreased Nadph - Cytochrome-P-450 Reductase-
Activity and Impaired Drug Activation in a Mammalian-Cell Line Resistant to Mitomycin-C 
under Aerobic but Not Hypoxic Conditions. Cancer Research. 50, 4692-4697 
55 Randaccio, L., Geremia, S., Demitri, N. and Wuerges, J. (2010) Vitamin B-12: 
Unique Metalorganic Compounds and the Most Complex Vitamins. Molecules. 15, 3228-
3259 
56 Lenhert, P. G. and Hodgkin, D. C. (1961) Structure of 5,6-
Dimethylbenzimidazolylcobamide Coenzyme. Nature. 192, 937-938 
57 Blakley, R. L. (1969) The Biochemistry of Folic Acid and Related Pteridines 
(Frontiers of Biology, Vol. 13) 
176 
 
58 Michel, C., Buckel, W. and Linder, D. (1991) Purification of the Coenzyme B12-
Containing 2-Methyleneglutarate Mutase from Clostridium-Barkeri by High-Performance 
Liquid-Chromatography. Journal of Chromatography. 587, 93-99 
59 Shen, A. L. and Kasper, C. B. (2000) Differential contributions of NADPH-
cytochrome P450 oxidoreductase FAD binding site residues to flavin binding and catalysis. J 
Biol Chem. 275, 41087-41091 
60 Wolthers, K. R. and Scrutton, N. S. (2004) Electron transfer in human methionine 
synthase reductase studied by stopped-flow spectrophotometry. Biochemistry. 43, 490-500 
61 Ghisla, S., Massey, V., Lhoste, J. M. and Mayhew, S. G. (1974) Fluorescence and 
Optical Characteristics of Reduced Flavines and Flavoproteins. Biochemistry. 13, 589-597 
62 Ghisla, S. and Massey, V. (1989) Mechanisms of Flavoprotein-Catalyzed Reactions. 
European Journal of Biochemistry. 181, 1-17 
63 Muller, F., Walker, W. H., Massey, V., Brustlei.M and Hemmeric.P. (1972) Light-
Absorption Studies on Neutral Flavin Radicals. European Journal of Biochemistry. 25, 573-& 
64 Sancho, J. (2006) Flavodoxins: sequence, folding, binding, function and beyond. 
Cellular and Molecular Life Sciences. 63, 855-864 
65 Mukherjee, T., Zhang, Y., Abdelwahed, S., Ealick, S. E. and Begley, T. P. (2010) 
Catalysis of a Flavoenzyme-Mediated Amide Hydrolysis. J Am Chem Soc. 132, 5550-5551 
66 Tu, S. C., Lei, B. F., Liu, M. Y., Tang, C. K. and Jeffers, C. (2000) Probing the 
mechanisms of the biological intermolecular transfer of reduced flavin. Journal of Nutrition. 
130, 331s-332s 
67 Awad, S., Henderson, G. B., Cerami, A. and Held, K. D. (1992) Effects of 
Trypanothione on the Biological-Activity of Irradiated Transforming DNA. International 
Journal of Radiation Biology. 62, 401-407 
68 Murataliev, M. B., Feyereisen, R. and Walker, A. (2004) Electron transfer by diflavin 
reductases. Biochimica Et Biophysica Acta-Proteins and Proteomics. 1698, 1-26 
69 Damiani, M. J., Yalloway, G. N., Lu, J., McLeod, N. R. and O'Neill, M. A. (2009) 
Kinetic Stability of the Flavin Semiquinone in Photolyase and Cryptochrome-DASH. 
Biochemistry. 48, 11399-11411 
70 Wang, Z., Chernyshev, A., Koehn, E. M., Manuel, T. D., Lesley, S. A. and Kohen, A. 
(2009) Oxidase activity of a flavin-dependent thymidylate synthase. Febs J. 276, 2801-2810 
71 Despicer, P. O. and Maloy, S. (1993) Puta Protein, a Membrane-Associated Flavin 
Dehydrogenase, Acts as a Redox-Dependent Transcriptional Regulator. P Natl Acad Sci USA. 
90, 4295-4298 
177 
 
72 Mallett, T. C., Wallen, J. R., Karplus, P. A., Sakai, H., Tsukihara, T. and Claiborne, A. 
(2006) Structure of coenzyme A-disulfide reductase from Staphylococcus aureus at 1.54 
angstrom resolution. Biochemistry. 45, 11278-11289 
73 Niederpruem, D. J. and Hackett, D. P. (1958) The Oxygen Affinity of a Flavin 
Oxidase Involved in the Respiration of Streptococcus Faecalis. Plant Physiology. 33, 113-115 
74 Eswaramoorthy, S., Bonanno, J. B., Burley, S. K. and Swaminathan, S. (2006) 
Mechanism of action of a flavin-containing monooxygenase. P Natl Acad Sci USA. 103, 
9832-9837 
75 Karplus, P. A., Daniels, M. J. and Herriott, J. R. (1991) Atomic-Structure of 
Ferredoxin-Nadp+ Reductase - Prototype for a Structurally Novel Flavoenzyme Family. 
Science. 251, 60-66 
76 Watenpaugh, K. D., Sieker, L. C. and Jensen, L. H. (1973) Binding of riboflavine 5'-
phosphate in a flavoprotein. Flavodoxin at 2.0 Ang. resolution. Proc. Nat. Acad. Sci. U. S. A. 
70, 3857-3860 
77 Gutierrez, A., Munro, A. W., Grunau, A., Wolf, C. R., Scrutton, N. S. and Roberts, G. 
C. K. (2003) Interflavin electron transfer in human cytochrome P450 reductase is enhanced 
by coenzyme binding - Relaxation kinetic studies with coenzyme analogues. European 
Journal of Biochemistry. 270, 2612-2621 
78 Zhang, J., Martasek, P., Paschke, R., Shea, T., Masters, B. S. S. and Kim, J. J. P. 
(2001) Crystal structure of the FAD/NADPH-binding domain of rat neuronal nitric-oxide 
synthase - Comparisons with NADPH-cytochrome P450 oxidoreductase. J Biol Chem. 276, 
37506-37513 
79 Finn, R. D., Basran, J., Roitel, O., Wolf, C. R., Munro, A. W., Paine, M. J. I. and 
Scrutton, N. S. (2003) Determination of the redox potentials and electron transfer properties 
of the FAD- and FMN-binding domains of the human oxidoreductase NR1. European Journal 
of Biochemistry. 270, 1164-1175 
80 Haines, D. C., Tomchick, D. R., Machius, M. and Peterson, J. A. (2001) Pivotal role 
of water in the mechanism of P450BM-3. Biochemistry. 40, 13456-13465 
81 Crane, B. R., Siegel, L. M. and Getzoff, E. D. (1995) Sulfite Reductase Structure at 
1.6 Angstrom - Evolution and Catalysis for Reduction of Inorganic Anions. Science. 270, 59-
67 
82 Wada, F., Shibata, H., Goto, M. and Sakamoto, Y. (1968) Participation of Microsomal 
Electron Transport System Involving Cytochrome P-450 in Omega-Oxidation of Fatty Acids. 
Biochim Biophys Acta. 162, 518-524 
83 Gusarov, I., Starodubtseva, M., Wang, Z. Q., McQuade, L., Lippard, S. J., Stuehr, D. J. 
and Nudler, E. (2008) Bacterial nitric-oxide synthases operate without a dedicated redox 
partner (vol 283, pg 13140, 2008). J Biol Chem. 283, 19164-19164 
178 
 
84 Kurzban, G. P. and Strobel, H. W. (1986) Preparation and Characterization of Fad-
Dependent Nadph-Cytochrome P-450 Reductase. J Biol Chem. 261, 7824-7830 
85 Thaete, L. G., Siegel, D., Malkinson, A. M., Forrest, G. L. and Ross, D. (1991) 
Nad(P)H-Quinone Oxidoreductase (Dt-Diaphorase) Activity and Messenger-Rna Content in 
Normal and Neoplastic Mouse Lung Epithelia. Int J Cancer. 49, 145-149 
86 Iyanagi, T. (1990) On the Mechanism of One-Electron Reduction of Quinones by 
Microsomal Flavin Enzymes - the Kinetic-Analysis between Cytochrome-B5 and Menadione. 
Free Radical Res Com. 8, 259-268 
87 Weber, M. M., Lenhoff, H. M. and Kaplan, N. O. (1956) Reduction of Inorganic Iron 
and Cytochrome-C by Flavin Enzymes. J Biol Chem. 220, 93-104 
88 Vermilion, J. L. and Coon, M. J. (1978) Identification of the High and Low Potential 
Flavins of Liver Microsomal Nadph-Cytochrome P-450 Reductase. J Biol Chem. 253, 8812-
8819 
89 Yoshimoto, A. and Sato, R. (1968) Studies on Yeast Sulfite Reductase .I. Purification 
and Characterization. Biochim Biophys Acta. 153, 555-575 
90 Wang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S. S. and Kim, J. J. P. 
(1997) Three-dimensional structure of NADPH-cytochrome P450 reductase: Prototype for 
FMN- and FAD-containing enzymes. P Natl Acad Sci USA. 94, 8411-8416 
91 Gruez, A., Pignol, D., Zeghouf, M., Coves, J., Fontecave, M., Ferrer, J. L. and 
Fontecilla-Camps, J. C. (2000) Four crystal structures of the 60 kDa flavoprotein monomer of 
the sulfite reductase indicate a disordered flavodoxin-like module. J Mol Biol. 299, 199-212 
92 Watt, W., Tulinsky, A., Swenson, R. P. and Watenpaugh, K. D. (1991) Comparison of 
the Crystal-Structures of a Flavodoxin in Its 3 Oxidation-States at Cryogenic Temperatures. J 
Mol Biol. 218, 195-208 
93 Komori, H., Seo, D., Sakurai, T. and Higuchi, Y. (2010) Crystallization and 
preliminary X-ray studies of ferredoxin-NADP(+) oxidoreductase encoded by Bacillus 
subtilis yumC. Acta Crystallogr F. 66, 301-303 
94 Gutierrez, A., Lian, L. Y., Wolf, C. R., Scrutton, N. S. and Roberts, G. C. K. (2001) 
Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its 
component domains. Biochemistry. 40, 1964-1975 
95 Dunford, A. J., Rigby, S. E. J., Hay, S., Munro, A. W. and Scrutton, N. S. (2007) 
Conformational and thermodynamic control of electron transfer in neuronal nitric oxide 
synthase. Biochemistry. 46, 5018-5029 
96 Miller, R. T., Martasek, P., Omura, T. and Masters, B. S. S. (1999) Rapid kinetic 
studies of electron transfer in the three isoforms of nitric oxide synthase. Biochem Bioph Res 
Co. 265, 184-188 
179 
 
97 Knight, K. and Scrutton, N. S. (2002) Stopped-flow kinetic studies of electron transfer 
in the reductase domain of neuronal nitric oxide synthase: re-evaluation of the kinetic 
mechanism reveals new enzyme intermediates and variation with cytochrome P450 reductase. 
Biochem J. 367, 19-30 
98 Garcin, E. D., Bruns, C. M., Lloyd, S. J., Hosfield, D. J., Tiso, M., Gachhui, R., 
Stuehr, D. J., Tainer, J. A. and Getzoff, E. D. (2004) Structural basis for isozyme-specific 
regulation of electron transfer in nitric-oxide synthase. J Biol Chem. 279, 37918-37927 
99 Shen, A. L., Porter, T. D., Wilson, T. E. and Kasper, C. B. (1989) Structural-Analysis 
of the Fmn Binding Domain of Nadph-Cytochrome P-450 Oxidoreductase by Site-Directed 
Mutagenesis. J Biol Chem. 264, 7584-7589 
100 Bastiaens, P. I. H., Bonants, P. J. M., Muller, F. and Visser, A. J. W. G. (1989) Time-
Resolved Fluorescence Spectroscopy of Nadph Cytochrome-P-450 Reductase - 
Demonstration of Energy-Transfer between the 2 Prosthetic Groups. Biochemistry. 28, 8416-
8425 
101 Olteanu, H., Wolthers, K. R., Munro, A. W., Scrutton, N. S. and Banerjee, R. (2004) 
Kinetic and thermodynamic characterization of the common polymorphic variants of human 
methionine synthase reductase. Biochemistry. 43, 1988-1997 
102 Munro, A. W., Noble, M. A., Robledo, L., Daff, S. N. and Chapman, S. K. (2001) 
Determination of the redox properties of human NADPH-cytochrome P450 reductase. 
Biochemistry. 40, 1956-1963 
103 Noble, M. A., Munro, A. W., Rivers, S. L., Robledo, L., Daff, S. N., Yellowlees, L. J., 
Shimizu, T., Sagami, I., Guillemette, J. G. and Chapman, S. K. (1999) Potentiometric analysis 
of the flavin cofactors of neuronal nitric oxide synthase. Biochemistry. 38, 16413-16418 
104 Roman, L. J., Martasek, P., Miller, R. T., Harris, D. E., de la Garza, M. A., Shea, T. 
M., Kim, J. J. P. and Masters, B. S. S. (2000) The C termini of constitutive nitric-oxide 
synthases control electron flow through the flavin and heme domains and affect modulation 
by calmodulin. J Biol Chem. 275, 29225-29232 
105 Craig, D. H., Chapman, S. K. and Daff, S. (2002) Calmodulin activates electron 
transfer through neuronal nitric-oxide synthase reductase domain by releasing an NADPH-
dependent conformational lock. J Biol Chem. 277, 33987-33994 
106 Hannemann, F., Bichet, A., Ewen, K. M. and Bernhardt, R. (2007) Cytochrome P450 
systems - biological variations of electron transport chains. Bba-Gen Subjects. 1770, 330-344 
107 Porter, T. D. (1991) An Unusual yet Strongly Conserved Flavoprotein Reductase in 
Bacteria and Mammals. Trends Biochem Sci. 16, 154-158 
108 Isenberg, I. and Szentgyorgyi, A. (1958) Free Radical Formation in Riboflavin 
Complexes. P Natl Acad Sci USA. 44, 857-862 
180 
 
109 Dohr, O., Paine, M. J. I., Friedberg, T., Roberts, G. C. K. and Wolf, C. R. (2001) 
Engineering of a functional human NADH-dependent cytochrome P450 system. P Natl Acad 
Sci USA. 98, 81-86 
110 Hubbard, P. A., Shen, A. L., Paschke, R., Kasper, C. B. and Kim, J. J. P. (2001) 
NADPH-cytochrome P450 oxidoreductase - Structural basis for hydride and electron transfer. 
J Biol Chem. 276, 29163-29170 
111 Gutierrez, A., Paine, M., Wolf, C. R., Scrutton, N. S. and Roberts, G. C. K. (2002) 
Relaxation kinetics of cytochrome P450 reductase: Internal electron transfer is limited by 
conformational change and regulated by coenzyme binding. Biochemistry. 41, 4626-4637 
112 Watkins, D. and Rosenblatt, D. S. (1989) Functional Methionine Synthase Deficiency 
(Cble and Cblg) - Clinical and Biochemical Heterogeneity. Am J Med Genet. 34, 427-434 
113 Leclerc, D., Wilson, A., Dumas, R., Gafuik, C., Song, D., Watkins, D., Heng, H. H. Q., 
Rommens, J. M., Scherer, S. W., Rosenblatt, D. S. and Gravel, R. A. (1998) Cloning and 
mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients 
with homocystinuria. P Natl Acad Sci USA. 95, 3059-3064 
114 Galkin, A. A. G., O. Y., Dubinskii, A. A., Kabdin, N. N., Krymov, V. N., Kurochkin, 
V. I., Lebedev, Y. S., Oransky, L. G., Shuvalov, V. F. (1977) EPR Spectrometer in 2-mm 
Range for Chemical Research. Instrum. Experim. Techn. 20, 1229 
115 Poulos, T. L., Sheriff, S. and Howard, A. J. (1987) Cocrystals of Yeast Cytochrome-C 
Peroxidase and Horse Heart Cytochrome-C. J Biol Chem. 262, 13881-13884 
116 Orville, A. M., Lountos, G. T., Finnegan, S., Gadda, G. and Prabhakar, R. (2009) 
Crystallographic, Spectroscopic, and Computational Analysis of a Flavin C4a-Oxygen 
Adduct in Choline Oxidase. Biochemistry. 48, 720-728 
117 Banerjee, R. V., Frasca, V., Ballou, D. P. and Matthews, R. G. (1990) Participation of 
Cob(I)Alamin in the Reaction Catalyzed by Methionine Synthase from Escherichia-Coli - a 
Steady-State and Rapid Reaction Kinetic-Analysis. Biochemistry. 29, 11101-11109 
118 Wolthers, K. R. and Scrutton, N. S. (2007) Protein interactions in the human 
methionine synthase - Methionine synthase reductase complex and implications for the 
mechanism of enzyme reactivationt. Biochemistry. 46, 6696-6709 
119 Fujii, K., Galivan, J. H. and Huennekens, F. M. (1977) Activation of Methionine 
Synthase - Further Characterization of Flavoprotein System. Arch Biochem Biophys. 178, 
662-670 
120 Jarrett, J. T., Amaratunga, M., Drennan, C. L., Scholten, J. D., Sands, R. H., Ludwig, 
M. L. and Matthews, R. G. (1996) Mutations in the B-12-binding region of methionine 
synthase: How the protein controls methylcobalamin reactivity. Biochemistry. 35, 2464-2475 
121 Drennan, C. L., Huang, S., Drummond, J. T., Matthews, R. G. and Ludwig, M. L. 
(1994) How a Protein Binds B-12 - a 3.0-Angstrom X-Ray Structure of B-12-Binding 
Domains of Methionine Synthase. Science. 266, 1669-1674 
181 
 
122 Evans, J. C., Huddler, D. P., Hilgers, M. T., Romanchuk, G., Matthews, R. G. and 
Ludwig, M. L. (2004) Structures of the N-terminal modules imply large domain motions 
during catalysis by methionine synthase. P Natl Acad Sci USA. 101, 3729-3736 
123 Dixon, M. M., Huang, S., Matthews, R. G. and Ludwig, M. (1996) The structure of 
the C-terminal domain of methionine synthase: Presenting S-adenosylmethionine for 
reductive methylation of B-12. Structure. 4, 1263-1275 
124 Li, Y. N., Gulati, S., Baker, P. J., Brody, L. C., Banerjee, R. and Kruger, W. D. (1996) 
Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol 
Genet. 5, 1851-1858 
125 Olteanu, H., Munson, T. and Banerjee, R. (2002) Differences in the efficiency of 
reductive activation of methionine synthase and exogenous electron acceptors between the 
common polymorphic variants of human methionine synthase reductase. Biochemistry 41, 
13378-13385 
126 Resenblatt. (1995) The Metabolic and Molecular Bases of Inherited Disease, seventh 
edition-3-volume set. Edited by Charles R. Scriver, Arthur L. Beaudet, William S. Sly, and 
David Valle 
127 Fenton, W. A. a. R., D.S. (1995) The Metabolic and Molecular Bases of Inherited 
Disease, seventh edition-3-volume set. Edited by Charles R. Scriver, Arthur L. Beaudet, 
William S. Sly, and David Valle 
128 Leclerc, D., Campeau, E., Goyette, P., Adjalla, C. E., Christensen, B., Ross, M., 
Eydoux, P., Rosenblatt, D. S., Rozen, R. and Gravel, R. A. (1996) Human methionine 
synthase: CDNA cloning and identification of mutations in patients of the cblG 
complementation group of folate/cobalamin disorders. Hum Mol Genet. 5, 1867-1874 
129 Watkins, D. and Rosenblatt, D. S. (1988) Genetic-Heterogeneity among Patients with 
Methylcobalamin Deficiency - Definition of 2 Complementation Groups, Cble and Cblg. J 
Clin Invest. 81, 1690-1694 
130 Steen, C., Rosenblatt, D. S., Scheying, H., Braeuer, H. C. and Kohlschutter, A. (1997) 
Cobalamin E (cblE) disease: A severe neurological disorder with megaloblastic anaemia, 
homocystinuria and low serum methionine. J Inherit Metab Dis. 20, 705-706 
131 Wilson, A., Leclerc, D., Rosenblatt, D. S. and Gravel, R. A. (1999) Molecular basis 
for methionine synthase reductase deficiency in patients belonging to the cbIE 
complementation group of disorders in folate/cobalamin metabolism. Hum Mol Genet. 8, 
2009-2016 
132 Brown, T. A. (1991) The essential techniques in molecular biology. Essent. Mol. Biol. 
1, 1-11 
133 Madl, T., Felli, I. C., Bertini, I. and Sattler, M. (2010) Structural Analysis of Protein 
Interfaces from C-13 Direct-Detected Paramagnetic Relaxation Enhancements. J Am Chem 
Soc. 132, 7285-7287 
182 
 
134 Fand, S. B. and Spencer, R. P. (1964) Off-Peak Absorption Measurements in Feulgen 
Cytophotometry. J Cell Biol. 22, 515-520 
135 Otwinowski, Z. and Minor, W. (1997) Processing of X-ray diffraction data collected 
in oscillation mode. Method Enzymol. 276, 307-326 
136 Murshudov, G. N., Vagin, A. A. and Dodson, E. J. (1997) Refinement of 
macromolecular structures by the maximum-likelihood method. Acta Crystallogr D. 53, 240-
255 
137 Roussel, A. C., C. . (1991) TURBO-FRODO Version 1.1 release B.  
138 Emsley, P. and Cowtan, K. (2004) Coot: model-building tools for molecular graphics. 
Acta Crystallogr D. 60, 2126-2132 
139 Hevel, J. M., White, K. A. and Marletta, M. A. (1991) Purification of the Inducible 
Murine Macrophage Nitric-Oxide Synthase - Identification as a Flavoprotein. J Biol Chem. 
266, 22789-22791 
140 Dixon, M. (1953) The Determination of Enzyme Inhibitor Constants. Biochem J. 55, 
170-171 
141 Dawson, R. M. C. (1986) Data for Biochemical Research. 3rd Ed 
142 Odom, B., Hanneke, D., D'Urso, B. and Gabrielse, G. (2006) New measurement of the 
electron magnetic moment using a one-electron quantum cyclotron. Phys Rev Lett. 97, 30801 
143 Carrington, A., McLachlan, A. D. and Editors. (1967) Introduction To Magnetic 
Resonance; With Applications to Chemistry and Chemical Physics 
144 Steinhoff, H. J. (2002) Methods for study of protein dynamics and protein-protein 
interaction in protein-ubiquitination by electron paramagnetic resonance spectroscopy. Front 
Biosci. 7, C97-C110 
145 Kendrew, J. C., Bodo, G., Dintzis, H. M., Parrish, R. G., Wyckoff, H. and Phillips, D. 
C. (1958) 3-Dimensional Model of the Myoglobin Molecule Obtained by X-Ray Analysis. 
Nature. 181, 662-666 
146 Fletterick, R. J., Bates, D. J. and Steitz, T. A. (1975) Structure of a Yeast Hexokinase 
Monomer and Its Complexes with Substrates at 2.7-a Resolution. P Natl Acad Sci USA. 72, 
38-42 
147 Shefter, E. (1968) Structural Studies on Complexes 2 - Crystal Molecular Structure of 
a 1-1 Caffeine and 5-Chlorosalicyclic Acid Complex. J Pharm Sci. 57, 1163-1168 
148 Rini, J. M., Schulzegahmen, U. and Wilson, I. A. (1992) Structural Evidence for 
Induced Fit as a Mechanism for Antibody-Antigen Recognition. Science. 255, 959-965 
183 
 
149 Bossartwhitaker, P., Chang, C. Y., Novotny, J., Benjamin, D. C. and Sheriff, S. (1995) 
The Crystal-Structure of the Antibody N-10-Staphylococcal Nuclease Complex at 2.9 
Angstrom Resolution. J Mol Biol. 253, 559-575 
150 Coker, S. F., Lloyd, A. J., Mitchell, E., Lewis, G. R., Coker, A. R. and Shoolingin-
Jordan, P. M. (2010) The high-resolution structure of pig heart succinyl-CoA:3-oxoacid 
coenzyme A transferase. Acta Crystallogr D. 66, 797-805 
151 Hall, G. and Emsley, J. (2010) Structure of human thioredoxin exhibits a large 
conformational change. Protein Sci. 19, 1807-1811 
152 Mcpherson, A. (1990) Current Approaches to Macromolecular Crystallization. 
European Journal of Biochemistry. 189, 1-23 
153 Solomon, B. and Levin, Y. (1976) Flavin-protein interaction in bound glucose oxidase. 
Journal of Solid-Phase Biochemistry. 1, 159-171 
154 Buckholz, R. G. and Gleeson, M. A. G. (1991) Yeast Systems for the Commercial 
Production of Heterologous Proteins. Bio-Technol. 9, 1067-1072 
155 Jovin, T. M. A.-J., D.J. (1989) FRET microscopy: digital imaging of fluorescence 
resonance energy transfer Cell Structure and Function by Microspectrofluometry. (eds. 
Kohen, E., Hirschberg, J.G. & Ploem, J.S.)  99–117 
156 Slaughter, B. D., Unruh, J. R., Allen, M. W., Urbauer, R. J. B. and Johnson, C. K. 
(2005) Conformational substates of calmodulin revealed by single-pair fluorescence 
resonance energy transfer: Influence of solution conditions and oxidative modification. 
Biochemistry. 44, 3694-3707 
 
 
